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ABSTRACT 
Cystic fibrosis antigen (CFAg) is a protein which is present in the serum of cystic 
fibrosis (CF) patients and clinically normal heterozygotes, but not in normal individu-
als. CFAg has been shown to be a major granulocyte protein in normals, and the gene 
mapped to chromosome 1. This thesis describes the molecular cloning and subsequent 
characterization of the cDNA for CFAg. 
The availability of monoclonal antibodies to CFAg facilitated the identification of 
myeloid tissues which were actively synthesising the protein. A specific radiolabelled 
protein could be immunoprecipitated from 35S-methionine labelled extracts of chronic 
myeloid leukaemia cells (CML), normal granulocytes and HL-60 cells differentiated 
towards granulocytes. In CML and granulocytes, CFAg appeared to be one of the most 
abundantly synthesised proteins. 
Messenger RNA was isolated from CML cells and a cDNA library of - 70,000 
members was constructed in the vector 2gt10. The cDNA clone for CFAg was 
identified by screening the library with a highly degenerate oligonucleotide probe 
designed using available protein sequence data. 
Verification of the identity of the largest cDNA clone isolated was obtained by 
comparing the amino acid sequence derived from the cDNA with that of the partially 
sequenced protein. The size of the protein from the deduced sequence combined with 
protein sequencing data is 10,938 Kd, which is in approximate agreement with the size 
observed on a reducing gel system. Using the cDNA clone in Northern blot analysis, a 
550bp transcript was observed which was highly abundant in CML and differentiated 
HL-60 cells. Southern blotting of genomic DNA indicates that there is only a single 
gene for CFAg in both human and rodent. The availability of a series of somatic cell 
hybrids containing fragments of human chromosome 1, enabled the assignment of the 
gene for CFAg to the region q12-q22. Comparing the predicted sequence of CFAg 
with protein sequences in the NBRF database, significant similarity was discovered to 
two calcium-binding proteins (S-lOO and intestinal calcium-binding protein) found in 
various mammalian species. These proteins are of unknown function but may be 
involved in signal transduction. Homology was also observed to two sequences as yet 
not present in the database, but from the same family of calcium-binding proteins. 
The CF locus is linked to DNA markers on chromosome 7, and therefore CFAg 
cannot be the product of the aberrant gene. However the function of this novel, granu-
locytic calcium-binding protein must now be pursued to explain its abnormal accumu-
lation in CF serum and point the way to the biochemical pathway affected in CF. 
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This thesis describes the cloning and characterisation of the cDNA for cystic 
fibrosis antigen (CFAg). Cystic fibrosis (CF) is a life threatening disease, the biochemi-
cal basis of which remains unknown. CFAg is present at raised levels in the serum of 
individuals with CF and heterozygotes. Importantly, the amount of CFAg present in 
the serum appears to track the CF gene, i.e. heterozygotes have reduced levels of the 
protein compared to affected individuals. This fact, together with the fact that hetero-
zygotes are clinically unaffected and yet still demonstrate the accumulation of CFAg in 
their serum, indicates that CFAg may be directly concerned with the basic gene defect 
in CF. The cloning of CFAg has revealed that it is a novel calcium-binding protein 
and allows speculation as to its involvement in CF. 
1.1 The genetics of cystic fibrosis. 
Cystic fibrosis is one of the commonest European genetic diseases. It is inhereited 
in an autosomal recessive fashion, i.e on average one in four of the offspring in 
affected families have CF. Romeo (1984) has shown that the number of first cousin 
marriages in Italian "CF parents" closely matches that expected from the hypothesis of 
a single locus disorder, as opposed to a model with mutations at two or more loci. 
Assuming Hardy-Weinberg equilibrium i.e random assortment of the gene in the gene 
pool, then approximately 1 in 23 individuals in Caucasian populations carry the reces-
sive gene. 
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CF heterozygotes (parents of CF children are obligate heterozygotes) are clini-
cally normal and therefore any abnormality that is present consistently in heterozygotes 
and homozygotes, must reflect the basic gene defect and is not a secondary affect of 
the disease. The high frequency of the CF mutation in the population means that pre-
natal diagnosis and heterozygote detection are of prime importance. 
1.2 Prenatal diagnosis. 
1.2.a Microvillar enzymes. 
A prenatal diagnostic assay has been developed based on the observation that 
amniotic fluid supernatants from fetuses affected with CF, contain reduced levels of 
microvillar enzymes (Carbarns et al 1983). The deficiency of the enzymes are probably 
the consequence of abnormal passage of a thickened and viscid meconium from the 
fetal gut into the fluid. There are two main disadvantages of measuring the level of 
microvillar enzymes in amniotic fluid to predict the CF Status of the fetus. The first is 
that the deficiency of these enzymes is due to a physiological abnormality which is 
secondary to the basic gene defect This means that the frequencies of false negative 
and positive prognoses are too high to offer the test except to mothers with a 1 in 4 
risk of recurrence of an affected child (Brock 1984). The second disadvantage is that 
optimally the test is carried out at 18 weeks of gestation after which time a termination 
of pregnancy can be very traumatic for the mother. The advantage of the test is that 
although a previous affected child is required to identify the family as "at risk", the 
test does not require any tissue from that individual. 
1.2.b Restriction Fragment Length Polymorphisms (RFLPs). 
The other method of prenatal diagnosis which can be used to determine whether a 
fetus has CF, uses RFLPs identified by DNA probes linked to the CF locus. Recently a 
number of groups (Wainwright et al 1985; White et al 1985; Knowlton et al 1985) 
have shown that the CF locus is tightly linked to DNA markers on chromosome 7. A 
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variety of DNA polymorphic markers have been characterized which are close enough 
to the CF gene to be used confidently in prenatal diagnosis. The test is based on the 
assumption that there will be no recombination between the CF gene and the closely 
linked DNA probe(s). Consequently, for a certain individual if the CF gene can be 
associated with a particular allele of a tightly linked DNA probe, then it is assumed 
that the association will remain in the next generation. One of the limitations of the 
test is that the prospective parents must be informative for at least one DNA probe, i.e 
it must be possible to distinguish allelic variants for at least one linked probe by res-
triction enzyme digestion of their genomic DNA. A further limitation is that there must 
be DNA available from a previous, affected child. This is so that it can be determined 
which alleles of the linked probe are associated with the maternal and paternal CF 
genes. The fact that CF is a life reducing disease often means that the previous child is 
dead, and so DNA is not available unless some tissue has been stored at the time of 
death. 
The advantages of this method of prenatal diagnosis are that :- 
due to the tight linkage to the CF locus of the DNA probes available, the false pred-
iction frequency is low; 
the fetus DNA sampling can be performed at 9 weeks of gestation using chorionic 
villus sampling which reduces the trauma inflicted on the mother, should a termination 
of pregnancy prove advisable. 
1.3 Heterozygote detection 
Both the prenatal tests described above are only appropriate in families where a 
CF child has already been born. In the microvillar enzyme assay, the previous affected 
child identifies the 1 in 400 couples who on average have a 1 in 4 chance of producing 
a CF child. In the RFLP test, DNA from a previous affected child is intrinsic to the 
assay. Ideally a heterozygote detection system should be designed to identify "at risk" 
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couples before a CF child is born. If this could be achieved the microvillar enzyme 
test could be used on the relevant pregnancies. 
1.3.a Prospects for the cloned gene. 
The gene for CF has not been cloned as yet. However when this happens, it will 
be possible to determine the molecular basis of the CF mutation. If the mutation is 
shown to be identical in every case and not a heterogeneous set of intragenic muta-
tions, then the presence of the mutant gene may be easy to diagnose by DNA analysis. 
This has been shown to be possible for sickle cell anaemia, where the same base 
change in the DNA is always responsible for the disease. Only the normal allele gene 
sequence will form stable duplexes with an oligonucleotide probe (Conner 1983). Thus 
the presence of the mutant allele can be determined for any individual or fetus directly, 
by hybridising the oligonucleotide probe to their DNA. Even if this were possible for 
CF, screening the whole population using DNA analysis to identify heterozygotes 
would be unthinkable even if only considering the expense involved. What is required 
is a reliable, economical and technically simple test which uses a sample of easily 
available tissue or body fluid to distinguish CF heterozygotes. At present, the 
biochemical basis of the CF phenotype is unknown. It maybe that cloning the CF 
gene will immediately enable identification of its product and the biochemical basis of 
CF will be obvious. The techniques of reverse genetics which have been used for clon-
ing the gene for Duchenne muscular dystrophy (Kunkel et al 1985) and are being 
applied to the isolation of the CF gene (Scambler et al 1986), will not necessarily 
identify the gene product at fault in the disease. The putative genes for Duchenne mus-
cular dystrophy (Monaco et al 1986) and for retinoblastoma (Friend et al 1986) have 
been cloned, but as yet no gene product has been identified although linked DNA 
probes to Duchenne muscular dystrophy have been available for the last five years. 
However, identification of the CF gene product surely must improve the possibility of 
designing a simple heterozygote test. Alternatively, it may be possible to design a 
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carrier detection test by examining in detail the physiological phenotype in CF hetero-
zygotes and homozygotes. 
1.3.b Biochemical detection of genetic diseases. 
Two model systems which identify disease-affected individuals and heterozygotes 
are described below. 
Phenylketonuria 
The disease phenylketonuria (PKU), is due to impaired phenylalanine oxidation 
resulting in elevated tissue and serum phenylalanine (Tourain and Sidbury 1983). 
Because phenylalanine hydroxylase is absent and phenylalanine cannot be converted to 
tyrosine, homozygotes have hyperphenylalanemia which leads to neurotransmitter syn-
thesis deficit and brain dysfunction. Neonatal diagnosis is performed by measuring the 
phenylalanine:tyrosine ratio and clinically normal heterozygotes can also be identified 
by this ratio (Paul et al 1978). Heterozygotes have reduced levels of phenylalanine 
hydroxylase, and consequently, raised levels of phenylalanine and reduced levels of 
tyrosine in plasma. However, these deviations from normal levels are not enough to 
affect the heterozygote individual clinically. It should be noted that the diagnosis of 
PKU does not involve measuring the amount of phenylalanine hydroxylase, the gene 
product of the mutant gene. It involves measuring the amount of a substrate and pro-
duct directly affected by fluctuations in the level of the mutant gene product. A final 
point is that the understanding of the basic defect in PKU not only allows diagnosis of - 
the disease, but enables the design of a complete therapy i.e a restricted diet (without 
phenylalanine) avoids hyperphenylalanemia in affected individuals and results in a nor-
mal phenotype. 
I-cell disease 
I-cell disease, is so called because skin fibroblasts, from patients with the disease, 
are filled with innumerable, phase-dense, acid phosphatase-positive inclusions (Neufeld 
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 and McKusick 1983). The disease is caused by the complete or partial deficiency of 
the phosphorylating step of acid hydrolases which is the identifying signal for their 
inclusion into lysosomes. As a consequence, they are secreted instead. Serum levels of 
some acid hydrolases are raised 20 fold in homozygotes, and 2 fold in heterozygotes, 
compared to normals (van Elsen et al 1976). The measurement of serum levels of heat 
stable hexosaminidase, which is not the product of the defective gene, can be used to 
identify I-cell disease heterozygotes from normals (Vidgoff and Buist 1977). 
Clearly, identifying the basis of the CF disease is very important. Abnormalities 
present in heterozygotes merit investigation because they must reflect a defect related 
directly to the CF gene and their use in a heterozygote detection assay must be 
assessed. Before discussing factors present in CF heterozygotes, it is of value to 
examine the overall clinical picture of CF and the probable affected tissues in which to 
look for clues as to which process is perturbed in the disease. 
1.4 The Clinical picture 
Any theory which postulates the aberrant pathway in CF must take into con-
sideration the clinical symptoms associated with the disease and account for them 
somehow. However, it must be acknowledged that some disease symptoms may be 
secondary to the basic disease process. 
Cystic fibrosis is a generalized disease of the exocrine glands. The name is 
derived from the histological changes which are characteristically seen in the pancreas 
of diseased individuals (Talamo et al 1983). These include fibrosis of acini, dilation of 
ductules, plugs within acini and focal acinar calcifications. The main pathology of the 
disease involves the respiratory tract and pulmonary complications invariably arise. 
However autopsy studies of neonatal lung samples (from infants who die as a sequel to 
meconium ileus) show that they are normal at birth (Oppenheimer 1981). Once lung 
involvement sets in, obstruction of the small airways is evident and secondarily to this 
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there is bronchiolitis and mucual plugging of the airways with bronchial changes being 
more apparent than parenchymal ones (Bedrossian et al 1976). The lung epithelium 
shows stratification, metaplasia of squamous cells, and loss of cilia which contributes 
to the retention of secretions. Chronic infection of the respiratory tract is very com-
mon, affecting 80% of CF patients, and bronchitis and airway obstruction eventually 
lead to respiratory or cardiac failure. Later pulmonary infection is mainly due to the 
bacterium Pseudomonas aeruginosa. Chemotherapy remains a problem with longterm 
antibiotic treatment being controversial (Zimarkoff et al 1983). It is not known why 
CF patients are so susceptible to infection by the very unusual mucoid Pseudomonas 
variants and although pulmonary alveolar macrophages are basically normal their 
phagocytic function can be impaired by CF serum (Thomassen et al 1980). 
The upper respiratory tract is also affected secondarily to hyperactive mucus 
secreting glands. Nasal polyps give rise to nasal obstruction in 6-24% of CF patients 
(Schwachman et al 1962). 
The classic fibrosis of the pancreas appears to follow loss of pancreatic enzyme 
activity and in all but a few cases this must be treated with enzyme replacement 
therapy to correct the malabsorption of fats, proteins and carbohydrates (Johansen et al 
1968). The clinical repercussions of malabsorption are: poor weight gain in spite of 
large food intake, lack of muscle tissue and subcutaneous fat, the passage of bulky, 
oily, foul-smelling stools leading to rectal prolapse, and delayed puberty (Chase et al 
1979). An increased fecal bile loss and a decreased bile acid pool is found as is bile 
malabsorption (Fondacaro et al 1980). Malabsorption of the fat soluble vitamins is also 
due to pancreatic insufficiency and reduced levels of vitamins A, D, E, K and B12 are 
common (Talamo et al 1983). 
Carbohydrate intolerance, present in 40% of patients, develops into frank diabetes 
mellitus in 1-2%, although this is generally very mild due to the observed increase in 
the number of insulin receptor sites in peripheral tissues (Lippe et al 1980). 
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A blockage of the gut by meconium (meconium ileus) is present in 7% of 
newborn CF babies and is almost always an indication of the disease (Donnison et al 
1966). It is thought that this is due to loss of pancreatic enzymes preceding morpho-
logical pancreatic damage (Oppenheimer et a! 1973). Transient blockage of the fetal 
intestine appears to be present around 18-19 weeks of gestation in most CF fetuses, 
allowing the resulting reduced levels of intestinal microvillar enymes to be used for 
prenatal diagnosis of CF by amniocentesis (section 1.2.a). 
The liver is also damaged in CF probably due to excessive accumulation of bili-
ary mucus. The number of microvilli on bile canalicular epithelium has been shown to 
be reduced (Dominick et al 1976). However normal liver function is usual, and failure 
rare. 
Infertility is observed in 98% of adult males with CF due to absence or reduction 
of vas deferens (Taussig et al 1972). The testes show active, but decreased spermato-
genesis and neonatal autopsy reveals normal genital tract. CF women however can 
bear children, and infertility is mainly due to excessive extracellular cervical mucus 
(Oppenheimer et al 1970). 
The salivary mucus secreting glands also show ductal dilation and eventual 
fibrosis. A significant rise in Na concentration has been observed in small salivary 
gland saliva (Wiesman et al 1972). 
The commonest clinical finding in CF is elevated sweat concentration of sodium, 
chloride, and potassium ions due to decreased transductal reabsorbtion of sodium and 
chloride (Schultz 1969). Mangos (1973b) showed that in vitro sweat gland ducts had 
defective reabsorption of sodium, but normal water permeability and Quinton et al 
(1983a, 1983b) more recently observed reduced chloride permeability. Diagnosis of CF 
is based on the quantitative pilocarpine iontophoresis sweat test (Gibson et al 1959) 
where localised sweating is stimulated by iontophoresis of pilocarpine into the skin and 
the electrolytic composition of collected sweat is measured. This defect was first 
discovered in i  a New York heatwave in 1948. More recently the level of neonatal fae-
cal proteases has been used as a. diagnosis of CF as they are found to be highly 
reduced. 
1.5. Functional changes in CF cells 
CF appears to be a disease characterized by chronic lung disease, exocrine pan-
creatic insufficiency, and elevated sweat electrolytes (Di Sant' Agnese et al 1976). 
Consequently an examination of the cells closely involved in these functions may pro-
vide an indication of the pathophysiology of the disease. 
Epithelial cells include the cells lining the respiratory and digestive tracts as well 
as the ducts of exocrine glands. In respiratory epithelia (cells which line the nasal 
cavity, trachea, lung, bronchus, and alveoli), it has been shown using electrophysiolog-
ical techniques (Davis and Nadel 1983), that active transport of chloride ions occurs 
towards the airway lumen and sodium ions towards the submucosa. In CF tissue there 
appears to be an increased potential difference across airway epithelium (Knowles et al 
1981). Knowles et al (1981) showed that the nasal tissue excised from subjects with 
CF exhibited higher voltage and lower conductance than control tissue. 
Epithelial cells from normal human and CF nasal polyps were isolated, implanted 
into tracheal grafts, and injected into nude mice by Yankaskas et al (1985). The theory 
being that this technique, followed by analysis of the grafts, would separate secondary 
effects of the disease from primary cellular defects. Knowles et al (1981, 1983a, 
1983b) previously demonstrated abnormalties of airway epithelial ion transport in vivo 
and in vitro. Amiloride induced a greater inhibition of the current generated by CF 
than normal cells. In normal cells amiloride abolishes Na absorption but induces a 
secretion of Cl -. In CF grafts, a diminished capacity to secrete Cl - results in a smaller 
residual current than in normal cells. Normal tissues pretreated with amiloride can be 
stimulated by isoprenaline to secrete Cl - more rapidly and hence increase the short cir-
cuit current. Freshly excised CF tissue does not respond quickly to the 3-adrenergic 
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agonist isoprenaline, and nor do the CF cells which have been through immu-
nosuppressed mice. In these grafted cells the major bioelectric abnormalities of CF 
respiratory epithelia observed by Knowles (1981) are retained. 
Widdicombe et al (1985) used the fact that epithelial cells will grow easily in cul-
ture to establish confluent monolayers. These cells have tight junctions separating 
discrete apical and basolateral cell membranes and appear to retain their electrical pro-
perties (Handler et al 1979). Dog tracheal epithelium grown in culture retains 
differentiated transport function (Coleman et al 1984); active chloride and sodium ion 
secretion as well as absorption can be demonstrated. CF tracheal cells cultured 4 hours 
after the death of a 12 year old CF girl were compared with normal and dog tracheal 
cells. CF cultured cells' short circuit current was unaffected by bumetanide (an inhibi-
tor of chloride secretion), and the responsiveness to isoproterenol and prostaglandin E 2 
was one tenth that of normal cultured epithelial cells. This compounds the mounting 
evidence that chloride ion secretion and its stimulation by secretagogues is defective in 
CF tissue. 
It has been subsequently shown (Knowles 1983a, Knowles 1983b) that 
amiloride-induced chloride secretion occurs only in normal cells and a chloride-free 
cell-bathing solution induces a smaller hyperpolarization in CF tissue than in normal 
tissue (Knowles et al 1983b). This implies that sodium ion absorption occurs across an 
epithelium relatively impermeable to chloride ions. Treatment with indomethacin, a 
chloride ion movement inhibitor, did not alter the potential difference in either control 
or disease groups (Knowles et al 1983a). 
Stutts et al (1985) also cultured cells from CF and non CF individuals. Primary 
cultures of airway epithelial cells from CF and atopic (disease control) polyps and nor-
mal nasal airway epithelium were established and 36C,- uptake was measured. The 
results showed that even in cultures where 88% of the cells had been produced by in 
vitro divisions there was still significantly reduced chloride uptake in the CF cells. 
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The work on chloride reabsorption has recently been clarified by Welsh (Welsh 
1986a, Welsh and Liedtke 1986b) and Frizzell et al (1986). Welsh and Liedtke exam-
ined excised cell free patches of membrane from CF epithelial cells and normals and 
compared their chloride channel conductance. The results indicated that in excised cell 
free patches, chloride channel activity was identical in normal and CF samples. It 
appeared that the chloride channel was not acutely regulated by internal calcium ion 
concentration, indicated by changing the 1mM internal calcium to mM and observing 
no effect on the channel activity. 
When chloride channels were examined in intact cells, only non-CF tracheal 
epithelial cells recorded any activity. The tissue from both CF and non CF was stimu-
lated with -agonists (isoprenaline and adrenaline), 8-bromo-cAMP and/or forskolin 
(an adenylate cyclase activator). Only cells from normal individuals responded to these 
stimuli. However a normal dose-dependent increase in cAMP was observed in both CF 
and normal tracheal epithelium when exposed to -adrenergic stimulation. This 
implies that the defect in chloride channel regulation is at a point distal to cAIVIP accu-
mulation and probably not in the actual channel protein itself. 
Frizzell et al (1986) have essentially equivalent findings; although using the same 
patch clamp technique on primary cell cultures of airway epithelial cells, they find two 
different channel conductance levels. In excised patches both these channels exhibited 
identical chloride activity in normal and CF cells. However using cell attached assays 
once again no chloride channel activity was observed in the cells from CF airways 
even when stimulated with adrenaline, dibutryl cyclic AMP or forskolin (adenylate 
cyclase activator). The excised CF and normal patches had chloride channel activity 
which was inhibited by the addition of EGTA (a calcium chelator) to the bath. A free 
calcium ion concentration of 180 mM was required by inside out patches to activate 
the chloride channel activity. The calcium ionophore A23187 could stimulate chloride 
channel activity in cell attached CF cells, when added to a bath containing 1mM C2, 
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in an equivalent manner to epinephrine or dibutryl cAMP stimulation in normal cells. 
The calcium activation of the chloride channel is not seen in the study by Welsh and 
Liedtke and may be due to differences in tissue culture technique (Case 1986). 
Frizzell believes that the calcium signal that he observes does not involve phos-
phorylation as the inside Out excised CF patches which demonstrated chloride channel 
activity when stimulated with calcium did not require adenosine 5' triphosphate in the 
medium. 
Epithelial cells from the digestive tract are difficult to obtain, but buccal cells 
have been used. Mangos and Boyd (1984) report that CF patient buccal epithelium cell 
cytosol contains three times as much ionized free calcium as control cells (Mangos 
1983). 
Epithelial cells of the CF pancreatic duct are generally completely destroyed. A 
more accessible and more fully characterized gland is the sweat gland. This consists of 
a proximal secretory coil followed by an intermediate coiled duct segment and then a 
straight portion opening into the epidermis. Although there have been no morphologi-
cal alterations observed in CF sweat glands (Spicer et a! 1982), but based on the 
observation that sweat of CF patients contains increased levels of sodium and chloride, 
and on results that showed sodium reabsorbtion was defective (Mangos et al 1973a 
1973b), Quinton (1983a) examined microdissected sweat glands from skin biopsies and 
examined their function. 
Quinton (1983b) microdissected the reabsorptive duct from the secretory coil of 
sweat glands from skin biopsies from CF and normal patients. One end of the reab-
soptive duct was cannulated with a micropipette which also served as a microelectrode 
in the lumen of the duct. During periods of perfusion when there were identical con-
centrations of NaCl in the bath and lumen, the average spontaneous potential across 
normal ducts was -6.8mV compared with -76.9mV in CF patients. Quinton performed 
a series of experiments on the CF and normal sweat duct which enabled him to 
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conclude that the chloride permeability of CF ducts was an order of magnitude lower 
than that of control ducts. 
Sato and Sato (1984) also examined the secretory coils from normal and control 
subjects. They found a normal level of sweat secretion in both coil types. Sato (1983) 
had shown that in monkey palm eccrine sweat glands, maximal sweat rate was highest 
after cholinergic agonist stimulation (methacholine, acetylcholine, piocarpine), reduced 
with -athenergic agonist (isoprotenol) and least of all with the a -adrenergic agonist 
phenylepbrine. Removal of calcium ions from the medium abolished the sweat secre-
tion induced by a-adrenergic or cholinergic agonists. Only the beta-agonists increased 
cAMP induction and this was not reduced by removal of calcium ions from the exter-
nal medium. Isoproterenol, theophylline, and dibutryl cAIMIP all induced eccrine sweat 
secretion and Sato concluded that cAlvlP was the beta-adrenergic second messenger for 
sweat secretion from these glands. 0-adrenergic stimulation of sweat secretion did not 
require external calcium, but this does not necessarily exclude the involvement of cal-
cium released from internal stores. 
Single sweat glands were isolated from skin biopsy specimens from normal and 
CF volunteers. Samples were either from the secretory coil or the end of the proximal 
tubule. CF sweat glands responded very poorly to either epinephrine or isoproterenol 
compared to normal sweat glands, although their response to methacholine was as avid 
as normals. The CF sweat glands accumulated tissue cAMP in response to isopro-
terenol alone or to the combination of isoprotenerol and theophylline or methacholine 
in a manner similar to the normal controls. The 3-adrenergic response in normal 
sweat glands was not perturbed by the absence of calcium in the bathing medium. 
These results indicate that 3-adrenergic stimulation of CF sweat glands is faulty and 
the defect is at some point distal to the adenylate cyclase step in the cAIMP cascade. 
In 1985 Heinz-Brian et al discovered that patients with CF were found to have a 
marked deficiency of vasoactive peptide (VIP) immunoactive nerves in both acini and 
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ducts of sweat glands in chest region skin biopsies. VIP promotes blood flow and 
movement of water and Cl- across epithelial surfaces and stimulates HCO 3 - secretion 
by pancreatic acini. It is an attractive hypothesis that deficient VIP innervation may be 
responsible for the relative impermeability of epithelium to Cl_. The localisation of 
VIP immunoreactive nerves was determined using an anti-VIP antiserum. It was found 
that normal skin showed a rich network of VIP-immunoreactive nerves around secre-
tory acini and a moderate innervation of the ducts. Individual VIP-positive nerve fibres 
were closely associated with the basement membrane of both acinar and duct cells. 
VIP innervation in CF samples was less pronounced in both cell types and absent 
around the ducts in 5 of 7 samples and minimal in the remaining 2. It is not known 
whether the depletion is a progressive symptom of CF or if it is present from birth and 
possibly a primary defect. 
The secretory cells of exocrine glands are also of epithelial origin but have 
differentiated into complex structures. Mangos et al (1981) compared isolated CF paro-
tid acinar cells with control cells and studied a variety of functional activities. CF cells 
had decreased potassium efflux in response to cholinergic receptor stimulation; reduced 
intracellular cGMP response to cholinergic receptor stimulation; reduced Ca 2 uptake 
by cells and reduced efflux of 22Na+  across cell membranes. Intracellular cGMP 
response was increased upon -adrënergic stimulation as was the secretion of amylase. 
The response of cellular ATP and oxygen consumption was unchanged relative to nor-
mal cells when stimulated with cholinergic agonists. McPherson et al (1985,1984) 
report a decreased stimulation of CF submandibular glands by 13-adrenergic agonists 
resulting in a lack of mucin and amylase secretion. However a normal level of cAMP 
increase was observed when the agonist was applied. 
Owing to the relative ease with which skin fibroblasts can be cultured, many stu-
dies have been carried out on this type of CF cell (Talamo et al 1983). The most 
interesting findings are that (Ansah et al 1980) CF skin fibroblasts have reduced mem- 
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brane Mg2 /Ca2 -ATPase activity, which may indicate a defect in the handling of cal-
cium ions which would have far reaching functional implications. There is consider -
able evidence for altered calcium homeostasis in CF cells (Case 1984). Ca 2+  concen-
tration is increased in CF salivary secretions (Martinez 1982), isolated CF parotid 
glands (Mangos and Donnelly 1981) and cultured CF fibroblasts but there is decreased 
45 C2+  efflux from preloaded cells (Shapiro et al 1982). 
CF fibroblast mitochondria have increased accumulation of calcium ions (Shapiro 
et al 1982). The Ca 2+  concentration goes up in normal fibroblasts when exposed to 
cultured medium from CF fibroblasts (Ceder et al 1983). 
These physiological studies, indicate that the basic defect in CF lies in the control 
of chloride channel activity. However, there are no candidate proteins at present. It 
seems reasonable to assume that abnormalities associated with CF that are also 
observed in clinically normal heterozygotes must be relevant to the basic defect. 
1.6 "Factors" associated with the CF genotype 
Pursuing the identification of "factors" present in CF individuals, and more impor-
tantly clinically normal obligate heterozygotes, has been tempting as an indication of 
the basic gene defect and for the possibility of their use in a heterozygote detection 
system. Unfortunately research in this area has been dogged by findings that cannot be 
reproduced in other laboratories and promising carrier detection systems which fail in 
blind trials. 
Breslow et al (1978) showed that cultured fibroblasts from patients with CF accu-
mulate less Na+  in the presence of ouabain than do normal cells. There was a 
significant difference between CF homozygotes or heterozygotes and normals, but 
heterozygotes and CFs had a considerable degree of overlap. This was subsequently 
shown not to be reproducible (Breslow et al 1981). 
Another effect employing cultured fibroblasts was demonstrated by Shapiro et al 
(1982a). They found that when mitochondrial NADH dehydrogenase activity was 
measured, the pH optimum was related to genotype. CF patients gave optimal activity 
at pH 8.6, heterozygotes at pH 8.3 and normals at pH 8.0. Further, the Michaelis con-
stant of the enzyme for NADH was also different for the three genotypes. This test 
appears to be limited to cultured fibroblasts and although the ability to distinguish the 
three classes is exciting, the results seem to be disappointingly not reproducible in 
other laboratories (Sanguinetti-Briceno and Brock 1982). 
Lieberman et al (1981) using S-300 gel filtration, isolated from serum an 1gM 
bound lectin cofactor. 95% of obligate heterozygotes had high lectin titres, controls 
had low titres and CF patients had elevated titres equal to, and exceeding, those of 
heterozygotes. Lectin cofactor was only found in the urine of CF individuals. However 
involvement of a lectin-like factor or an 1gM bound cofactor in CF has not been deter-
mined and the test has not been reproduced in other laboratories as yet. 
In a recent study, the erythrocyte superoxide dismutase and catalase activities in 
cells from CF sufferers and their parents were found to be significantly higher than in 
cells from age and sex matched controls, while the peroxidation of lipids was reduced 
(Markovics et al 1982). 
Reduced f-adrenergic responses in lymphocytes and granulocytes of patients with 
CF and heterozygotes have been demonstrated by Davies et al (1983), although the 
absolute number of receptors is unaltered between CF and normal leucocytes. 
Another system has been reported by Hosli and Vogt (1979) where gentle heat 
inactivation of plasma a-mannosidase and acid phosphatase allows differentiation of 
normals from both CF heterozygotes and patients. They reported that these two 
enzymes retained full activity (80-100%) in normals, (40-60%) in heterozygotes and 
lost all activity in homozygotes. There was no overlap between groups. The research-
ers claimed to have demonstrated that the genetic defect in CF affects the intracellular 
digestive system in a way that leads to a multiple leakage of hydrolytic enzymes into 
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the extracellular fluid and an accompanying partial deficiency of corresponding hydro-
lases. However the test has proved completely unreproducible in several cases (Patrick 
et al 1979, Harris et al 1979, Huitberget al 1981). Sack et al (1980) could only repeat 
the results in Hosli's laboratory. Ceder et al (1983a) repeated the results with a-
mannosidase and acid phosphatase from plasma as well as from the medium from cul-
tured fibroblasts. The non-reproducibility of the test outside the Pasteur Institute is 
puzzling. Ceder hypothesises that it may be due to the distilled water used at the 
Pasteur which is produced by pyrolysis and may contain a "factor" essential for the 
success of the test. A blind trial undertaken by the group at the Pasteur Institute 
(Katznelson et al 1983) correctly genotyped a whole set of 45 Israeli plasma samples. 
This remains an intriguing phenomenon and cannot be discounted in its relevance to 
CF. 
The thickened mucus in CF was thought to be due to abnormal ciliary function. 
Sera from CF homozygotes and heterozygotes have been reported to contain one or 
more substances that inhibit the motility of rabbit tracheal cilia in tissue culture (Spock 
et al 1967). It has also been discovered that sera from CF genotypes will inhibit ciliary 
action in gills from freshwater oysters (Bowman et al 1969) or gills of freshwater 
mussels (Adshead et al 1975). Mouse sperm motility was also inhibited by sera from 
CF homozygotes and heterozygotes (Pivetta et al 1979). Fleming and Sturgess(1981) 
demonstrated that rat submandibular glands secrete more glycoprotein when submerged 
with CF sera and CF heterozygote sera than with normal sera. Conod et a! (1977) 
found that the factor which caused ciliary dyskinesis in rabbit trachea was bound to 
IgG and had a molecular weight of 1 to 10 Kd. Wilson and Fundenberg (1977) 
described a factor similar to diary dyskinesis factor in the serum of asthmatic 
patients, and this was found to be C3a or a fragment thereof (Wilson and Fundenberg 
1977b). The calcium ionophore A23187 causes diary dyskinesis and mucus secretion 
similar to CF sera when tested in the rabbit system (Bogart at a! 1977). Bogart et a! 
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(1979) showed that CF sera or CF IgG increase uptake of C2 in rabbit tracheal 
explants relative to control sera or IgG. Three ciliary dyskinesis factors are secreted by 
CF lymphocytes and only one is specific for CF and T lymphocytes secrete this one 
(Wilson and Bahm 1980). 
The oyster ciliary dyskinesis factor is nondialysable, heat labile, cationic and 
associated with IgG (Bowman et al 1973). It has also been detected in the media of 
fibroblasts from CF heterozygotes and patients (Bowman et al 1977). However, neither 
rabbit tracheal nor oyster gill assay systems could reliably identify the CF genotype of 
samples in a blind trial (Wood et al 1973,). 
1.7 Cystic Fibrosis antigen (CFAg) 
The factor associated with CF which can be most consistently demonstrated is the 
so called CFAg. Wilson et (1975) described a unique protein doublet at p1 8.4 when 
carefully collected serum samples were exposed to isoelectric focussing in the presence 
of urea. The doublet band, designated CF protein, was demonstrated in both CF 
patients and their parents (Wilson et al 1978). Other laboratories have also found this 
banding pattern on isoelectric focussing gels pH 2.5 - 10, in the pH8-9 range (Tully et 
al 1979, Jamieson et al 1984, Super et al 1984, Brock et al 1982, Scholey et al 1978, 
Nevin et al 1981). The bands are rarely seen in normals, and those that are positive 
could be undiagnosed carriers. 
In an attempt to look specifically at CF protein (renamed CFAg), Manson and 
Brock (1980), excised portions of the acrylaniide gel with the doublet band between p1 
values 8.2 and 8.5. The homogenized gel was then injected into guinea pigs. The 
absorption of the resulting crude antiserum with sera from individuals devoid of CFAg, 
produced a monospecific antiserum. The antiserum was then included in a rocket elec-
trophoresis system with the serum from CF, heterozygotes, and normals. The pattern 
produced is shown below. 
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CF/CF CF/+ 	 +1+ 
The observed pattern of expression with high levels in homozygotes, reduced lev-
els in heterozygotes and very low levels in normals is a classic pattern for a single 
gene defect. The implication is that the antigen may be the product of the defective 
gene or involved in the same metabolic pathway. Immunoprecipitation and immunora-
diometric assay (Bullock et al 1982) enabled the correct assignment of genotype on 
94% of cases. However the collection of blood appears to very important for the suc-
cess of this test. Blood must be collected into plain glass tubes and clotted overnight 
at 4°C. Sera collected into EDTA or lithium heparin tubes produce high levels of 
CFAg but give poor rockets. In the expectation of improving the characterization of 
CFAg by immunopurification, tissue localization, and accurate quantification, mono-
clonal antibodies were raised against CFAg. Repeated attempts to purify this antigen 
from serum by conventional fractionation techniques using guinea pig antiserum to fol-
low purification, were unsuccessful. However identification of granulocytes as the tis-
sue source of CFAg in normals (van Heyningen et al 1985) enabled the raising of 
monoclonal antibodies to this serum protein (Hayward et a! 1986). The specificity of 
the monoclonal antibodies was established by their ability to remove CFAg, as 
detected by the antiserum, from CF serum. The monoclonal antibodies which were 
produced, defined at least two epitope regions on CFAg. This allowed a two site 
(sandwich) enzyme linked immunosorbent assay (ELISA) to be designed. The 
sandwich assay presents a sensitive reproducible quantitation of CFAg in serum and on 
this basis it is confirmed that there is a significant difference in CFAg between nor-
mals, CF heterozygotes and CF patients (Hayward et al 1987), although there is 
- 20 - 
considerable overlap between the genotypes. 
The fact that CFAg is a granulocyte protein, and CF patients are not healthy indi-
viduals due to secondary infections, raises the point that increased levels of CFAg in 
the serum may be due to increased levels of granulocytes and therefore unrelated to 
the basic defect. Hayward et al (1987) have examined the serum levels of another 
granulocyte protein (lactoferrin), and an acute phase reactant (C-reactive protein) in 
CF, heterozygotes, normals and disease controls. The data show that CFAg levels are 
raised significantly in CF and heterozygotes, but lactoferrin and C-reactive protein are 
only significantly raised in the CF homozygotes and disease controls. This suggests 
that the elevated CFAg levels observed in heterozygotes are due primarily to a CF 
gene specific component. The raised level of CFAg in diseased controls is probably 
due to increased numbers of granulocytes as there is a concomitant increase in lac-
toferrin and C-reactive protein. In CF homozygotes the elevated CFAg levels may be 
ascribed to the compound effects of the presence of the CF gene and disease. 
The tissue distribution of CFAg has been examined using the antiserum available. 
van Heyningen et al (1985) showed that peripheral leukocytes from chronic myeloid 
leukemia (CML) patients proved consistently to be strongly positive for CFAg and 
antigen from normal granulocytes was immunologically identical as demonstrated by 
Ouchterlony double diffusion. An exhaustive immunohistochemical tissue search, 
using the monoclonal antibodies raised against CFAg, has resulted in CFAg only being 
detected in polymorphonuclear granulocytes in blood or where these cells enter other 
tissues. The only exception has been squamous epithelial cells in tongue and oeso-
phagus (M. Wilkinson personal communication). Both of these cell types are non-
keratinised stratified epithelia. Exocrine tissue (apparently affected in CF) from nor-
mals were carefully studied and lung, pancreas, intestine and skin sweat glands from 
normals were all negative for CFAg. Adult CF tissues were not available, but CF fetal 
pancreas and lung samples were negative. The abnormal tissues were found to be 
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positive for CFAg by Wilkinson (personal communication) with the monoclonals from 
both epitopal groups. Squamous cell carcinoma of the skin and lung stained strongly in 
inimunohistochemistry and so did the squamous epithelial cells from eczema and 
psoriasis. 
van Heyningen et a! (1985) also demonstrated, using a series of somatic cell 
hybrids, that CFAg expression was concordant with the presence of chromosome 1. 
This was done by fusing mouse myeloid stem cells (WEHT-TG) with CML cells and 
subcloning repeatedly for chromosome stability. Cell lysates were tested in Ouchter-
lony double diffusion analysis with antisera raised against the excised isoelectric 
focussing band, and also antisera raised against CML lysate partially purified material. 
The two antisera showed complete immunological identity against various antigen 
sources in this system. 
Surveying the literature, there does not appear to be a granulocyte protein with 
the same properties as CFAg previously described, even though CFAg appears to be so 
abundant in polymorphonuclear granulocytes. 
A large number of physiological and biochemical changes have been described to 
take place in CF. One of the most appealing observations as far as direct relevance to 
aetiology is concerned, is the elevation of serum levels of CFAg in CF homozygotes 
and heterozygotes. I set out to clone the gene for this protein when it was still a can-
didate product of the CF gene. The CFAg gene had been assigned to chromosome 1 
by somatic cell genetics, so that when the segregation of CF with chromosome 7 
markers put the CF gene on that chromosome, it was clear that CFAg is not the pro-
duct of the CF gene. 
Nevertheless the identity and function of CFAg remained of interest. The main 
justification for this research was that CFAg could be detected immunologically in 
sera, and the amount of CFAg which accumulated appeared to reflect the CF genotype 
of the individuals. Thus it could be postulated that although CFAg was not coded for 
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by the defective gene in CF, it may be affected directly by it or at least be involved in 
the aberrant pathway in CF. Hence characterization of the function of CFAg might elu-
cidate the biochemical basis of CF. 
A further aspect of CFAg research was the possibility that immunological quanti-
tation of serum levels could be used in a heterozygote detection assay. The fact that 
antiserum was available and that serum was an accessible fluid made this an attractive 
possibility. Monoclonal antibodies raised against CFAg allowed purification and 
refinement of the heterozygote detection assay. However the test still contained spuri-
ous results although in general samples could be divided into three genotypes. It was 
felt that characterization of CFAg (which had only been identified immunologically) 
might help to improve the heterozygote test. 
In this thesis I present the strategy used to clone the cDNA for CFAg. The 
sequence of the successfully cloned cDNA is given. The gene is sublocalized to a 
region on chromosome 1 and the abundance of mRNA in various tissues is examined. 
The predicted amino acid sequence is compared to other protein sequences in a com-
puter database and its homology to calcium-binding proteins is discussed in relation to 
CF. 
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CHAPTER 2 
MATERIALS AND METHODS 




All cells were grown in RPMI 1640 medium (Gibco) with oxalocetate (1mM); 
pyruvate (0.45mM); porcine insulin (Novo) 0.2 International Units /ml; 0.03% glutam-
in 3-(N-morpholino)propanesulphonic acid (MOPS) buffer 0.0125M plus 5% foetal 




HL-60, uninduced, were grown in RPMI 1640 without serum but with insulin, 
sodium selenite, and transferrin, (ITS) (Sigma), and used according to the manufactur-
ers instructions. Cells to be induced were grown in standard RPMI 1640 medium with 
the inducer present at the relevant concentration. 
SECTION 2.3 
Nitroblue retrazolium (NBT) reduction assay 
In order to test for differentiation, HL-60 cells were spun down and washed in 
phospate buffered saline (PBS). iø cells were resuspended in 0.5m1 PBS containing 
1mg/mi NBT (Sigma) and l.tg/ml PMA (phorbol myrisate acetate) (Sigma) and incu- 
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bated for 20 minutes at 37 °C. The cells were then examined under the microscope, and 
the percentage of blue (differentiated) cells was determined. 
SECTION 2.4 
Isolation of polymorphonuclear cells from whole blood 
Polymorphonuclear cells were isolated from lOmi normal blood after collecting 
the sample into lithium heparin tubes. Plasma was removed after spinning the sample 
for 10 minutes at 1000 rpm in a Sorvall RT6000 centrifuge. The original volume of 
the sample was reconstituted with standard medium containing heparin (Evans Medical 
Ltd) at 10 units/mi. In order to remove the red blood cells, the cell suspension was 
mixed 1:3 (volume/volume), with 6% dextran 250 (Sigma) in 0.15M NaCl solution, 
and incubated at 37°C for 30 minutes. The straw coloured top layer was then removed 
and the remaining sample discarded. The polymorphonuclear cells were separated from 
the mononuclear cells by loading the suspension onto a cushion of lymphoprep 
(Gibco). The gradient was then spun at 2,000 rpm for 20 minutes. The mononuclear 
cells moved to the interface, and the granulocytes travelled with the remaining red 
blood cells to the bottom of the tube. Isolated cells were washed in PBS and counted 
in a haemocytometer by diluting 1 volume of cell suspension into 9 volumes of a solu-
tion of crystal violet in 2% acetic acid. lOmi of normal blood yielded - 10 polymor -
phonuclear cells. 
Granulocytes were isolated from CML blood samples by allowing the blood col-
lected into lithium heparin to settle. The buffy coat which formed was rich in granulo-
cytes, and having removed this from the top of the blood sample, no more purification 
was necessary. 
SECTION 2.5 
Preparation of cell lysates 
Cell pellets were lysed by the addition of lOOj.tl phosphate buffered saline (PBS) 
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containing lOM phenylmethylsuiphonyl fluoride (Sigma) (a potent serine protease 
inhibitor) to 107 cells and subjecting them to 3 cycles of freezing and thawing. The 
cell lysate was then spun in a microfuge centrifuge for 5 minutes and the supernatant 
(lysate) was removed to a fresh tube. 
SECTION 2.6 
Ouchterlony double diffusion 
lOjtl samples for Ouchterlony analysis (Ouchterlony 1967) were placed in wells 
formed in 1.5% noble agar (Difco) / 0.9% NaCl and allowed to diffuse overnight at 
room temperature in a moist, level chamber. The gel was poured into plastic plates and 
six peripheral and one central well were cut in the gel an equidistance apart. The gels 
were washed in 0.05% Tween 20 in 0.9% NaCl. The gels were then dried down onto 
a hydrophilic surface (Gelbond FMC Corporation) by covering the gel on the gelbond 
with Whatmans filter paper #1, paper towels and a glass plate and leaving at room 
temperature overnight. Gels were stained for protein in 0.25% Coomassie blue (Bio 
Rad) in methanol water : acetic acid 5 : 5 : 1 for 30 minutes and destained in the 
same solution without Coomassie blue until the bands became clear. 
SECTION 2.7 
Internal Cell labelling 
Cells to be labelled were spun down and counted. 108  cells were resuspended in 
approximately Sml of FlO nutrient mixture (Gibco) without valine, methionine, lysine, 
isoleucine or L-glutamine. The missing amino acids were supplemented to a final con-
centration of 0.03% w/v except those for which radiolabelled analogues were to be 
used. The cells were incubated for 1 hour at 37 0C in the medium to reduce the intra-
cellular pool of the unlabelled amino acid of choice. Cells were resuspended in imi of 
the same medium with 25OpCi of the radio-labelled methionine (800 Cilmmole, 
Amersham) added together with 1% volume/volume dialysed FCS, and incubated at 
370C for 4 hours. In the case of HL-60 cells, the uninduced cells were incubated 
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without FCS and ITS supplement was used instead. Induced cells were labelled in the 
continuous presence of the inducer (10 6M retinoic acid). After the 4 hour incubation, 
the cells were washed three times with PBS and iysed in 10041 PBS/10 7 cells by 
repeated freeze/thawing. The percentage of incorporation of radiolabel into protein was 
measured by trichloroacetic acid (TCA) precipitation on glass fibre filters and scintilla-
tion counting in Aquasol (Amersham) (section 2.15). 
SECTION 2.8 
Immunoprecipitations 
Labelled cell lysates ( lx 106  cpm) were incubated with 50j.tl monoclonal anti-
body culture supernatant for 1 hour followed by incubation with donkey anti-mouse 
antibody coupled to cellulose beads (Sac-cell; Wellcome Reagents Limited) for 1 hour. 
The cellulose-coupled antibodies were then spun down and washed with 0.05% Tween 
20 in PBS, three times. The final wash contained 1% f3-mercaptoethanol. The precipi-
tate was resuspended in 30j.tJ SDS PAGE (polyacrylamide gel electrophoresis) sample 
buffer (section 2.9) and boiled for 5 minutes, then analysed by SDS PAGE. 
SECTION 2.9 
SDS polyacrylamide gel electrophoresis 
CHEMICALS 
acrylamide, bisacrylamide, ammonium persulphate, N N' tetramethylethylenediamine 
(TEMED), glycine, Coomassie blue and molecular weight standards were obtained 
from Biorad Laboratories, Tris from Sigma Chemicals. 
STOCK SOLUTIONS 
30% acrylamide (30% acrylamide with 1% bisacrylamide) in distilled water. 
Separating gel buffer: 1.5 M Tris pH 8.8, 0.5% SDS) 
Stacking gel buffer: 0.5M Tris pH 6.8, 0.5% SDS) 
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lOx Electrode buffer: 0.5M Tris, 0.5M glycine, 10% SDS) 
Sample Buffer: 10% stacking gel buffer, 2% SDS, 5% -mercaptoethanol, 10% gly-
cerol, 0.005% bromophenol blue. 
PROCEDURE 
The glass plates were washed thoroughly and wiped with ethanol. 1.5mm spacers 
were sandwiched between two glass plates with LKB clamps and then placed on the 
gel casting apparatus. The acrylamide solutions were made up as follows- 
15% acrylaniide gel solution consisted of 18.5 ml 30% acrylamide stock solution, 
9.25ml of separating gel buffer, 7.3m1 of distilled water, 200j.d freshly prepared 10% 
ammonium persuiphate, 20p.l TEMIED. After the addition of the TEMIED and 
ammonium persuiphate, the gel was quickly poured between the plates to about 5cm 
below the wells. The gel was overlaid with isobutanol saturated water and allowed to 
set. After about 1 hour, the isobutanol and any unpolymerised acrylamide was washed 
away, a comb inserted and the stacking gel poured. The stacking gel consisted of 
1.5m1 of 30% acrylamide stock plus 2.5m1 of stacking gel buffer, 5.7m1 distilled water, 
30il 10% ammonium persuiphate and 10.tl TEMED. The gel was left for 30 minutes 
to set and then the comb was removed and the wells thoroughly washed out with elec-
trophoresis buffer. At least one litre of electrophoresis buffer was added to the lower 
tank and 1 litre to the upper reservoir. 
Samples were prepared by addition of up to 30.tl of sample buffer and boiling for 
5 minutes. Gels were run at 15mA overnight to ensure the blue dye only just ran off 
the bottom of the gel. The gel was then removed from the apparatus and soaked in 
destain (methanol : water : acetic acid, 5 : 5 : 1) solution for 30 minutes to fix the pro-
teins in the gel. The gel was then soaked for half an hour in Amplify (Amersham) to 
enhance the signal. The gel was then placed on dampened filter paper and dried down 
on a gel drier (Bio Rad) following the manufacturer's instructions. 
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SECTION 2.10 
Autoradiography 
Gels to be autoradiographed were placed on filter paper and preflashed kodak 
XAR-5 X-ray film or Fuji X-ray film was placed over the gel. Fuji film gave clearer 
results -but the Kodak film was more sensitive. Nitrocellulose blots to be autora-
diographed were covered with clingfilm and prefiashed Kodak X-ray film was routinely 
used. Both gels and blots were then placed in lead autoradiograph cassettes with 
intensifing screens and put at -70 0C for various periods of time. 
- 29 - 
SECTION 2.11 
Vectors 
The following vectors were used in the experiments contained within the work 
described by this thesis. 
Restriction endonuclease maps of 1. Xgtll 	 2. XgtlO (Huynh et al 1985). 
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Restriction Endonuclease map of pUC 9 (Vieira and Messing 1982) and M13mp8 
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SECTION 2.12 
Bacterial strains 
E.coli C600 = E.coli hsdR- hsdtv!+ sup E thr leu thi lacYl tonA21. 
E.coli C600 lift = E.coli C600 hflAlSO(chr:.TnlO). 
E.coli Y1088 (ATCC no 37195) = E.coli ^lacU169 supF supE hsdR- hsdM+ metB trpR 
tonA21 proC::TnS (pMC9). pMC9 =pBR322 lac# 
E.coli Y1090 (ATCC no 37197) = E.coli ^lacU169 proA+ ^1on araD139 strA 
supF(trpC22 :.TnlO) (pMC9). 
E.coli JIM 83 = E.coli JIM 83 ara, '1acpro, str A, thi, o80d, lac Z M15. 
E.coli =E.coli JIM 101 iacpro, thi, supE, F'traD36, proAB, M15. 
SECTION 2.13 
Media and buffers for bacterial and phage culture 
The E.coli bacterial strains C600, C600 lift, Y1090 and Y1088 were all grown on LB 
(Luria-Bertani) agar plates or in LB medium. E.coli C600 hfl was grown in medium 
containing tetracycline (Sigma) (12.5p.g/ml). E.coli Y1090 and Y1088 were grown in 
medium containing 50j.tg/ml ampicillin (Sigma) to maintain the plasmid pMC9. 
LB Medium: per litre (pH 7.5): 
10 g bacto-tryptone (Difco) 
5 g bacto-yeast extract (Difco) 
10 g NaCl 
LB agar: LB medium plus 1.5% agar (Difco). 
LB top agar: LB medium plus 0.7% agarose (Sigma). 
2x TY medium: per litre 
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16g Bacto tiyptone 
lOg yeast extract 
59 NaC1 
H plates: per litre 
lOg Bacto tryptone 
89 NaCl 
12g agar 
H top agar: as for H agar, but with 0.7% agarose instead of agar. 




ig NH 4C1 
The pH was adjusted to 7.4, autoclaved and then the following reagents were added: 
2 ml of 1 M MgSO4; 10 ml of 20% glucose; 0.1 ml of 1 M CaC1 2. 
Glucose/minimal medium plates: 
15 g minimal agar (Difco) in 1 litre M9 medium plus 10 mM thiamine Cl. 
Cells selected for pUC9 plasmid transformation, were grown on H plates containing 
50j.tg/ml ampicillin. For indication of function of the lac Z gene in pUC plasmids, 
0.02% X-gal (5-bromo-4-chloro-3-indolyl--D-galactoside (2% in dimethylformamide 
stock solution)) was included in the agar media. For Xgtl1 and M13 both 1mM IP1'G 
(isopropyl-j3-D-thiogalactopyranoside) and 0.02% X-gal were included in the top 
agarose medium. 
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SECTION 2.14 
RNA extraction 
This was successfully carried out using the method of Chirgwin et al (1979) 
with some modifications. For extraction of RNA from cell lines, the cells were har-
vested and then washed in sterile phosphate buffered saline and pelleted in an Eppen-
dorf microfuge. In the case of tissue (leukophoresis material), the cells were spun at 
2000 rpm in a Sorvail RT6000 for 10 minutes . 4m1 of 8M GHC1 (8M Guanidine 
Hydrochloride 0.01M EDTA 0.05M Tris pH 7.5 ) per 108  cells was added to the cell 
pellets and either homogenised in a tight ball homogeniser, or else as in the case of 
tissue, a motor driven homogeniser was used for 30 seconds at the highest speed set-
ting. The cells were then spun to remove debris (8,000 rpm for 10 minutes in an Sor-
vail superspeed RC 2-B) Half a volume of cold ethanol was then added to the superna-
tant, this was mixed and incubated at -200C for 45 minutes. The RNA was then pre-
cipitated by centrifugation at 10,000 rpm for 15 minutes. The pellet was then taken up 
in 6M GHC1 (6M Guanidine Hydrochloride 0.01M EDTA 0.05M Tris ), homogenised, 
a half volume cold ethanol added, and the mixture incubated at -20 °C for 45 minutes. 
The centrifugation step was then repeated and the pellet taken up in 6M GHC1 as 
before. After spinning the precipitate down, the pellet was taken up in an appropriate 
volume of DEPC water (0.1% Diethylpyrocarbonate in double distilled water), homo-
genised and a half volume of filter sterile 7.5M ammonium acetate was added followed 
by two volumes of ethanol. This was then incubated at -70°C for 45 minutes or at 
-200C overnight. The pellet was then collected by centrifugation as before, 
resuspended in DEPC water plus a one tenth volume of 2M sodium acetate pH 5.5 and 
2.5 volumes of ethanol, and incubated at -70 for 45 minutes. This precipitation step 
was repeated and the amount of RNA determined by reading the optical density at 260 
nanometers. At this wavelength, an absorbance of 1 is equivalent to an RNA concen-
tration of 40 gg of RNA/ml. 
-- 
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SECTION 2.15 
Isolation of poly (A) RNA 
This was carried out according to the method of Aviv and Leder (1972). Essen-
tially, total RNA was dissolved in DEPC water and heated to 65 0C for 5 minutes. An 
equal amount of 2x loading buffer (20mM Tris.Cl pH7.6; 0.5M NaCl; 1mM EDTA; 
0.1% SDS) was then added to the RNA and applied to a imi oligo(dT)-cellulose 
column previously equilibrated with loading buffer and washed in turn with 3 column-
volumes of a) sterile 1120;  b) 0. 1M NaOH and 5mM EDTA; c) sterile 1120.  The 
column was checked to ensure that the effluent pH was less than 8, and was exten-
sively washed with 5 volumes of loading buffer. After the RNA was loaded onto the 
column, the flow through was reheated to 650C and reloaded. The column was washed 
with 5 volumes of loading buffer and then with loading buffer containing 0.1M NaCl. 
The poly (A) RNA was then eluted with 3 column volumes of elution buffer (10mM 
Tns.Cl pH 7.5; 1mM EDTA; 0.05% SDS ) and collected in 500.tl fractions. Each frac-
tion was checked for RNA by reading the OD at 260nm. The positive fractions were 
then pooled and the RNA precipitated with 03M sodium acetate (pH 5.2) and 2.2 
volumes of ethanol. 
SECTION 2.16 
Gel electrophoresis of RNA 
RNA was electrophoresed through formaldehyde denaturing gels (Maniatis et al 
1982). 1.5% agarose; 10 mM NaPO4 pH 6.5; 18% formaldehyde (from a 37% formalin 
solution, Fisher Scientific Ltd) in lOOmi distilled water were run as horizontal subma-
rine gels at 25 volts overnight. Samples were loaded in 3 volumes of l.Sx sample 
buffer (10mM NaPO4 ; 18% formaldehyde; 50% formaniide) and heated to 50°C for 
10-15 minutes. The samples were then loaded in loading buffer (lOx loading buffer is 
10% bromophenol blue, 50%glycerol; 5mM EDTA; 0.4% xylene cyanol). If the RNA 
was not going to be transferred to nitrocellulose, the gel was stained in 0.5 J.Lg/ml 
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ethidium bromide to visualise the 28s and 18s ribosomal RNAs. 
SECTION 2.17 
Northern blot analysis 
After overnight electrophoresis the formaldehyde/agarose gel described above was 
soaked for 10 minutes in lOx SSC (1.5M NaCl; 0.15M sodium citrate) and laid 
inverted onto the transfer apparatus (Maniatis et al 1982). The nitrocellulose paper was 
soaked in water before being laid onto the gel, followed by one piece of Whatman 
filter paper number 17 soaked in water, and then one piece of dry filter paper and fol-
lowed by paper towels. The RNA was then left to transfer overnight. The transfer 
buffer was lOx SSC. The nitrocellulose filter was then removed from the apparatus 
and baked at 800C in a vacuum oven for 2 hours. The filter was then prehybridised in 
a solution of 10% dextran sulphate, 2x Denhardts (lOOx Denhardts = 2% 
(weight/volume) polyvinylpyrrolidone; 2% bovine serum albumin (BSA); 2% Ficoll 
400; in distilled water), 6xSSC, 0.1% SDS, 0.1% sodium pyrophosphate and 150j.tg 
denatured salmon sperm for at least 1 hour at 68 0C. The probe to be hybridised was 
then radiolabelled by nick translation (see section 2.4) and the boiled probe added to 
the hybridisation mix. Hybridisation was carried out at 68 °C overnight. Filters were 




Double stranded DNA probes were labelled by nick translation (Rigby et al 
1977). Typical reaction mix contained lOOng of DNA in a total volume of 20pi. This 
mix contained: 2tl lOx translation buffer (500mM Tris.Cl pH 7.5, 50mM MgSO41  
0.1M 13-mercaptoethanol, 10mg/mi BSA, and ljfl each of 0.1mM dATP, dCTP,dGTP 
(Sigma), lOj.tCi of dTTP 800Ci/mmol (Amersham), 11.11  of DNase I (BRL) (0. lj.Lg/ml 
freshly diluted from a 1mg/mi stock) and 1-3 units of E.coli DNA polymerase 1 
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(Boehringer Mannheim). The reaction was incubated at 16 °C for a maximum of 2 
hours. 
The percentage incorperation of added labelled nucleotides into the DNA was 
estimated using trichioroacetic acid (TCA) precipitation (Furlong 1967). Briefly 0.5j.tl 
aliquots from the reactions were spotted onto glass fibre filters (Whatman GF/A) and 
the number of disintegrations per minute (dpm) recorded in a scintallation counter. The 
filter was then washed with 10% TCA and the dpm recounted. Normally the 
labelled probes were prepared with specific activity of greater than 108  dpm/.tg. The 
reaction was stopped by the addition of 20mM EDTA and the free counts were 
separated from the incorporated nucleotide over a Sephadex C-50 (Pharmacia) column. 
5 ml of a suspension containing 30g/250m1 Sephadex C-SO in column buffer (lOx 
column buffer = 3M NaCl; UM sodium acetate 0.5% SDS), was poured into a 
disposable 5m1 plastic pipette, plugged with glass wool. The DNA was loaded onto the 
column in 100.tl lOx column buffer and the progress of the DNA down the column 
was monitored with a geiger counter. As the separation of DNA from the unincor -
porated labelled nucleotides by gel filtration is on the basis of size, the larger labelled 
DNA molecules emerged from the column in the first peak. The DNA probe was then 
boiled for 5 minutes to separate the strands and put into the hybridisation bag. 
SECTION 2.19 
Random priming of DNA 
When using small DNA molecules (- 300bp), as probes, random priming (Fein-
berg and Vogeistein 1983) is a more efficient method of radiolabelling the DNA. 
Briefly, mixed sequence hexadeoxynucleotides are hybridised to the DNA, and DNA 
synthesis is primed from them. A typical lOjfl reaction, contained lOOng of DNA (pre-
boiled for 3 minutes and then on ice for 3 minutes), 2j.il lOx nick translation buffer 
(see section 2.18), 1.tl each 50mM dATP, dCTP, dGTP, 25p.Ci dTTP (800 CiJmMol), 
and 2-3 units DNA polymerase I large fragment (Boehringer Mannheim). The reaction 
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was then incubated for 1 hour (or overnight) at 37 °C in a lead pot. The reaction was 
then treated as for a nick translated piece of DNA (section 2.18). 
SECTION 2.20 
In vitro translation of mRNA 
The translation of CML polyadenylated mRNA, was carried out using the rabbit 
reticulocyte lysate system (N90) supplied by Amersham. The lysate was stored in 
liquid nitrogen and when used, it was removed and thawed quickly. A reaction mix 
was made up of 40.tl of reticulocyte lysate, 7p.l L- 35 S-methionine (Amersham code 
SJ.204, 400 CiImMol) and 3fl (0.5p.g) poly(A) CML RNA. The mix was then left 
at 300C and 1tl samples were withdrawn at 5 minute intervals over a 2 hour period. 
These aliquots were placed into 0.5m1 of 1M sodium hydroxide/hydrogen peroxide and 
placed at 37°C for 10 minutes to hydrolyse the aminoacyl-tRNA complexes. The tubes 
were then removed to an ice bath and 2ml of ice cold 25% trichioroacetic acid solution 
containing casein hydrolysate was added. After 30 minutes the tube contents were 
filtered through Whatmann glass fibre discs and these were then washed with 8% TCA 
solution to remove unreacted, radiolabelled amino acid. The discs were then counted in 
scintillation fluid (Amersham) in a scintillation counter. The experiment was then 
repeated with an incubation time of 45 minutes as this was the time at which the maxi-
mal number of precipitable counts was recorded. The lysate was divided into 3 ali-
quots and each sample was immunoprecipitated with a different McAb (section 2.8). 
SECTION 2.21 
cDNA library construction 	- 
In constructing a cDNA library, the production of the first strand of cDNA from 
the RNA template is considered the most important and critical step. The pH of the 
reaction must be 8.3, and deviation of even 0.5 of a unit will reduce the number of full 
length transcripts. Potassium monovalent ions are considered give higher transcrip-
tional efficiency than sodium-ions (Maniatis et al 1982). Retzel et al (1980) showed 
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that a high concentration of dNTPs is important for maximal production of cDNA. 
The optimal concentration of reverse transcriptase enzyme over template has been 
shown to be at 50-fold molar excess of enzyme (Freidman and Rosbash 1977), but this 
necessitates the use of highly purified reverse transcriptase and RNase inhibitors. 
SECTION 2.21.1 
First strand 
A 200p.l reaction mixture was made by adding the reagents in the order listed 
here. DEPC treated water and 10.tg of polyadenylated RNA was added initially then 
40 xl mix I (0.25M Tris.Cl pH8, 15mM MgC12, 1mM d(A,G,C)TP, 0.3mM dTTP), 5p.l 
oligo(dT) at 100pg/m1 (Collaborative Research), 4tl 1.5M KC1, 50 gCi (a- 32P) d1TP 
( 800Ci/mmol), 10.tl 100mM DTT (Boehringer Mannheim) and 60 units RNAsin 
(Biotech). The reaction was put at 42 °C for 10 minutes and then 200 units reverse 
transcriptase XL (NBL Enzymes) was added. The reaction was allowed to proceed for 
30 minutes and was terminated by the addition of EDTA to a final concentration of 
20mM. The reaction was then extracted twice with an equal volume of ultra pure 
phenol (BRL) saturated with TE (10mM Tris (pH 8.0); 1mM EDTA) followed by an 
ether extraction to remove the phenol. The cDNA was then precipitated twice with 
0.2M sodium acetate and 2.2 volumes absolute alcohol at -70 °C for 15-30 minutes. 
SECTION 2.2 1.2 
Second strand 
The precipitated first strand cDNA was taken up in 50pJ of DEPC water, and 5.il 
was retained for analysis. The remaining cDNA was made up to a reaction volume of 
200p.l with DEPC water and 40tl of a mix of 500p.M each d(A,T,C,G)TPs , lOp.l 
0.15mM -NAD, 20.tl lOx single strand buffer (200mM Tris pH7.5, 50mM MgC1 2, 
1M KC1, 100mM NaOAc 500p.g/ml BSA), 10 units E.coli DNA ligase (NBL), 3 units 
RNase H (Boebringer Mannheim) and 45 units DNA polymerase I (New England 
Biolabs). The reaction was then incubated at 12 0C for 1 hour followed by another hour 
incubation at 220C. The reaction was terminated by the addition of 1/10 volume 
200mM EDTA and after 2 phenol extractions, the cDNA was precipitated with 0.2M 
sodium acetate and 2.5 volumes of ethanol. 
SECTION 2.2 1.3 
Si nuclease digestion 
The cDNA was resuspended in 50Jtl of DEPC water and 5p.l were retained for 
analysis. SRl  of lOx Si buffer (1mM ZnC12, 250mM NaCl, 30mM sodium acetate 
pH5.5) was added to the reaction and 100 units of Si nuclease (Boebringer-
Mannheim). The reaction was allowed to proceed for 20 minutes at 37 0C. The cDNA 
was then extracted twice with phenol, once with chloroform and finally with ether. The 
eDNA was then precipitated twice with 0.2M sodium acetate and 2.5x volume of 
ethanol. 
SECTION 2.2 1.4 
Methylarion 
The precipitated cDNA was resuspended in a volume of 45fl, and 5.tl were 
retained for analysis. This sample and the samples from the first and second strand 
synthesis were run on a 1.5% agarose gel to compare the size of the eDNA after each 
step. 4x174 digested with Hae III was run as a size marker, and the position of the 
virus fragments marked on the gel with a scalpel blade. The gel was then dried down 
onto Whatman number 3 filter paper on a BioRad gel drier and autoradiographed (sec-
tion 2.10). 
The methylation reaction proceeded by the addition of 5d of methylase buffer 
(100mM NaCl, 100mM Tris-Ci (pH 8.0), 1mM EDTA,) and 5p1 S-adenosylmethiornne 
(100 p.M (Sigma)) and 40units of E.coli methylase (New England Biolabs) and was 
incubated for 20 minutes at 37°C. The enzyme was then inactivated by heat treatment 
at 70 °C for 10 minutes. 
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SECTION 2.21.5 
Filling In 
2.t1 of 300mM MgC12, 6p1 d(A,C,G,T)1'P (500.iM), liii  DEPC water and 1il (10 
units) DNA Polymerase I large fragment (Kienow fragment) were added to the inac-
tivated methylase reaction and was allowed to proceed for 1 hour at room temperature. 
SECTION 2.21.6 
Addition of linkers 
The cDNA was precipitated twice with 0.2M sodium acetate pH5.5 and 2.5 
volumes of ethanol, and was then passed over a 200j.tl DE52 column (Pharmacia). The 
DE52 was equilibriated with 10mM Tris.Cl (pH 7.6), 1mM EDTA, 60mM NaCl. A 
slurry of the equiibriated DE52 (0.6m.l will bind 20 .tg DNA) was packed into a imi 
syringe containing a glass wool plug. The column was washed with TB (pH 7.6) con-
taining 0.6M NaCl, followed by 3m1 TB alone and finally 3ml 0.1M NaCl in TB. The 
cDNA was loaded onto the column in TB and the fiowthrough was collected and reap-
plied to the column. The column was then washed twice with 1.5m1 of TB containing 
0.3M NaCl and the cDNA was eluted with three 0.5ml washes of TB containing 0.6M 
NaCl. The fractions containing radioactivity were pooled, phenol extracted, chloroform 
extracted, and finally ether extracted. The cDNA was then recovered by precipitation 
with ethanol and lOp.g of yeast tRNA was used to promote precipitation. 
In order to follow the addition of the Eco Ri linkers to the cDNA the linkers 
were end-labelled (section 2.22). 
The cDNA pellet was then taken up in 20jfl of DBPC water and 5jfl of the cDNA 
solution was added to 5p1 of radiolabelled linker mix and 2i.i.l  lOx ligase buffer 
(500mM Tris-Ci (pH 7.8), 100mM MgC12, 200mM DTT, 10mM ATP, 500j.Lg/ml 
BSA), 100 units T4 DNA polynucleotide ligase (New England Biolabs). DBPC water 
was then added to a final volume of 20pJ and the reaction was incubated at 16 0C over- 
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night. 
In order to test whether the ligation reaction had been successful, the cDNA and 
linkers were run on a 1.5% agarose gel which was then dried down, and autora-
diographed. 
SECTION 2.2 1.7 
Generation of Eco Ri cohesive ends, and separation of excess linkers from cDNA 
The ligation reaction was stopped by heat inactivation and the volume of reaction 
was increased to 50.tl with DEPC water and 2p.l. of lOx Eco RI digestion buffer 
(500mM NaCl, 100mM Trs.Cl (pH 7.5), 100mM MgC12, 10mM DTI). 10 units of 
Eco Ri was added to the reaction and incubated for 1 hour at 37 0C followed by a 
further addition of 10 units of Eco Ri and a further 45 minute incubation at 37°C. 
The excess of linkers were separated from the cDNA by running the Eco Ri cut 
sample on a 1.8% agarose gel. x174 cut with Hae III was used as marker DNA. 
When the gel had been run and stained with ethidium bromide, the cDNA over 300bp 
was excised from the gel and put into dialysis tubing containing 2m1 of 0.5x electro-
phoresis buffer (TBE) (0.5x ME = 0.044 M Tris-borate; 0.044 M boric acid; 0.001 M 
EDTA), (Maniatis et al 1982). The sealed tubing was then laid across an electric field 
of 125v in 0.5x TBE for 1.5 hours. During this time the DNA is electroeluted from the 
gel onto the wall of the dialysis tubing. The field was then reversed for 2 minutes to 
release the DNA from the wall of the tubing. The tubing was then opened and the 
buffer into which the DNA had been eluted was collected, and the bag washed out 
with a small volume of 0.5x TBE. The cDNA was then made 0.2M with NaCl and 
passed through a primed Elutip-d mini-column (Schleicher and Schull) which binds up 
to lOOp.g of DNA of 50bp to 50,000bp in length. The column was then rinsed with 
low salt buffer (0.2M NaCl, 20mM Tris.Cl (pH 7.5), 1mM EDTA). The bound cDNA 
was eluted from the Elutip-d mini-column by passing 400j.tl of high salt buffer (1M 
NaCl, 20mM Tris.Cl (pH 7.5), 1mM EDTA) through the column and collecting the 
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elutant in a 1.5m1 Eppendorf tube. The cDNA was then recovered by the addition of 
two volumes of ethanol and incubation at -70 0C, spun down in a a microfuge, and the 
DNA pellet resuspended in an appropriate volume of TE buffer. 
SECTION 2.2 1.8 
Ligation of cDNA to lambda gtlO 
The cDNA isolated from the agarose gel was resuspended in a small volume, for 
ligation to the lambda vector. For efficient ligation, equimolar amounts of insert DNA 
to vector DNA should be present in the ligation. As it was not clear how much cDNA 
was remaining, half the remaining cDNA was included in the ligation. The reaction 
was in a volume of 5j.tl and contained lp.g lambda gtlO DNA (NBL), 0.5p.l lOx liga-
tion buffer (0.5M Tris pH7.4, 0.1M MgC129  0.2M DDT, 10 mM spermidine, 10 mM 
ATP, 500 pJml BSA), 100 units of T4 ligase (New England Biolabs) and was incubated 
at 120C overnight. To check the efficiency of selection for recombinant phage, a con-
trol ligation without any cDNA was also prepared. After overnight incubation, the 
phage was packaged using Gigapack (NBL) packaging mixture and packaging was car-
ried out according to the manufacturers instructions. The packaged DNA was then 
plated out on 4 large (20x2Ocm) plastic plates. 
SECTION 2.22 
End labelling of DNA 
lOp.g Eco Ri linkers were diluted in lOp.l lOx PNK buffer (0.7M Tris.Cl (pH 
7.6), 0.1M MgCl2, 50mM DTT), lOOj.tCi P-cx ATP (8000Ci/mMol), 10 units T 4 
polynucleotide kinase (PNK) (New England Biolabs) and DEPC water to a volume of 
lOOp.l. The enzyme catalyses the transfer of the y phosphate of ATP to a 5' OH ter-
minus in DNA or RNA (Richardson 1971). The labelling was allowed to proceed for 
30 minutes at 370C for and then lOjfl 10mM ATP (neutralized) and 6 units polynu-
cleotide kinase were added to the labelled linker mix and incubated at 37 0C for a 
further 30 minutes. End labelling of oligonucleotides was carried out essentially in the 
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same way except that 5 pmole of oligonucleotide 5' ends was used in a lOj.tl reaction 
volume with 30Ci P-a ATP, lOjil PNK buffer and 10 units T 4 PNK. 
SECTION 2.23 
Plating and screening a lambda gtlO library 
The A.gtlO phage were plated out on a lawn of the permissive host E.coli C600, 
and the non permissive host E.coli C600 hfl. 
The following procedure was followed. An overnight culture of cells was grown 
up by innoculating LB broth /0.2% maltose with a single colony from a plate. Follow-
ing incubation at 370C overnight the cells were pelleted and resuspended in 1/2 the 
original culture volume of 10 mM MgSO4. The cells were stored at 40C until required 
for use. Cells up to 3 days old were routinely used. 
The phage were then added at a suitable concentration to a 0.1ml aliquot of 
E.coli, if using 90mm petri dishes, and imi if using 200mm square petri dishes to 
plate out the phage. A suitable screening density is 5,000 - 10,000 pfu on 200mm 
square plates and 500-1000 pfu on 90mm petri dishes. After allowing the phage to 
adsorb for 15 minutes, 4m1 of soft top agarose was added to the tube and poured onto 
an LB agar plate. The phage were then grown on inverted plates at 37 °C overnight. 
In order to screen the phage with a radiolabelled DNA probe, the procedure of 
Benton and Davis (1977) was used. Basically, plates were placed in the fridge for 1 
hour and then overlaid with a sheet of nitrocellulose. The filter was laid onto the agar 
in such a way so as to avoid trapping any air bubbles. The filter position was marked 
on the plate by piercing the filter and agar with a needle filled with waterproof ink. 
The first filter remained on the agar for 30 seconds and subsequent lifts were left on an 
additional 30 seconds to the preceding filter time. The filter was then peeled from the 
plate and laid (plaque side up) in a shallow dish of denaturing solution (0.5 M NaOH, 
1.5 M NaCl) for 30 seconds. The filter was then transferred for 5 minutes to a second 
dish containing neutralising solution (0.5 M Tris-Ci; pH 8.0, 1.5M NaCl). The filter 
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was then finally rinsed in 2x SSC (0.3M NaCl; 0.03 M sodium citrate) and then dried, 
and baked at 800C for 2 hours. Filters prepared in this way were then hybridised with 
the appropriate probe under the same conditions as for Northern blots (section 2.14), 
and washed in 2xSSC, 0.1% SDS, 0.1% Na2112P207). When the library was screened 
with oligonucleotides, the probes were endlabelled (section 2.22), hybridised at 37 0C 
overnight in 6x SSC, 2x Denhardts, 0.1% SDS, 0.1% sodium pyrophosphate, and 
washed at 31 0C or 370C, in 2x SSC, 0.1% SDS, 0.1% sodium pyrophosphate, with a 
final wash at 360C or 42°C. The hybridisation and washing temperatures, depended on 
the oligonucleotide size and base composition (section 6.1.b). Filters were then autora-
diographed, and any positive plaques were lined up to the plate and the plaques 
picked. The plaque was isolated from the agar with a toothpick and put into imi of 
SM buffer (50 mM Tris-Ci (pH 7.5); 100 mM NaCl; 10 mM MgSO4 ; 2% gelatin). The 
phage were then plated out again, and rescreened. These phage should be enriched for 
positive phage and the process was repeated until all the plaques were positive, i.e a 
pure population of clonal phage was obtained. Phage were stored at 4 0C over chloro-
form. 
SECTION 2.24 
Preparing phage DNA 
Phage DNA was prepared by, producing a large scale plate lysate on a 200mm 
square LB agar plate. Bacteria were infected so that there was a confluent lawn of 
phage, and then following the method of Helm et a! (1985), 25ml of SM buffer (50 
mM Tris-Cl (pH 7.5); 100 mM NaCl; 10 mM MgSO4 ; 2% gelatin) was put onto the 
plate and left shaking in the cold room overnight. The next day the phage had 
diffused into the buffer and the buffer was removed from the plate. Any agarose in the 
buffer was removed by spinning at 2,000 rpm in a Sorvall RT6000 centrifuge for 10 
minutes. The phage were then pelleted from the supernatant by spinning at 35,000rpm 
for 90 minutes in a MSE Prepspin 63, for 90 minutes. Phage were resuspended in imi 
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phage buffer (10 mM Tris-CL (pH8.0); 2 mM MgC1 2) overnight at 40C, and then spun 
10 seconds in an microfuge centrifuge. The supernatant was then loaded onto a 2m1 
DEAE-cellulose column. The column run-through was discarded and the column was 
washed with 5m1 of chase buffer (10mM Tris-Ci (pH8.0); 10 mM magnesium acetate; 
60 mM sodium acetate). lml of elution buffer (10 mM Tris-Ci (pH8.0); 50 MM mag-
nesium acetate) was then loaded onto the column and discarded. 0.6m1 of of elution 
buffer was then loaded onto the column and the run-through was collected into a 1.5m1 
Eppendorf tube. 
To the tube containing the 0.6m1 of phage, lOj.tl of 0.1mg/mi proteinase K and 
24j.i.l of 10% SDS were added, and left at room temperature for 5 minutes. Then 100fl 
of 3 M potassium acetate was added and a precipitate formed. The tube was then 
heated to 88 0C for 20 minutes and the precipitate disappeared. After cooling to 0 °C 
for 5 minutes the precipitate reformed. The tube was then spun at - 12,000 x g for 15 
minutes and the supernatant transferred to a fresh tube with 20p.l of 1 mg/ml mussel 
glycogen being added to help precipitate the phage DNA. 700i.tl of isopropanol was 
then added and the sample was cooled to -20 °C for 30 minutes, then precipitated by 
spinning at 12,000 x g for 20 minutes. The pellet was then washed in 100% ethanol 
and respun, dried and resuspended in 25-40x1 of TB (pH8.0). 
SECTION 2.25 
Cloning into ?gt11 
The cDNA for cloning into ?gt1 1 was prepared as described in section 2.21. The 
cDNA was ligated into alkaline phosphatase treated ?.gt1 1 arms (NBL) overnight at 
120C. The phage were then packaged with Gigapak (NBL) according to the manufac-
turers instructions. The phage were then plated out as with AgtlO but the bacterial 
strain used was Y1088 which are hsdR- hsdM+; this means that unmodified phage will 
not be restricted and will be modified to grow in hsdR+ bacteria. The Y1088 also 
carry a lac repressor which will repress the production of the recombinant 3- 
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galactosidase protein and so avoid creating a bias against poorly growing phage during 
library amplification. Packaged phage are plated out as for A.gtlO (section 2.23) using 
E.coli Y1088. The percentage of recombinant phage was determined by including 40pJ 
of 40mg/mi Xgal and 40tl of 1M IPTG in the top agarose for a 90mm petri dish. 
Bacteria infected with Xgtl 1 are grown at 42 0C because the phage has a temperature 
sensitive repressor (C1857) which is active at 370C but inactive at 42°C. 
SECTION 2.26 
Screening 7gt11 libraries with antibody probes. 
Screening the A.gtl 1 liver library (Clontech) with antibody probes, was carried out 
in the following manner. The phage were plated out on a lawn of E.coli Y1090 which 
contains lac repressor, Ion protease deficiency and supF to suppress the phage mutation 
which causes defective lysis (S100). After the plaques had grown (by growing at 42 0C 
for 3 hours), the plates were put at 37 °C and overlaid with dry nitrocellulose filters, 
previously saturated with 10 mM IPTG. The filters were left on the plates for 2-3 
hours, their positions marked, and then removed. The filters were rinsed briefly in TBS 
(Tris-Ci pH 8.0; 150 mM NaCl) and then incubated overnight in TBS ± 3% bovine 
serum albumin (BSA) (Sigma). The filters were then incubated for 1 hour in TBS plus 
antiserum at a suitable dilution. Using a test system with purified albumin (Sigma) it 
was determined that a dilution of 11500 Dako rabbit anti-human albumin antiserum 
would detect >lng of albumin. It was also checked that the anti human albumin 
antiserum did not cross react with the BSA. After antibody incubation, the filters were 
washed in TBS 0.05% Tween 20 for 30 minutes and then 15 minutes in TBS plus 3% 
BSA followed by 15 minutes in TBS. The filters were then incubated in TBS contain-
ing 1251-protein A (106  cpml 82 mm filter, specific activity 30 mCilmg (Amersham)) 
for 1 hour at room temperature. The filters were then washed extensively in TBS plus 
0.05% Tween 20 with 4 or 5 changes of wash. The filters were then dried and autora-
diographed. In order to check that any positive clones were albumin clones, replica 
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This was carried out as follows. The library to be screened was plated out as pre-
viously described (section 2.23) and screened with first strand cDNA made to ljtg of 
poly adenylated RNA as described in section 2.21.1. Randomly primed cDNA was 
made by the method of Arrand (1986). Filters were hybridised and washed in the same 
conditions as for Northern and Southern blots (sections 2.17 and 2.37). Screening with 
the albumin probe was carried out as described in section 2.23. 
SECTION 2.28 
Restriction endonuclease digestion 
Restriction enzymes were obtained from Boehringer Mannheim or New England 
Biolabs or NBL enzymes and used in high salt, low salt or medium salt (Maniatis et a! 
(1982)) according to the manufacturers instructions. 
High salt buffer 
100 mM NaCl; 50 mM Tris (pH7.5); 10 mM MgC12; 1mM dithiothreitol. 
Mid salt buffer 
50 mM NaCl; 10 mM Tris (pH7.5); 10 mM MgC12; 1mM dithiothreitol 
Low salt buffer 
10 mM Tris (pH 7.5) 10 mM MgC12; 1 mM dithiothreitol. 
Plasmid DNA was generally digested at a concentration of - 50j.tg /ml in buffer con-
taining 3 to 10 fold enzyme units per j.tg of DNA, for several hours at the optimimum 
temperature for the enzyme. Digestion of genomic DNA was carried out at a concen-
tration of 100-200p.g DNA /ml in buffer containing 3 units of enzyme/ p..g DNA, over-
night at the optimum temperature for the enzyme. 
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SECTION 2.29 
Agarose gel electrophoresis 
DNA digestion and size were analysed by agarose gel electrophoresis. Small 
amounts of DNA (> 1.tg ) were analysed on 3mm thick 15 ml gels in tris-borate 
buffer (TBE) buffer (0.089M Tris; 0.089M boric acid; 0.002M EDTA (pH8.0)). 
Genomic DNA restriction enzyme digestion was checked by running a 1.Lg sample on 
a 3mm thick 100 ml agarose gel, buffered with iris-acetate buffer (TAE) (0.04M Tris-
acetate; 0.002M EDTA (pH 8.0). Analysis of genomic DNA by Southern blotting was 
performed by initially running 10ig of digested DNA on a 3mm thick 300m.1 TAE 
buffered 0.8% agarose gel. DNA was loaded onto gels in "STOP mix" (30% Ficoll 
(Pharmacia Fine Chemicals); 0.25% Orange G; 0.5M EDTA and lOx electrophoresis 
buffer). The Ficoll increases the sample density and the Orange G enables the sample 
to be easily visualised and acts as a marker close to the front of the migrating DNA. 
After electrophoresis, gels were stained in electrophoresis buffer containing 1 drop of 
10 mg/ml ethidium bromide for 15 minutes. The gels were then destained for 15 
minutes in double distilled water. Ethidium bromide intercalates with DNA and its 
fluorescent properties allowed the DNA to be visualised when illuminated with UV 
light. 
SECTION 2.30 
Ligation of DNA fragments 
Ligations were carried out in the following conditions :- linearised vector DNA 
(2-5J.Lg/ml), insert DNA at 3-5 fold molar excess, 1/10th volume of ligation buffer (lOx 
ligation buffer = 0.5M Tris pH 7.5; 0.1M MgCl2), 1mM dithiothreitol, 1mM r-ATP, T4 
DNA ligase and sterile water to the required volume. Reactions were carried out at 
120C overnight in as small a volume as possible ( 10.tl). 
SECTION 2.31 
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Transformation of bacterial cells 
The E.coli K12 strain JIM 83 was used for growing all plasmids. Competent cells 
were prepared as described by Maniatis et al (1982). Essentially, lOOmI of LB medium 
was innoculated with imi of an overnight bacterial culture. The cells were then grown 
at 370C with vigorous shaking to a 0.5 0D550. The culture was then chilled on ice for 
10 minutes and centrifuged at 4000 x g for 5 minutes at 40C. After discarding the 
supernatant the cells were resuspended in half the original culture volume of 50mM 
CaC12. The cells were then left on ice for 20 minutes and recenthfuged. The resulting 
pellet was resuspended in 1/10 of the original volume of an ice cold, sterile solution of 
50mM CaCl2 and kept at 4°C for up to 48 hours. 300pi of cells were used in each 
transformation, and plasmid DNA was added in lOOp.l at a concentration of 1tg/ml. 
The tubes were kept on ice for at least 40 minutes and then heat shocked for 90 
seconds at 420C. The transformation mix was then made up to imi with LB broth and 
incubated for 1 hour at 37 °C to allow expression of the plasmid encoded antibiotic 
resistance genes before growth on selective medium. Normally 50 to 200p1 of the 
incubated mix was plated directly onto H-agar plates containing the appropriate antibi-
otics using a bent, sterile glass rod to distribute the mix. In the case of pUC 9, indi-
cation of insert DNA was the presence of white colonies when plated on X-gal plates. 
The bacterial strain E.coli JIM 101 was used for M13 transformations. The cells 
carry a plasmid which codes for the production of the pilus which is necessary for the 
M13 infection. This plasmid also codes for the, proline gene while the bacterial DNA 
is deleted for the proline gene. Thus stock plates are glucose/minimal medium so only 
E.coli with the plasmid can grow. 0D 550  of - 0.4. At this time, 20m1 of 2xTY was 
innoculated with a drop of the culture and allowed to grow. The bacteria with an OD 
of 0.4 were pelleted and resuspended in 1/2 volume of 50mM calcium chloride and 
left on ice for 20 minutes. The cells were then repelleted and resuspended in a volume 
1/10th that of the original volume (2m1). The transformations were carried out by the 
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addition of the M13 DNA to 0.3m1 of cells and left on ice for 40 minutes. The cells 
were then heat shocked as for the JM 83 cells but after the heat exposure 200j.tl of 
fresh cells were added and 40j.tl of 2% X-gal and 40.tl of 100mM IPTG. The cells 
were then plated in 4m1 of soft agarose on a 90mm LB agar plate. 
SECTION 2.32 
Small scale plasmid preparation 
Small scale preparation of plasmid DNA was used to analyse large numbers of 
single colony bacteria to ensure they contained the correct plasmid before continuing 
with a large scale preparation. The technique used (a modification of Maniatis et al 
1982) is as follows. 5m1 of LB broth containing ampicillin at 50.tg/m1 was innoculated 
with a single bacterial colony. The culture was then grown overnight at 37 0C with 
vigorous agitation. 1.5m1 of the culture was then poured into a 1.5 ml Eppendorf tube 
and the bacterial cells were pelleted. The pellet was then resuspended in 200.tl of 
TELT (50 mM Tris-Ci (pH7.5); 62.5 mM EDTA; 2.5 M LiC1; 0.4% Triton X100) plus 
1 mg/nil freshly added lysozyme, and boiled for 1 minute. The sample was then placed 
on ice for 8 minutes, spun at 12,000 x g for 15 minutes and the supernatant removed 
to a tube containing 0.6 volumes of isopropanol. After incubation on ice for 10 
minutes, the tube was spun again for 15 minutes, the pellet dried and redissolved in 
30p.l of TB (pH 8.0). 10.d was then checked by digesting with a diagnostic restriction 
enzyme and run on a small (15m1, 3mm thick) gel. 
SECTION 2.33 
Large scale preparation of plasmid DNA 
The fact that E.coli DNA is much larger than commonly used plasmid vector 
DNA, and that genomic DNA is isolated as broken linear molecules where plasmid 
DNA is on the whole, isolated as covalently, closed, circular DNA, allows plasmid 
DNA to be separated from genomic DNA. Exposure to heat or to alkali will irreversi-
bly 
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denature the E.coli DNA whereas the covalently closed plasmid DNA will not be dam-
aged in this way. When the two types of DNA are centrifuged to equilibrium in 
caesium chloride gradients, containing saturating amounts of the intercalating dye ethi-
dium bromide, the plasmid DNA will bind much less of the dye and will band at a 
higher density in the gradient (Radloff et al 1967). The large scale preparation of 
plasmid DNA used was a modification of Maniatis et a! (1982). Essentially, an over-
night culture of transformed bacteria was grown in 500m1 of LB Broth plus 0.1% glu-
cose. The culture was spun down into two pellets and each dissolved in 10 ml of GTE 
(50mM glucose, 25mM Tns.Cl (pH8.0), 10mM EDTA) plus 20mg lysozyme and left 
on ice for 10 minutes. After this time, 40m1 of alkaline SDS solution was added to the 
pellet (2ml 20% SDS, 2ml 5N NaOH, 36m1 H 20) and slowly stirred in. After 5 
minutes on ice, 30 ml of high salt solution (3M potassium acetate, 2M acetic acid 
(pH4.8) was stirred into the mix. This was made by dissolving the potassium acetate 
in half the required volume of water and pH to 4.8 with glacial acetic acid. The full 
volume was then made up and this makes the acid molarity 2M.) The tubes remained 
on ice for 10 minutes and then were centrifuged at 10,000 rpm in a Sorval RC-5B for 
15 minutes. 160ml of absolute ethanol was then added to the muslin filtered superna-
tant and left at -20 °C for 20 minutes. The solution was then resupun for 15 minutes at 
10,000 rpm and the pellet was resuspended in 6m1 TE plus 4m1 7.5M ammonium ace-
tate and put on ice for 20 minutes after which time the tubes were spun at 14,000 rpm 
for 20 minutes. The supernatant was then treated with 20m1 absolute alcohol to precip-
itate the DNA and spun at 10,000 rpm for 15 minutes. The pellet was then treated in 
one of two ways. Either the pellets * were resuspended in lml TE and half was frozen. 
The other half was treated with lOp.l of a 10 mg/mi stock of RNase A for 30 minutes 
at 370C. The DNA was then phenol extracted and the aqueous phase re-extracted with 
chloroform followed by ether. 160p.l of 7.5M ammonium acetate was then added to the 
tube and 350p.l of isopropanol. The precipitated DNA was spun out in an Eppendorf 
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centrifuge and then resuspended in 400Rl  DEPC treated water. This DNA solution was 
then cut with a suitable enzyme and the amount estimated by running the DNA on an 
agarose gel. 
Alternatively the pellets * were resupended in 3.21m1 TB plus 3.55g caesium 
chloride and 0.34m1 of a 10mg/nil solution of ethidium bromide. The final density 
should be 1.55 g/ml. The solution was then transferred to a 5m1 polycarbonate tube 
and spun in a TV 865 rotor in the Sorvall OTD-65 overnight at 40,000 rpm at 20 0C. 
The following morning 2 bands should be visible, the lower band being the closed cir-
cular plasmid DNA. This lower band was collected into a tube and extracted with 
butan-2-ol to remove the ethidium bromide. As many extractions as were necessary to 
remove the dye plus one more, were carried out, and after dialysis against several 
changes of TB (pH 8.0) the DNA was precipitated and the concentration determined 
by reading on the spectraphotometer at 260nm. At 260nm, 1 OD = 50tg DNA. 
SECTION 2.34 
Isolation of insert DNA 
The clone 8-9 cDNA insert was isolated from plasmid DNA by the following 
method (Weislander 1979). The plasmid was cut to completion with the enzyme Eco 
Ri and 10tg was run slowly on a 1% low melting point agarose (FMC) gel. The gel 
was then stained with ethidium bromide and the relevant band excised with a scalpel. 
The agarose was then melted in 5 volumes of 20mM Tris-Cl (pH8.0) and 1 mM 
EDTA at 65°C for 15 minutes. The melted gel slice was then extracted by the addition 
of an equal volume of prewarmed phenol. The aqueous phase was recovered by centri-
fugation at 200C and re-extracted with phenol/chloroform, chloroform and finally 
diethyl ether. The fragment DNA was then recovered by the addition of 1/10 volume 
of 2M sodium acetate (pH 5.5) and 2.2 volumes of ethanol. 
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SECTION 2.35 
Sequencing in M13 
The first stage in sequencing eDNA clone 8-9 was to subclone the DNA into 
M13. This was carried out by cutting the vector in its replicative form with Eco Ri 
and cutting the plasmid containing the insert DNA with the same enzyme. The DNA 
was then ligated overnight (section 2.30) and JM 101 cells were transformed with the 
ligated DNA (section 2.31). The recombinant phage (single stranded) were identified 
from nonrecombinant phage by plating on X-gal plates. Recombinant phage gave 
colourless plaques. Recombinant plaques were picked with a toothpick and grown in 
1.5m1 of a 1/100 dilution of an overnight culture of JM 101 in 2xTY broth. The cul-
tures were then grown at 37 °C for 5 hours. The cultures were then transfered to 
Eppendorf tubes and centrifuged for 5 minutes. The supernatant (containing the single 
stranded phage) was then removed from the bacterial cells (containing the replicative 
double stranded form) and the supernatant was recentrifuged to ensure no bacterial 
cells were remaining. The "clean" supernatant was then added to 200p.l of PEGINaC1 
(20% polyethylene glycol 600012.5M NaCl), shaken, and allowed to stand for 15 
minutes at room temperature. The tube was then centrifuged for 5 minutes and the 
supernatant was discarded. The tube was then recentrifuged for 2 minutes and any 
remaining PEG was carefully removed. lOOjfl of TE pH 8.0 was added to the pellet 
and lOOi.Ll of ultra pure phenol (BRL) was added. After vortexing, the tube was 
allowed to stand for 15 minutes and then was centrifuged for 3 minutes. The aqueous 
layer was transferred to a new Eppendorf tube and re-extracted with chloroform. The 
aqueous layer was then removed and the DNA precipitated with 10p.1 2M sodium ace-
tate (pH 5.5) and 250.tl of ethanol, overnight at 20 °C. The resulting pellet of single 
stranded template obtained after 10 minutes centrifugation, was resuspended in 50tl 
TE (pH8.0). 
Sjfl of single stranded template was annealed to the 17 nucleotide primer supplied 
- 54 - 
with the Amersham sequencing kit. lp.l of primer (2.5ng) was added to 5j.tl of template 
with 1.5t1 lOx buffer (100mM Tris pH 8.0; 50 mM MgCl 2) and 2.5pi double distilled 
water. The annealing reaction mix was then placed at 60 °C for 1-2 hours after which 
the radiolabelled dl'TP (1tl of >400Ci/mmol (Amersham)) was added to the tube 
together with 1.tl of Kienow fragment (1U/j.Ll (Boebringer Mannheim)). The reaction 
was then divided into four tubes numbered 1-4. 
Stock 0.5mM deoxy NTP solutions and 0.5mM dideoxy ATP, 0.05mM dideoxy GTP, 
0.02mM dideoxy CT? and 0.15M dideoxy TTP solutions were used to make the solu-
tions for each of the four tubes. Ao consisted of 20p.1 dCTP, 201.tl dGTP, 1l dATP 
and 20p.1 TB pH8.0. Co consisted of 20jfl dGTP, 1.tl dCTP, 20m1 dATP and 20pi TB. 
Go consisted of 20p.l dATP, 20fl dCTP, lp.l dGTP and 20il TB. To consisted of 20p.l 
dATP, dCTP, dGTP and 20p.l of TB. 
A' contained 25p1 Ao + 25j.tl ddATP, C' contained 25.tl Co + 25d ddCTP. G' con-
tamed 25p.l Go + 25p1 ddGTP. T' contained 25p.l To + 25p.l ddlTP. 
Tube 1 contained 2p1 A', tube 2 contained 2tl C', tube 3 contained 2tl G' and tube 4 
contained 2.tl T'. The reaction was divided between these four tubes as described 
above and left at room temperature for 15 minutes. After this time, 2il of chase mix 
(0.5mM dTTP) was added. After a further 15 minutes 4gl of formamide dye mix 
(lOOm! formamide, 0. ig xylene cyanol FF, 0. ig bromophenol blue, 4m1 500mM 
EDTA) was added to the tubes and the samples were placed in boiling water bath for 
at least 3 minutes directly before loading 3p1 aliquots onto a gel. 
The gels were prepared as follows. Two glass plates 20cm x 40cm, one with notched 
"rabbit" ears and one without, were cleaned with ethanol. The plate with the "rabbit" 
ears was coated with a siliconising solution (2% dimethyldichiorosilane in 1,1,1-
trichioroethane (BDH)) and the unnotched plate was treated with y-
methacryloxypropyl-trimethoxy silane (Sigma). This silane compound was prepared by 
adding 30p.l to lOmi ethanol and adding to this solution, 30p1 of acetic acid in 300j.ti 
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of water. The gel side of the plate was then coated with this solution, allowed to dry 
and washed with ethanol. Plastic 0.35mm spacers were then placed down the sides of 
the plates and they were taped together with vinyl tape. 21g ultrapure urea (BDH), 
7.5m1 of acrylaniide stock (38g acrylaniide, 2g NN'-methylenebisacrylamide, in lOOmi 
distilled water), 5m1 lOx TBE buffer (section 2.29), in 50 ml with distilled water was 
prepared. 300p.l freshly made 10% ammonium persuiphate solution and 501.tl TEMED 
was added just before the gel was poured. The gel was poured between the plates and 
a comb with 5mm teeth at 3mm intervals was inserted into the gel when it was set. 
The plates were held together more firmly with bull dog clips and the gel was then put 
into the vertical gel apparatus (BRL) with TBE as the running buffer. Gels were run at 
27 watts until the blue dye front reached the bottom of the gel. Gels were then 
removed from the gel tank, the notched plate removed, and fixed in 10% acetic acid 
for 10 minutes. After extensive washing, the gel was dried onto the glass plate by 
placing it in an 800C oven for 1 hour. The gel was then autoradiographed overnight at 
room temperature and the sequence could be read the following morning on develop-
ing the autoradiograph. The smallest fragment is the first band at the bottom of the gel. 
The next fragment up in the next smallest and so on. Gels read up towards the comb 
are being read in a direction 5'-3' from the primer. If the smallest fragment for exam-
ple was in the T track, then the M13 template DNA is an A as the bases are comple-
mentary to the template. The gels could be read more easily by remembering that the 
upper C in a doublet is always more intense than a lower C and an upper G is often 
more intense than a lower G in a doublet. 
SECTION 2.36 
Extraction of DNA from cell pellets 
Cell pellets of approximately 107 cells were used to extract DNA for analysis by 
Southern blotting. Pellets of 5 x 10 were stored at -20 0C and when DNA was 
extracted, they were thawed into 3 ml of lysis buffer (0.5% SDS; 150 mM NaCl; 10 
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mM Tris (pH 8.0) 10 mM EDTA). 10i1 boiled, DNase free RNase A was added per 
ml of lysate, and the cells were incubated at 37 °C for 1 hour after which time 50RIJml 
of proteinase K (5mg/ml in lysis buffer) was added. The tube was then placed at 37 °C 
for 4br-overnight. The solution was extracted with an equal volume of phenol (water 
saturated) followed by reextraction of the aqueous phase with chloroform:phenol 1:1, 
and finally chloroform:isoamyl alcohol 24:1. After each organic addition the tube was 
shaken vigorously and spun at 12,000 x g to clarify the upper aqueous phase. After the 
final extraction, 0.5 volumes of 7.5M ammonium acetate was added to the solution 
and 2.5 volumes of absolute alcohol. The DNA was precipitated by the alcohol and 
was removed from the tube on a flame-sealed glass pipette. The DNA was then air 
dried, washed in 66% ethanol in 0.8M ammonium acetate, redried, and redissolved 
overnight in Tris-EDTA (10 mM Tris (pH7.5); 1mM EDTA). The amount of DNA 
was estimated by reading the optical density at 240, 260 and 280nm. At 260nm, 1 mg 
of DNA gives an OD of 20. Alternatively 1 OD at 260nm = 50p.g of DNA/mi. The 
purity of the sample can be roughly estimated by the ratio of the 260nm:280nm read-
ing. If the ratio is 2, then the absorption is probably due to nucleic acids, if it is 
below 1.6 there may be protein or other UV absorbing molecules in the sample. 
SECTION 2.37 
Southern blotting 
The technique of Southern blotting (Southern 1975) was used to transfer DNA 
from agarose gels to nitrocellulose filters. The DNA is denatured, neutralised and 
transferred in a high salt buffer by capillary action. The denatured, single stranded 
DNA binds to the filter, is then permanently bonded by baking the filter and is then 
hybridised to a radiolabelled probe to detect homologous sequences. In detail, a large 
(20 cm x 40cm) agarose gel was run to electrophoreticaily separate DNA which had 
been previously digested with restriction enzymes. The gel was then stained with ethi-
dium bromide and a photograph taken. After this, the gel was placed in a plastic tray 
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containing 500m1 of denaturing solution (1.5 M NaCl; 0.5M NaOH) for 1 hour at 
room temperature. The gel then was neutralised in 1 M Tris-Ci, 1.5 M NaCl (pH 5.5) 
for 1-2 hours at room temperature. The was gel transfered to a nitrocellulose filter on a 
transfer apparatus (Southern 1975) containing 20x SSC. The gel, covered with a nitro-
cellulose filter (presoaked in 2x SSC), 2 sheets of Whatmann 3mm filter paper and a 
wad of paper towels, was left at room temperature overnight. The following day, the 
nitrocellulose filter was removed and baked for 2 hours in a vacuum oven at 80 °C for 
2 hours. The filter was then ready to be hybridised (as for Northern blotting, section 
2.17) to a suitable radiolabelled probe (section 2.18), and autoradiographed (2.10). 
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CHAPTER 3 
CFAg EXPRESSION IN MYELOID CELLS 
3.1 Turnover of CFAg in various cell types 
In order to isolate the cDNA for CFAg, it was first necessary to determine which 
of the tissues which express CFAg are actively synthesising the protein. It was 
assumed that if active protein turnover could be demonstrated then the mRNA for the 
gene would be present. 
Granulocytes 
Using the guinea pig antiserum (Manson and Brock 1980) raised against the 
excised isoelectric focussing band cut Out of the gel (anti-IEF), van Heyningen et al 
(1985) demonstrated demonstrated that CFAg was present in normal and CML granu-
locytes. However granulocytes (polymorphonuclear leukocytes) are short lived end 
cells and the majority of their tissue specific products are synthesised in the bone mar -
row when granule formation occurs. The variable lobulated shape of the nucleus 
(which gives polymorphs their name) contains mainly clumped chromatin; there is 
almost no disperse chromatin and no nucleolus implying that little of the genome is 
being transcribed, and there is very little formation of new ribosomes (Rogers 1983). 
Neutrophils have very little rough endoplasmic reticulum (RER) and only a small cen-
trally placed Golgi apparatus. Secretory granules and primary lysosomes are manufac-
tured on the RER and processed through the Golgi apparatus in the course of 
differentiation. The lack of these organelles suggests that synthesis of protein and its 
packaging in external membrane have ceased. 
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The granulocytes' main function is to protect the body from infection and they 
are the first cell type at the site of inflammation. The bone marrow stage of the neutro-
phil life cycle commences with proliferation of commited stem cells and ends with the 
release of the neutrophil into the blood stream. Proliferation lasts about 5 days, matura-
tion is completed after approximately 10 days and the mature cells are released into 
the circulation 1.5 days later (Athens 1970). The mature neutrophil stays in the circula-
tion for less than 1/2 a day on average and then migrates into the tissue. 1011  neutro-
phils are released every day even in healthy adults with no inflammation. 
The term granulocyte population refers to all polymorphonuclear (PMN) cells in 
the blood and they comprise of neutrophils, eosinophils and basophils. Neutrophils 
however account for 90% of these cells. 
The neutrophil consists of primary and secondary or azurophilic and specific 
granules. The primary granules are peroxidase positive and uniquely contain myelo-
peroxidase, elastase, cathepsin G, proteinase 3, beta-glucuronidase, alpha-mannosidase, 
cathepsin B, cathepsin D (Baggiolini et al 1978) and all these components are pro-
duced in the promyelocyte cell. The next cell stage the myelocyte produces the specific 
granules which contain collagenase, lactoferrin, vitamin B12 binding proteins and in 
common with the primary granules, they also contain lysozyme. The developing neu-
trophil then continues through metamyelocyte and band cell stages to mature neutro-
phil characterised by its lobed nucleus. There also appears to be another granule type 
named a C particle which contains some proteases and the bulk of plasminogen activa-
tor (Bretz 1978). Although at the time of these experiments it was not known whether 
CFAg is associated with the cytoplasm or particulate fraction of granulocytes, there is 
now considerable evidence to suggest that CFAg is cytoplamic. 
CML cells 
CML cells also contain CFAg. It was hoped that if normal granulocytes did not 
actively synthesise CFAg then it might be synthesised by these more immature cells. 
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CML is characterised by massive expansion of pools of committed myeloid progenitors 
(Champlin et al 1985). In the chronic stage of the disease mature segmented cells, are 
found alongside myeloblasts, through promyelocytes to myelocytes of variable matura-
tion. Subtle abnormalities in granulocytic function are observed (Olofsson et al 1976). 
The number of granulocytes is highly elevated 1-4 x 101 1 /litre compared to 1-2x 1O 9 
/litre in normals (Chikkappa et al 1976). In the aggresive leukemia stage the proportion 
of promyelocytes and blast cells increases and in blast crisis the cells no longer 
differentiate to mature granulocytes. Blast crisis can be "lymphoid" or "myeloid" 
(Rosenthal et al 1977) and at this stage other karyotypic abnormalities are superim-
posed on the Phildeiphia chromosome phenotype which is present 90% of CMLs 
(Rowley 1975). 
HL-60 cells 
A third possibility for isolating mRNA coding for CFAg was to examine esta-
blished myeloid cell lines. If a cell line growing in culture produced immunologically 
detectable antigen then it must contain mRNA for the protein. The promyelocytic cell 
line HL-60 (Collins et al 1977) was chosen as a possible candidate cell line. HL-60 
was established from a patient with acute promyelocytic leukemia. These cells can be 
induced to differentiate towards macrophage like cells (Lotem et a! 1979; Huberman 
and Callahan 1979; Rovera et al 1979; Rovera et al 1979a ; Koeffler et al 1981) when 
treated with tumour promoting phorbol diesters. This is characterised by arrested divi-
sion and DNA synthesis and adherence of the cells to plastic substrates. The cells 
acquire complement receptors and phagocytic ability (Chaio et al 1981). 
HL-60 can also be induced to differentiate towards granulocytic cells when 
treated with a variety of chemicals. These chemicals do not include glucocorticoids but 
this unresponsiveness is not due to a lack of steroid receptors (Freidman et al 1976). 
High concentrations of agents which induce a rise in intracellular levels of cAMP and 
500 mM N,O dibutryl cAMP also induce HL-60 to mature to the myelocyte and 
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metamyelocyte stage (Chaplinski et al 1982). Low levels of retinoic acid (RA), lOnM 
or agents known to increse levels of cAMP will not induce differentiation, but priming 
for 24hrs by treatment with RA followed by treatment with cAMP inducing agents will 
stimulate the cells to mature towards granulocytes (Olsson et al 1982). 
A large variety of compounds will induce differentiation of HL-60 along the 
granulocyte pathway (Koeffler 1983). These include dimethyl sulphoxide, hypox-
anthine, hexamethylene bisacetamide, thymidine, butyric acid, retinoic acid, vitamin 
D3, actinomycin. The degree of maturation is determined on the basis of morphology 
and the ability of the cells to reduce nitroblue tetrazolium (NBT) due to the presence 
of superoxide anion. 
RA appears to be one of the most powerful inducers of HL-60 as relatively low 
concentrations are necessary to produce a high percentage of mature cells. The 13-cis 
form of the chemical is reported to be equally as effective as the all trans form (Breit-
man et a! 1981). Ferrero et al (1983) examined the surface changes HL-60 produced 
on stimulation with DMSO and RA. The cells did not produce all the biochemical 
markers symptomatic of differentiation but treatment with RA produced significantly 
more cells which react with a monoclonal antibody (McAb) specific for mature 
myeloid cells. The induced maturation of HL-60 to granulocytes is not therefore a per-
fect model of myeloid differentiation and the absence of alkaline phosphatase and lac-
toferrin from induced cells indicates that the secondary granules are absent (Gallagher 
et al 1979). However they do not possess IHLA-DR antigen which is present normally 
on myeloblasts and not on mature granulocytes (Zebrowski et al 1977). 
On the basis of the apparent effectiveness of RA in inducing HL-60 to mature 
towards granulocytic cells, it was decided to use this compound to induce HL-60 and 
look for CFAg expression. 
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3.2 Method of analysis 
The antibody used to detect CFAg in the' above mentioned tissues was kindly 
supplied by Professor D. Brock. It was raised in guinea pigs against the band peculiar 
to CF and heterozygote individuals visible in isoelectric focussing gels of these indivi-
duals' serum (Manson and Brock 1980). This antiserum is termed anti-IEF antiserum. 
Another antiserum which was used was raised in guinea pigs against partially purified 
CFAg-positive fraction of myeloid leukaemia cells and is termed anti-CML (van Heyn-
ingen et al 1985). The method used to establish immunoreactive identity between these 
two antisera was by Ouchterlony double diffusion. In this technique a buffered agar 
gel is prepared and antigen and antibody are loaded in wells bored in to the agar. After 
incubation for 12-48 hrs antibody antigen recognition is detected by an immunoprecipi-
tin line between the wells. The formation of a fused immunoprecipitin line between 
two different antibody sources to the same antigen well infers immunoreactive identity 
i.e the antisera recognise the same antigen in the protein mix in the antigen well. 
Equally, a fused precipitin line without spurs between an antibody and two different 
antigen sources suggests antigen identity. 
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3.3 Results 
3.3.a CFAg in HL-60 cells 
HL-60 cells were grown in serum-containing and serum-free medium and cell 
lysates were tested against the guinea pig antiserum raised against the band Cut out of 
the isoelectric focussing gel (Manson and Brock 1980), in Ouchterlony double 
diffusion analysis. No reaction was observed when cells were grown in serum-free 
medium but a very faint immunoprecipitation was seen on cell lysates grown in 5% 
fetal calf serum, suggesting that fetal calf serum acts as a mild inductive agent. Cells 
were then induced to differentiate by the continuous presence of 10M RA and cells 
were harvested on each day from day 0 to day 6. Differentiation was assesssed by the 
ability of cells to reduce NBT and figure 1 shows a typical view of dark blue 
differentiated cells and colourless undifferentiated cells. 
Figure 2 shows the number of viable cells on each day and the number of cells 
capable of reducing NBT when grown in the continuous presence of RA. The results 
agree with the findings of Breitman et al (1980, 1981). By day 2 over 40% of the cells 
were morphologically mature i.e metamyelocytes and beyond. After 5 days continual 
exposure to 10M RA, only 70% of the cells were viable as determined by trypan 
blue exclusion and 80% of the viable cells were differentiated as determined by NBT 
reduction. 
Cells were harvested and lysed in PBS (10 cells per 100i1 ) and tested for 
antigen. The results show that there is no CFAg detected in cells grown in medium 
with 5% FCS when undiluted (anti-IEF) antiserum is used. However when the 
antiserum is diluted to 1/8, a precipitin line is visible. In this technique, antigen and 
antibody diffuse towards each other through theagar. Where a precipitin line forms is 
dependant on the molecular weight of the antigen and upon equivalence concentration 
being obtained at some point in the overlapping antigen /antibody gradients. When 
antigen concentration is very low precipitation may only occur if the antibody is 
diluted. When HL-60 was grown in serum free medium no precipitation was seen at 
any antigen or antiserum dilution. 
Figure 3a-c shows antigen levels as detected by Ouchterlony double diffusion on 
days 1-5. 
Day 0 - equivalence is at 1 in 8 dilution of anti-IEF antiserum. 
Day 1 - equivalence is at 1 in 2 dilution of antiserum 
Day 2 - equivalence is at 1 in 4 dilution of cell lysate 
Day 3 - equivalence is at 1 in 2 dilution of antiserum 
Day 4 - equivalence is at 1 in 2 dilution of antiserum 
Day 5 - equivalence is at 1 in 2 dilution of antiserum 
This implies that CFAg expression is increased 32 fold from day 0 to day 2 and 
HL-60 grown on serum free medium has no detectable levels of CFAg. CFAg levels 
in HL-60 cell (grown for 2 days in the presence of RA), and CML cell lysates, were 
compared. Both cell lysates were prepared from equal cell numbers. Equivalence 
against anti-IEF was achieved at a 1 in 32 to 1 in 64 dilution of CML lysate and at a 1 
in 4 dilution of HL-60 lysate. Thus CML appears to have at least 16 fold greater 
steady state CFAg compared to HL-60 induced with RA for two days. No CFAg could 
be detected when HL-60 was treated with the tumour promoting agent 12-0-
tetradecanoylphorbol- 13-acetate. 
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FIGURE 1 
Photograph to show the appearance of a differentiated and undifferentiated HL-60 
cell as determined by NBT reduction. The dark cells are differentiated while the light 
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FIGURE 2 
Graph to show the number of viable HL-60 cells and the number of differentiated 
cells on each day of a five day stimulation with 10M RA. Differentiation was deter-
mined by NBT reduction, and cells were assessed as to their viability by exclusion of 
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FIGURE 3 a,b,c 
Figure 3 shows Ouchterlony double diffusion analysis of HL-60 cell lysates 
against anti-IEF antisera at various dilutions. The cell lysates are from cells grown in 
the presence of RA for variable lengths of time. The well contents and the dilution 
are shown adjacent to the wells. H stands for HL-60 and the number following indi-
cates the length of time exposed to RA, and the lysate dilution. For example "H-O 1:2" 
is lysate from HL-60 (grown without RA) diluted 1 in 2. Equivalent numbers of cells 
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3.3.b CFAg protein turnover in granulocytes from normals, CML patients and 
HL-60 cells. 
In order to determine if CFAg was actively synthesised in CML and normal 
granulocytes, cell labelling with 35S-methionine was carried out. 35S-methionine will 
only be incorporated into proteins that are being synthesised i.e the mRNA for the pro-
tein is being translated and the protein assembled. In the case of CML samples buffy 
coats from lOmis of blood were used as >90% of the cells were myeloid. Lympho-
cytes were separated from red blood cells in normal samples over dextran 250 and 
PMN were separated from mononuclear cells by separation over Ficoll-hypaque. Cells 
were incubated for 1 hour without methionine and then for 4 hours with 35S-
methionine. 
Ouchterlony double diffusion analysis 
Cell lysates were tested after labelling, by Ouchterlony analysis and stained ini-
tially with Coomassie blue and then autoradiographed to see if any label had been 
incorporated into the precipitin band. Figure 4-a shows the immunodiffusion of anti-
CML antiserum against internally 35S-methionine labelled cell lysates of CML and 
normal granulocytes. Both cell sources appear to have incorporated the radiolabel into 
the precipitin line, indicating that there is active CFAg synthesis in both CML and nor-
mal granulocytes. 
SDS polyacrylamide gel electrophoresis of bands excised from Ouchterlony gels. 
A second step was to cut out the labelled precipitin band from the Ouchterlony 
gel and run the sample on a polyacrylamide gel to indicate subunit size. Figure 4-b 
shows the gel which had the bands in figure 4-a cut out and electrophoresed. The gel 
has CML total lysate and VvH normal PMN total lysate, the band patterns of which 
look similar but more complex in the CML lysate. Only the tracks which have CML 
lysate irnmunoprecipitates give detectable bands in the autoradiograph of the gel. In 
this case two bands are seen of - 14 kDa and 12.5 kDa. Both these bands appear to be 
sum 
abundant proteins in the total labelled lysate samples of both CML and normal PIvIN 
samples. 
The immunoprecipitated antigens are contaminated. 
As a negative control lactoferrin and catalase antisera were used to in a parallel 
experiment. CIVIL internally labelled lysate was immunoprecipitated in an Ouchterlony 
with lactoferrin, catalase and anti-CIVIL antisera. The precipitin bands for all three 
antisera were cut out and run on a 12% SDS polyacrylamide gel. The results are 
shown in figure 5. Each antiserum has the same two radiolabelled bands. This means 
that it is not possible to identify a specific protein band for CFAg. The two protein 
species which are present in the precipitin bands irrelevant of the antisera used are 
major bands in the total lysate. It is thus due to their abundance and perhaps the nature 
of the proteins that they are trapped non specifically in the antigen/antibody lattice. 
These gels were washed for 48 hours in saline containing 0.05% Tween 20, but this 
was obviously insufficient. 
3.3.c Immunoprecipitation of CFAg using McAb, from normal, CML granulocytes 
and induced HL-60. 
HL-60 cells induced for 2 days with RA, uninduced HL-60, CML and normal 
granulocytes were all internally labelled for 4 hours with 35S-methionine. Using 
monoclonal antibodies to alphafetoprotein (AFP) (van Heyningen et al 1983) as a 
negative control and lactoferrin (Chung et al 1985), as a positive control in the case 
of CIVIL, a series of imrnunoprecipitations was carried out. The precipitations were 
washed extensively with buffer containing 0.1% SDS and f3-mercaptoethanol. The 
results are shown in figure 6a, 6b and 6c. Lactoferrin monoclonal precipitates a protein 
of 79 kDa only from the CML lysate. CFAg monoclonal antibody CF46 precipitates 
two specific molecules of - 14 and 12.5 KDa from CML, normal PIVIN and induced 
HL-60. There is no specific molecule precipitated by CF46 from uninduced HL-60. 
These results are convincing because in the total HL-60 2 day RA lysate the 
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precipitated band is not a major species whereas it is in the granulocyte lysates. It is 
therefore less likely to be a contaminant purely because the protein is very abundant. 
3.4 Conclusions 
CFAg is synthesised in the promyelocytic cell line HL-60 when it is induced to 
differentiate towards granulocytes. With 10M RA maximal antigen production is 
achieved after 2 days of continual exposure. 
CFAg is actively synthesised in normal and CML granulocytes. 
Monoclonal antibodies directed against CFAg, precipitate two molecules from 
labelled cell lysates of approximately 12 and 14 kDa. 
Both these proteins appear to be abundant in the total cell lysates of  35 S-
methionine labelled CML and normal granulocytes but poorly represented in induced 
HL-60 and not present in HL-60 grown in serum free medium. This agrees with the 
steady state CFAg protein data. 
On the basis of these results it was decided that CIVIL tissue contains the highest 
level of protein synthesis and therefore was used as the source of mIRNA in the con-
struction of a cDNA library. 
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FIGURE 4-a 
Autoradiograph of an Ouchterlony double diffusion gel, where 35S-methionine 
internally labelled CML and normal granulocytes, are allowed to diffuse with undiluted 
anti-rEF antiserum. Well 1 contains anti-IEF antiserum. Well 2 contains  35 S-
methionine labelled CML lysate. Well 3 contains 35S-methionine labelled normal 
granulocyte lysate. 
p 
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FIGURE 4-b 
Autoradiograph of a 12% SDS PAGE separating labelled proteins present in 
Ouchterlony precipitin bands. lane 1 CML total lysate; lane 2 granulocyte total lysate; 
lane 3 excised Ouchterlony precipitin band between normal granulocytes and anti-CML 
antiserum; lane 4 excised Ouchterlony precipitin band between CML and anti-CrvlL 
antiserum; lane 5 normal granulocyte labelled lysate; lane 6 excised Ouchterlony pre-
cipitin band between normal granulocytes and anti-IEF antiserum; lane 7 CML total 
lysate; lane 8 excised Ouchterlony precipitin band between CML lysate and anti-IEF 
antiserum. 
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FIGURE 5 
Autoradiograph of 12% SDS PAGE to show labelled proteins present in Ouchter-
lony precipitin bands between CML lysate and a variety of antisera. 
lane 1- Excised Ouchterlony precipitin band between CML labelled lysate and 
catalase antiserum, lane 2-Excised Ouchterlony precipitin band between CML labelled 
lysate and anti-CML antiserum. lane 3-Excised Ouchterlony precipitin band between 
CML labelled lysate and lactoferrin antiserum. lane 4-Excised Ouchterlony precipitin 
band between CML labelled lysate and anti-IEF antiserum. lane 5- Excised Ouchter-
lony precipitin band between CML labelled lysate and anti-IEF antiserum. 
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FIGURE 6 a-c 
Autoradiograph of 15% SDS PAGE of immunoprecipitations from 35S-methione 
internally labelled cell lysates. In each case i0 6  cpm were used as starting material in 
the immunoprecipitations, and 2 x 1O 4  cpm were loaded straight onto the gel in the 
case of total lysates. Numbers next to arrows down the side of the gels indiccte the 
position of the molecular weight markers and their size in kDa. 
FIGURE 6-a 
lane-1 molecular weight markers, with their size in kDa indicated; lane-2 total 
labelled lysate of HL-60 cells grown without serum; lane-3 as above immunoprecipi-
tated with a pool of anti- lactoferrin monoclonal antibodies; lane-4 as in lane . jmmu-
noprecipitated with a pool of monoclonal antibodies against CFAg; lane-5 total 
labelled lysate of HL-60 cells grown 2 days in the presence of RA; lane-6 as lane 5 
immunoprecipitated with a pool of anti- lactoferrin monoclonal antibodies; lane-7 as 
lane 5 immunoprecipitated with a pool of CFAg monoclonal antibodies; lane-8 total 
cell lysate from internally labelled CML cells; lane-9 as lane 8 immunoprecipitated 
with a pool of anti-lactoferrin monoclonal antibodies, the position of lactoferrin indi-
cated with an arrow; lane-10 as lane 8 immunoprecipitated with a pool of CFAg 
monoclonal antibodies. 
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FIGURE 6-b 
lane-1 total labelled lysate from normal peripheral blood granulocytes; lane-2 as 
lane 1 immunoprecipitated with anti-APP monoclonal antibody; lane-3 as lane 1 immu-
noprecipitated with CF145 monoclonal antibody; lane-4 total labelled lysate from HL-
60 cells grown 2 days RA; lane-5 as lane 4 immunoprecipitated with anti-APP mono-
clonal antibody; lane-6 as lane 4 immunoprecipitated with C17145; lane-7 internally 
labelled uninduced HL-60 cell lysate; lane-8 as lane 7 immunoprecipitated with anti-
APP monoclonal antibody; lane-9 as lane 7 immunoprecipitated with CF145. 
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FIGURE 6-c 
lane-1 lysate from intermally labelled uninduced HL-60 cells; lane-2 as lane 1 
immunoprecipitated with anti-AFP monoclonal antibody; lane-3 as lane 1 immunopre-
cipitated with CF145; lane-4 internally labelled HL-60 induced with RA for 2 days; 
lane-5 as lane 4 immunoprecipitated with anti-AFP monoclonal antibody; lane-6 as 
lane 4 irnmunoprecipitated with CF 145; lane-7 labelled lysate from CML cells; lane-8 
as lane 7 immunoprecipitated with anti-AFP monoclonal antibody; lane-9 as lane 7 
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CHAPTER 4 
cDNA LIBRARY CONSTRUCTION 
4.1 Introduction 
In order to isolate the cDNA for CFAg it was decided to construct a cDNA 
library in AgtlO using polyadenylated RNA from CML cells as a starting material. 
The frequency at which cDNA clones of a particular mRNA species appear in a cDNA 
library is generally proportional to the abundance of that species in the mIRNA popula-
tion. It was assumed that as CFAg appeared to be an abundantly synthesised protein in 
CML cells then the mRNA would be abundant. This means that CFAg should be 
highly represented in a library made from CMLmRNA and candidate clones could be 
isolated by differential screening -see Chapter 5. 
A lambda vector was chosen instead of a plasmid because of the high efficiency 
and reproducibility of in vitro packaging as a method of transfecting E.coli. ?gt10 was 
chosen because it has a selection system for recombinant phage which remain healthy 
and grow well to give large plaques. Murray et al (1977) describe a series of vectors 
which utilize the repressor Cl gene to select for recombinants. In wild type lambda the 
CI gene product binds to the operator genes to suppress transcription of the genes 
necessary for lytic growth of the phage. Thus insertion into this gene yielding CI-
phage will give clear plaques as all phage will undergo lytic growth. CI+ phage give 
turbid plaques as some phage will express the Cl gene product and some will not. 
XgtlO does not require an insert fragment to yield packagable DNA and so without 
selection 70-90% of the cDNA library will be parent phage. When XgtlO is grown on 
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an E.coli strain carrying the high frequency lysogen mutation Hfi A150 (Hoyt et al 
1982) the CI+ phage are repressed so efficiently that plaque formation is supressed. 
CI- phage however will plaque with normal efficiency on the Hfl A150 strain. A.gtlO 
has a unique Eco Ri site in the CI gene, into which inserts are normally cloned. The 
phage can accept up to 7.6kb of insert assuming a packaging capacity of 105% wild 
type length (Huynh et al 1985) 
4.2 Synthesising and cloning double-stranded eDNA 
4.2.a The general methodology used is: 
Extraction of RNA from CML cells. 
Isolation of polyadenylated RNA 
cDNA synthesis catalysed by reverse transcriptase using poly(A) RNA as 
template and oligo (dT) 12-18  as a primer.(Efstratiadis et al 1976) 
mRNA-cDNA hybrid is used as a substrate for RNase H, E.coli DNA polym-
erase I and E.coli DNA ligase in the presence of deoxyribonucleoside triphosphates. 
RNase H introduces nicks in the RNA to produce Okazaki fragment like primers 
which provides substrates for the replacement of RNA by DNA (mediated by Polym-
erase I). E.coli DNA ligase will seal the nicks but unlike T4 ligase, will not ligate 
double-stranded molecules to each other. This technique for second strand synthesis 
was introduced by Okayama and Berg(1982) and modified by Gubler and 
Hoffman(1983). Classical methods of cDNA manufacture, hydrolyse the RNA with 
alkali and prime the second strand from a hairpin structure found at the 3' end of 
cDNA molecules (Efstratiadis et al 1976). This is disadvantageous because the looping 
results in loss of sequence at this region. 
The double stranded cDNA is blunt-ended by treatment with Si nuclease. 
This is a poorly controlled step and the enzyme must be titrated before use to prevent 
degradation beyond the overlapping ends. 
The cDNA internal Eco Ri sites are protected from subsequent cleavage by 
treatment with Eco Ri methylase. 
Synthetic linkers with Eco R1 restriction sites are ligated onto the cDNA. 
Cleaving with Eco RI to remove all but the terminal unit of the linker and 
thus generating Eco Ri termini on the molecule. 
Separation of cDNA from excess of linkers 
Cloning of cDNA into Eco Ri cut vector. 
4.2.b The practical problems encountered. 
Isolation of mRNA 
The initial problem en'countered was isolation of mRNA from CML cells-the tis- 
sue of choice. From lOmis of leukaemic blood, with 100 times normal levels of 
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polymorphonuclear leukocytes it was possible to separate 4 x 1O 9 myeloid cells, how-
ever extraction of RNA using buffer saturated phenol with proteinase K digestion (Fra-
zier et al 1983) or guanidium-HC1 (Chirgwin et al 1979) proved very difficult and 
yields of RNA were very low. No RNA could be successfully extracted from normal 
polymorphonuclear leukocytes. If the same number of liver cells were used ( 10), the 
yield would be at least 10mg of RNA. However the liver has several abundant mRNA 
species (Galau et al 1977 ). Granulocytes are terminally differentiated end cells 
designed to destroy invading organisms and therefore do not synthesise many proteins 
and are probably rich in endogenous ribonuclease. Finally, I received a leukophoresis 
sample from a CML patient and from 1011  cells using the guanidine-HC1 method it 
was possible to extract 10mg of RNA. More than 90% of the cells were of myeloid 
morphology and so no cell separation was undertaken. The patient (CD) from whom 
the leukophoresis sample was taken, had been admitted to hospital with symptoms of 
fatigue and anaemia. The haemoglobin was 7.9g/dl, the white cells 55.9 x 10/1 and 
platelets 54 x 10 /l. She was regarded by the consultant haematologist as having a 
chronic myeloid leukaemia distinct from typical chronic granulocytic leukaemia and 
chromosome analysis of the bone marrow was normal i.e no Philadelphia chromosome 
was seen. She had been treated with cytotoxic drugs with minor haematological 
improvement. The patient has since died of an intracerebral haemorrhage. The tech-
nique used to isolate RNA from this patient (CD) was used subsequently to isolate 
RNA from another leukophoresis sample (BS) who was Philadelphia chromosome 
positive. 
Enrichment for polyadenylated RNA 
The isolated RNA was then enriched for poly (A) RNA over an oligo(dT) 
column and yielded 400 jig from 4mgs. 
The mRNA was electrophoresed on a 1% agarose/2.2Mformaldehyde gel and 
probed with a catalase cDNA probe (van Heyningen et al 1985a) to show that the 
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mRNA was intact (Figure 7). This Northern blot also includes poly (A) samples from 
normal human liver, a liver hepatoma cell line (Hep G2), CD CML, and induced and 
uninduced HL-60 cells. The HL-60 cell mRNA is somewhat degraded, but the CML 
mRNA appears to be intact. 
The CML poly (A) RNA was then translated in a cell free rabbit reticulocyte 
lysate translation system and immunoprecipitated with monoclonal antibodies (McAb) 
to lactoferrin, AFP or CFAg. mRNA for lactoferrin is known to be present in the cells 
of CML patients (Rado et al 1984) but APP mIRNA will not be present. Figure 8 
shows that lactoferrin McAb immunoprecipitates a specific band from the translated, 
35S-methionine labelled products. The APP McAb does not precipitate a specific 
radiolabelled band, and CF46 immunoprecipitates a band assumed to be CFAg. 
Thus, the mRNA prepared from CML cells is intact and contains mRNA which 
can be translated in a cell free system and from the translation products a specific pro-
tein can be immunoprecipitated by McAb directed against CFAg. 
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FIGURE 7 
Autoradiograph of northern blot probed with human catalase cDNA clone to show 
that CML CD mRNA is intact. Each lane contains 2jtg poly(A) from various sources. 
Lane-1 uninduced HL-60; lane-2 HL-60 induced 2 days RA; lane-3 CML; lane-4 
I-IEPG-2 (hepatoma cell line); lane-5 human brain lane-6 human liver. 
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FIGURE 8 
Autoradiograph of 12% SDS polyacrylamide gel to demonstrate immunoprecipita-
tion of 35S-methionine labelled CFAg and lactoferrin, but not AFP from rabbit reticu-
locyte translation products of CML poly(A) RNA. 106  cpm were used as starting 
material in each immunoprecipitation and 50,000 cpm were loaded in lanes 1 and 5. 
lane-1 total translated products from CML RNA; lane-2 as lane 1 immunoprecipitated 
with anti-lactoferrin McAb; lane-3 as lane 1 immunoprecipitaed with anti-CFAg McAb 
145 ; lane-4 as lane 1 immunoprecipitated with anti-AFP McAb; lane-5 Rabbit reticu-
locyte translation system, no mRNA added. Lanes 1 and 5 are overexposed to reveal 
the bands in lanes 2, 3 and 4. 
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Double stranded cDNA synthesis, and Si nuclease treatment 
The cDNA library was constructed as described in the methods section 2.21. The 
synthesis of cDNA was traced by the incorporation of ( (x 32P)TrP. 
The average size of first strand products was determined by running 1/10 of the 
sample on a 1.5% agarose gel and autoradiographing the dried down gel. In initial 
experiments the first strand synthesis showed cDNA of low average size - less than 
1Kb. The reverse transcriptase (RT) used in this case was from Boehringer Mannheim 
and so in an effort to improve the size of cDNA molecules, reverse transcriptase from 
three sources were compared, in an experiment where 2 jig of CMI. poly (A)+  JA 
was used as a template for each of the three enzymes. The NBL Enzymes Ltd reverse 
Iranscriptase and Amersham reverse transcriptase required 60 units of enzyme where 
the NBL XL (a higher grade) needed only 20 units as it has 3 fold greater specific 
activity. The percentage of radiolabel incorporated in each case was the same, ( - 8%). 
It was found that Amersham reverse transcriptase gave poor cDNA size compared to 
NBL Enzymes' regular and XL RTs. The XL preparation was very concentrated com-
pared to the other two samples and gave cDNA molecules of high average size as 
shown in figure 9. 
It was noticed, that in some instances within the first strand cDNA products 
discrete bands could be visualised. These were probably due to self primed cDNA syn-
thesis from DNA and/or ribosomal RNA contaminating the preparation. This 
phenomenon was particular to certain poly (A) RNA preparations. 
The results below are for the cDNA used to make the library. Using lOjig CML 
poly(A)TRNA as starting material. 
1st strand- % of label incorporated 	 = 5% 
Amount of unlabelled dTTP 	 = 53nmoles 
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Amount of unlabelled dTTP incorporated 	= 5% of 53 nmoles 
2.65nmoles 
assume average Mwt of dNTP = 350 
Weight of cDNA 	 = 927ng 
Therefore % of mRNA transcribed = (927110,000)x 100 = 9.27% 
Assuming that at least 90% of 1st strand becomes second strand, total amount of 
cDNA = 1.8p.g. 
Figure 9 also shows the cDNA used to make the cDNA library. First strand has 
average sized species of - 1.5kb. The second strand is of the same size average as first 
strand and Si nuclease treatment reduces the average size very slightly. An alternative 
method to using Si nuclease to blunt end the cDNA, is to use T4 Polymerase. T4 
polymerase will "fill in" the ends of the cDNA and so the problem of over digestion 
with Si nuclease can be obviated. However as the Si nuclease appeared to cause no 
difficulties, this step was not altered. 
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FIGURE 9 
Autoradiograph of dried down non denaturing 1.5% agarose gel, containing sam-
ples of cDNA synthesised with three different reverse transcriptases. In each case, 2j.tg 
of CML poly(A) was used as starting material. 50,000 cpm from each reaction were 
saved from the first strand, second strand and Si stage and run on the gel. The size 
markers were Hind HI cut lambda DNA and Hae III cut 4x174. Lanes 1 to 3 uses 
NBL regular reverse transcriptase, lanes 4 to 6 uses NBL XL reverse transcriptase and 
lanes 7 to 9 uses Amersham RT. lanes 1,4,7 are first strands, 2, 5, 8 are second strand 
and lanes 3, 6, 9 are after the Si nuclease treatment. 
Lanes 10, 11, 12, first strand, second strand and Si nuclease treated double 
stranded cDNA used to construct the CML Xgtio library. 10pg of poly(A) +  RNA was 
used as starting material and NBL XL RT was used to synthesise the cDNA. The size 
markers are Hae III cut 4x174. 
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Methylation and addition of Eco Ri linkers 
The cDNA methylation step caused no problems but the addition of Eco Ri link-
ers proved extremely difficult. The methylation of the eDNA was not checked directly 
but the E.Coli methylase was shown to be active before being used in the reaction. 
This was done by treating purified lambda DNA with the enzyme and then demonstrat-
ing that the it could no longer be restricted with Eco Ri. In order to follow the liga-
tion of the linkers onto the cDNA, the linkers were end-labelled with (yP) ATP and 
polynucleotide kinase. It was found that polynucleotide kinase was extremely unstable 
and after being used once or twice it would be inactive. To ensure that the linkers 
could ligate to themselves, a control ligation reaction was carried out without the addi-
tion of the cDNA. It was possible to see quite easily when the linkers had ligated to 
themselves because the unlinked linkers at the bottom of a 1.5% agarose gel disap-
peared and a smear up the gel to about 600bp size was seen. Because double inser-
tions are undesirable, a molar excess of linkers to cDNA was used. This means that 
there should still be concatamers of linkers seen in a smear at the bottom of the gel 
and an increase of label in the eDNA when ligation of linkers and cDNA has success-
fully occurred. This would indicate that some linkers have ligated to themselves and 
some have ligated to the cDNA. It was difficult to detect appreciable increase in label 
in the cDNA but the smear of self ligated linkers and the diminished amount of free 
linkers should have been easily visualised. 
It was found that the ligation of the linkers would procede satisfactorily until 
cDNA was added to the reaction, when no reduction in the unligated linkers was seen 
and no smear of self ligated linkers. Sodium acetate was used to precipitate the cDNA 
after each step in case the ammonium ions from the ammonium acetate were inhibiting 
ligation. This appeared to make no difference. 1.tg of lambda DNA cut with Eco Ri 
and included in the ligation reaction without cDNA did not inhibit the ligation of the 
linkers to themselves. Precipitating the lambda DNA from each of the cDNA reaction 
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mixes and then including the DNA in the ligation reaction did not inhibit the reaction 
of the linkers ligating to themselves. 1mM spermidine was included in the reaction 
mix and appeared to reduce ligation of the linkers even in the control reaction without 
the cDNA. According to Pheiffer and Zimmerman (1983), polymers such as polyethe-
lyene glycol (PEG 6000), Ficoll, bovine serum albumin or glycogen can stimulate 
blunt-end ligation by a factor of up to ten. A reaction buffer including PEG 6000 
proved to give extremely efficient ligation of the linkers to themselves without the 
cDNA, but did not allow the reaction to proceed with the cDNA present. If there is 
some sort of inhibitor present then perhaps one would expect the polymer effectively 
to concentrate it in the reaction volume. It had to be concluded that there was some-
thing contaminating the cDNA, which was inhibiting the ligation reaction. In an effort 
to remove this inhibitor, a 200j.il DE 52 column was made and used in an attempt to 
clean up the cDNA preparation. The column is anionic and so it will bind negatively 
charged molecules. In this way the cDNA can be bound to the column and washed 
free of any contamnQn5. The cDNA was applied to the column in 0.1M NaCl in 
TE (pH 7.6), washed with 0.3M NaCl in TE and eluted in 0.6M NaC1ITE. The cDNA 
was then precipitated twice with ethanol and added to the ligation reaction. In fact the 
first time this step was used to try and eliminate any inhibitors it coincided with the 
making of completly fresh buffers and the linkers appeared to link very efficiently to 
the cDNA. However on subsequent attempts at least half of the Counts of the cDNA 
stayed on the DE52 column and could not be eluted even with 3M NaCl. Even with 
the inclusion of the column step in the method, the ligation reaction still did not work 
routinely. Figure 10 shows a typical example of experiments where the ligation reac-
tion was unsuccessful and then finally successful. 
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FIGURE 10 
Autoradiograph of dried down 1.5% agarose gel with an example of an unsucess-
ful ligation. Using 2 day RA induced HL-60 poly(A) as the template. lane-1 first 
strand cDNA; lane-2 double stranded cDNA; lane-3 Si nuclease treated double 
stranded cDNA; lane-4 cDNA plus linker ligation reaction mix with 1mM spermidine 
included in the reaction. lane-5 cDNA plus linker ligation reaction; lane-6 linker reac-
tion no cDNA; 
CML mRNA successfully linked to Eco Ri linkers. lane-7 blunt ended double 
stranded cDNA; lane-8 cDNA plus linker ligation reaction; lane-9 unligated linkers. 
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Cleavage of the synthetic linkers 
The cDNA was then cut with Eco Ri and there was a slight reduction of size of 
the cDNA indicating that the enzyme had successfully cut. 
Separation of the linker DNA from cDNA 
The unlinked linkers were partially removed from the cDNA by ethanol precipita-
tion which favours the larger cDNA molecules over the oligomers. The cDNA was 
then run on a 1.5% low melting point agarose gel and the DNA molecules above 
- 300bp were excised. The cDNA was extracted from the gel by excising the gel frag-
ment and removing the cDNA by electroelution. 
Ligation of cDNA to lambda DNA 
As it was unclear how much cDNA was remaining after all the sampling, the 
whole amount was ligated to l.tg of lambda DNA which was obtained from Promega 
already cut with Eco Ri. The lambda DNA was also ligated in parallel with the con-
trol insert provided by the company in parallel and then both reactions were packaged 
using Gigapak (Vector Cloning Systems). The test insert ligated to XgtlO produced - 2x 
i06  plaques per jtg ?. gtlO on the bacterial strain selecting for inserts (C600 MI) and 
_10 7 plaques on the permissive strain C600. 
The cDNA ligated to Xgt 10, when plated out gave a library on the C600HfI 
strain, of 40,000 recombinants, and subsequently a second library of 70,000 recom-
binants was obtained by the same techniques. Phage from the primary plating on 
C600Hfl were collected in SM buffer and 4m1 aliquots were stored at 4 0C over 
chloroform. 
4.3 Characterization of XgtlO CML cDNA library. 
The library was plated out ( 5,000 pfu) and screened with the plasmid pBR322 in 
order to check that there was no plasmid contamination. The autoradiograph of the 
filter probed with the nick translated plasmid was negative, indicating that the library 
was not contaminated with plasmid DNA. 
In order to ascertain whether the library contained eDNA inserts corresponding to 
expressed genes , lambda DNA was isolated from a clear plate lysate representing the 
whole library. The DNA was then analysed by Southern blotting using a human 
catalase eDNA probe (van Heyningen et al 1985a), or a mouse class I cDNA probe 
(gift of P.Brown). Figure 11 shows DNA from a human liver cDNA library (van 
Heyningen et al 1985a) and from AgtlO CIVIL library side by side, probed with the two 
cDNA probes. The class I probe hybridises to two major bands in the CML library 
DNA and to one slightly smaller band in the liver library DNA. The catalase cDNA 
probe hybridises to one band only in both libraries. This indicates that the CML cDNA 
library has cDNA inserts corresponding to mIRNA transcripts for catalase and class I 
genes. Analysing the DNA from the CML cDNA library and the human liver cDNA 
library with a human albumin probe did not reveal a hybridising band in the first case 




Autoradiograph of DNA from CML cDNA and human liver cDNA libraries 
probed with human catalase cDNA probe (lanes 1,2,3) or human 1-ILA class I cDNA 
probe (lanes 4,5,6). lanes 1 and 2 - 1tg CML cDNA library DNA cut with Eco Ri to 
release insert DNA; lane 3 human liver cDNA library DNA cut with Pst I to release 
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4.4 Construction of a Xgtll eDNA library 
As antiserum and McAb to CFAg were available, it was decided to make a 
cDNA library from CML cells in an expression vector. 
The vector of choice was Xgtll. This vector can produce a hybrid polypeptide 
consisting of the f3-galactosidase gene product and the insert gene coded polypeptide 
(Young et al 1983). This enables the library to be screened with antibodies directed 
against the protein and positive plaques can be identified using a radiolabelled or 
enzyme linked second antibody (Helfman et al 1983, Young and Davis 1983). Before 
the library was constructed the screening procedure was tested. Using an antiserum 
raised in rabbits against human albumin, a human liver library in Xgt 11 was screened 
according to section 2.26. Positive plaques were identified using 1125 radiolabelled pro-
tein A. Positive plaques were found at a frequency of 5%, and duplicate filters 
screened with a human cDNA albumin probe, showed that all the antibody positive 
plaques hybridised to the albumin probe, but not all the plaques hybridising to the 
probe were positive with the antibody (figure 12). This is as expected because some of 
the recombinant phage may have inserts which code for some of the albumin protein 
but not enough to enable the antibody to recognise the protein. However a high per-
centage (80%) of the plaques hybridising to the probe also gave positive signal with 
the antiserum. However only 1 in 6 of the albumin cDNA inserts will by chance be in 
the correct frame and orientation to produce albumin protein. The high number of 
clones which react both with the antibody and the probe is probably a statistical 
artefact due to the fact that only 6 albumin clones were present in the screen. 
It is to be expected that antiserum would be efficient at recognising native protein 
which has not necessarily been folded into its correct configuration as antiserum is a 
mix of antibodies directed to different immunogenic sites of the antigen. If McAb were 
to be used the success of the experiment would depend on whether the epitope on the 
protein to which the McAb was directed could still be recognised in the fusion protein. 
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However antiserum to CFAg was available as well as McAb to two separate epitopes 
(Hayward et al 1986) so success seemed probable if a suitable expression library was 
made. 
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FIGURE 12 
Autoradiograph of a set of replica filters from ?gt1 1 human liver cDNA library 
probed with (on the left) rabbit anti-human albumin serum followed by 1251-protein A, 
or (on the right) with a human albumin cDNA probe labelled by nick translation. The 
filters are aligned so that their orientations are the same, and positive colonies are 
arrowed. 
- 95 - 
Lambda gtl 1 contains a unique Eco Ri site within the lacZ gene. This gene 
codes normally for 3-galactosidase and the Eco Ri site is 53bp upstream from the 
translation termination codon. Foreign DNA sequences inserted into this site can then 
be expressed as hybrid proteins with -galactosidase. The phage have no selection for 
recombinants but there is an indication system. The 13-galactosidase will produce blue 
coloured plaques when plated on the chromogenic substrate 5-Bromo-4-chloro-3-
indoly-b-D-galactopyranoside (xgal). When the gene has an insertion the 3-
galactosidase can no longer function and so white plaques are produced. So that the 
proteins coded for by the foreign DNA do not harm the growth of the E.coli, the host 
bacteria contain a plasmid with the lac repressor gene (lad) which prevents transcrip-
tion of the lacz and hence the inserted gene until induced by the inactivation of the 
repressor by isopropyl -D-thiogalactopyranoside (IPTG). In order to prevent the bac-
teria destroying the antigen, the phage are grown in protease deficient bacteria (Ion-) 
(Charnay et al 1980). The phage also carry a temperature sensitive CI gene which 
facilitates the growth of phage as lysogens at 32 °C and as lytic phage at 42 ° C. The 
recombinant library is initially plated out on Y1089 which is hsdR- and hsdM-, and 
carries the plasmid borne lac repressor. 
The construction of Xgtl 1 library was carried out at the same time as the second 
XgtlO library was made. The protocol is identical for the two phage except that there 
is no selection for recombinants in the A.gtl 1 system so a molar excess of insert DNA 
is used in the ligation of the phage to the cDNA. Alkaline phosphatase treated 7gt1 1 
arms were purchased from Promega Biotech and the ligation was done in 2il volume. 
The control ligation with no insert DNA gave 80% of plaques (all blue) obtained with 
non alkaline phosphatase treated, Eco Ri cut lambda gtl 1. When the library was plated 
out, 50% were white plaques on x-gal and IPTG and assumed to be recombinant 
phage. I then amplified the library as for A.gtlO and replated out on Y1089 with x-gal 
and IPTG. The new ratio of recombinants to non-recombinants was 1:300. The non- 
am 
recombinants had obviously outgrown the recombinants in the course of amplification 
and hence the drop in number. A better strategy would have been to screen the library 
straight away, as this first plating out is the most representative. It was decided not to 
attempt to make another expression library, but to isolate possible myeloid specific 
clones from the XgtlO library and then redone those inserts into ?gtl 1 and see if any 
were positive with the antiserum raised against the band cut Out of the IEF gel. 
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CHAPTER 5 
Attempt to Isolate CML Specific Clones. 
5.1 General Strategy 
Having constructed a library which should contain the cDNA for CFAg the next 
step was to isolate those clones. At this time no protein sequence data was available. 
The strategy to isolate putative clones was as follows: 
Isolate CML specific clones by differential screening. Confirm their 
specificity by Northern analysis of mRNA from CML and other tissues 
Of these clones identify which ones will hybridise to mRNA isolated from 
HL-60 induced with RA but not to mRNA from HL-60 grown on serum free 
medium. 
Of these clones, it should be relatively easy to recognise which ones 
map to chromosome 1 due to the availability of chromosome 1 containing 
somatic cell hybrids. 
Any clones which are positive by all these criteria can be further 
tested to see if they will hybridise to mRNA extracted from CFAg 
expressing somatic cell hybrids (van Heyningen et al 1985) and not to mRNA 
from a non-CFAg expressing hybrid. 
As a definitive test, the positive clones could be recloned into a suitable 
expression vector so that the proteins for which the cDNAs code could be 
tested for reactivity with the anti-IEF antiserum. 
5.2 Differential Screening 
The technique of differential screening has been used successfully in a number of 
cases. Dworkin and Dawid (1980), found that 20% of the clones from a Xenopus 
laevis cDNA library contained inserts that could give detectable signal when screened 
with 32  P cDNA synthesised from homologous DNA. Clones which gave no detectable 
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autoradiographic signal contained sequences comprising less than 0.06% of the 
radioactive cDNA while positive clones contained sequences homologous to increas-
ingly larger fractions of of the probe, correlating to increasing autoradiographic signal 
intensity. Thus, for a specific mRNA population, only abundant or moderately abun-
dant sequences will be represented highly enough in the cDNA probe to carry enough 
signal to be effective in hybridisation. From the relative amount of CFAg radiolabelled 
in internally labelled cells it was thought that CFAg would be of at least moderate 
abundance in CML mRNA. 
In theory the cDNA library is plated out and replica filters are screened with a 
cDNA probe homologous to the mRNA used to construct the library and a cDNA 
probe synthesised from mRNA of a different tissue or stage in development. Plaques 
which hybridize only to the cDNA from one tissue type must be either expressed only 
in that tissue or else more abundantlly expressed in that tissue compared with the 
other. There is some evidence that the more abundant sequences may represent tissue 
specific sequences (Hastie and Bishop 1976). Dworkin and Dawid (1980) and Williams 
and Lloyd (1979) agree that a 5 fold difference in expression can be detected by this 
technique. Williams and Lloyd (1979), successfully used this technique to isolate 
developmentally regulated mRNAs from the slime mould Dictyostelium discoideum 
and Rebagliati et al (1985) localized maternal mIRNAs from xenopus eggs. 
Axel and Lemke (1985) isolated the cDNA for the rat Schwann cell glycoprotein 
Po using the technique of differential screening and hybrid selection. They constructed 
a 7gt10 cDNA library from poly(A) RNA isolated from the sciatic nerve of 8-10 day 
rats. The library was then screened in duplicate with 32P-labelled cDNAs from sciatic 
nerve and brain. They report that 2% of the cDNA clones hybridised only to the sci-
atic nerve cDNA, but 70% of these were found subsequently to cross hybridise. How-
ever one clone was completely absent in brain tissue and highly expressed in Schwann 
cells of the sciatic nerves. Thus the number of differentially expressed clones which 
S. 
were detected indicates that a less abundantly expressed clone would be much more 
elusive. 
5.3 Application of the differential screening technique to the XgtlO CML eDNA 
library 
1. Screening CML cDNA library with cDNA from various tissues in an attempt to iso-
late CML specific clones. 
It was decided to screen replica filters from the CML cDNA library with labelled 
cDNA complementary to mRNA from a B lymphoblastoid cell line (Daudi) (Klein et 
al 1968); mRNA isolated from uninduced HL-60 and to the CML mRNA which was 
used for the construction of the library. Both the former tissues should have had some 
mRNA species for housekeeping genes in common with CML, and the HL-60 cDNA 
should contain some myeloid specific sequences. The CML cDNA however should 
contain sequences which are specific to that tissue type and so it was expected to 
hybridise uniquely to some plaques. 
RESULTS 
The library was plated out on large 20x2Ocm plates at approximately 5,000 
plaques per plate. 3 replica filters were taken as described by Benton and Davis 
(1977). Poly-adenylated RNA was isolated from the tissues to be used in each case. 
The cDNA used to screen the filters was made essentially in the same way that 1st 
strand cDNA was made for constructing the library. The developing strand of comple-
mentary DNA was labelled by the incorporation of ((x 32p)dTTP. The RNA-DNA 
hybrid was then cleaved with alkali treatment and approximately equal number of 
counts was used for the cDNAs being compared. 
Three plates were screened and no differences between any of the filters could be 
identified. The CML cDNA hybridised to 5% of the clones giving a very strong signal, 
2% of the clones gave a fainter signal. Every clone which hybridised to the CML 
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cDNA also hybridised to both the Daudi cDNA and the HL-60 cDNA. Furthermore 
those clones which were less intense with the CML cDNA were also less intense with 
the other two cDNAs. At this point it was thought that perhaps the similarity of the 
tissue types was resulting in all the highly expressed transcripts being present in all 
three tissues. Consequently the next step was to try to isolate sequences that were 
present in CML and not present in liver mRNA. 
2. Screening with liver cDNA versus CML cDNA 
Liver poly(A) RNA contains highly expressed tissue specific mRNAs, (Galiu et 
al 1977) and therefore liver cDNA should contain a different pattern of abundant 
molecules from other tissues. The CML eDNA was rescreened with cDNA from CML 
poly(A) and cDNA made to normal liver poly(A) +. 
RESULTS 
The results were the same as before in that each plaque that was positive with the 
CML cDNA was also positive with the liver cDNA (see figure 13). 
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FIGURE 13 
Overnight autoradiographs of replica nitrocellulose filters taken from CML cDNA 
library, probed with CML cDNA or liver cDNA. Each 20x2Ocm plate contained 
- 5,000 plaque forming units (pfu). No differences could be observed between the two 
autoradiographs even after I week exposure. The filters are arranged in the same orien- 
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3. Screening fewer plaques per plate 
In the previous experiments large numbers of phage were being screened to detect 
differences in expression i.e 50,000 recombinant phage were screened distributed over 
10 plates and no differences were detected. 
As smaller filters are easier to handle and compare, it was decided to plate out 
smaller numbers of less dense phage. As cDNA reflects the mRNA population then 
genes which are represented as 0.5% of the mRNA should be present at 1 in 200 
clones. Replica filters from 20 small plates with 200 pfu per plate were screened with 
the liver, Daudi and CML cDNAs. 
RESULTS 
The results (figure 14) show - 5% of the screened clones are positive in each case 
and no hybridisation differences can be detected between any of the cDNAs. Two 
plaques only appeared to be very faintly positive with Daudi and liver cDNA and 
strongly positive with CML cDNA (figure 15; top row). This plaque (1 out of 2000 
plaques) however appeared to have no difference in signal when tested in secondary 
screening (figure 15 bottom row). The possibility that repeated sequences within the 
untranslated region of the mRNA could be masking tissue specific mRNA species was 
investigated next. 
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FIGURE 14 
Overnight autoradiographs of nitrocellulose filters taken from CML cDNA library 
probed with CML cDNA or Daudi cDNA. Plates contained 200 plaque forming units. 
No differences could be observed between the two autoradiographs after 10 days expo-
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The top row shows an overnight autoradiograph of 3 nitrocellulose filters (top line) 
taken from CML cDNA library probed with CML, Daudi or liver cDNA. The arrows 
indicate clones only positive with CML cDNA. Filters are arranged in the same orien-
tation. 
The autoradiograph in the bottom row shows filters probed with cDNA from Daudi 
(left hand filter) and CML (right hand filter), to show the positive clone (marked with 
the blue arrow in the CML filter in figure 15 (top row)) was no longer CML specific 
when isolated and rescreened. 
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4. Screening with Si nuclease treated human genomic DNA. 
The human genome is interspersed with repeated sequences including the most 
abundant mid-repetitive sequences i.e the Alu family (Houck et al 1979), and - 20% of 
human midtrimester fetal tissue poly(A) RNA have been reported to contain repeti-
tive sequences (Kurnit et al 1982). This being the case, lead us to consider whether 
human repeats in transcripts were masking tissue specific clones. Any clone containing 
a repeat element in the untranslated region, irrelevant of its true abundance would 
hybridise strongly to cDNA probe from any tissue because 20% of the probe would 
have labelled cDNA species containing repeats. However not all these repeats will be 
of the same family or abundance. 
Human DNA was enriched for repetitive sequences by isolating double-stranded 
DNA after annealing total human DNA to a C 
0  t of 1 and treating with Si nuclease 
(gift of R.Meehan). If the pattern of hybridisation was the same with Si nuclease 
treated DNA as with cDNA from a tissue, then it could be concluded that it is the 
abundant mid-repetitive sequences in the human genome that are hybridising to 
plaques irrespective of the unique sequence of the clone or abundance of the mIRNA. 
RESULTS 
The pattern of hybridisation of the Si nuclease treated genomic human DNA was 
compared with the pattern obtained with CIvIL cDNA and liver cDNA. Figure 16 
shows that of a plate of 5000 plaques, 300 clones hybridise to the CML cDNA, and 
100 clones hybridise to the Si nuclease treated human DNA. Of these Si nuclease 
positive clones only 10 correlate with the CML cDNA positive plaques. The liver 
cDNA hybridised to all the same plaques to which the CML cDNA hybridised. This 
experiment was repeated several times and gave the same result indicating that highly 
abundant repeats were not responsible for the lack of success in isolating tissue 
specific clones, unless all the tissue specific clones contained repeats and these are the 
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10% of Si treated DNA positive clones which cross-hybridise with CML cDNA. All 
the other CML cDNA positive clones which cross-hybridise with the liver cDNA must 
therefore be abundant non-tissue specific mRNA homologues. This seems an unlikely 
explanation of the results. Another person in our lab has found the same result using a 
2Lgtl 1 cDNA human liver library. Screening this library with CML cDNA, liver cDNA 
and Daudi cDNA, no difference was found in the pattern of hybridisation. Screening 
with Si nuclease treated, repeat enriched DNA it was found that the hybridisation pat-
tern was very different when compared to the liver cDNA hybridisation. Only 10% of 
the Si nuclease treated DNA positive plaques were also positive with the liver cDNA 
plaques. If all the tissue specific clones contained highly repeated sequences then albu-
min (one of the liver's major transcripts) must contain such a repeat and both CML 
and liver cDNA would hybridise to the albumin clones in a liver cDNA library. This 
was shown not to be the case. 
Those clones not hybridising to the Si treated DNA represent clones containing 
single copy DNA, or clones containing repeat sequences below the limit of detection 
In order to examine whether the method by which this technique was being car-
ried out, or whether the general theory was at fault a positive control experiment was 
designed. 
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FIGURE 16 
Autoradiographs of replica filters of CML cDNA library probed with liver cDNA, 
CML cDNA and nick translated Si nuclease treated human DNA. The Si nuclease 
treated human DNA gives a different hybridisation pattern to the library probed with 
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5. Identification of albumin cDNA clones by differential screening 
A ? gtl 1 cDNA clone was isolated with the human albumin cDNA probe. This 
clone was plaque purified and diluted into the XgtlO CML cDNA library at a ratio of 
1:30 albumin:CML. The CML library and albumin contaminated CML library were 
plated out at a density of - 150 plaques per plate. A plate of 50 albumin only clones 
was also prepared. Four replica filters were then taken from each plate and hybridised 
with CML, Daudi, liver cDNA or the nick translated albumin cDNA probe. Figure 17 
shows the experimental scheme and results. 
RESULTS 
The albumin clones seeded in the CML library were identified with the mouse 
albumin probe. None of these clones were positive with the CML cDNA or the Daudi 
cDNA. The liver cDNA hybridised strongly to all the albumin clones either when 
plated out separately or when seeded in the CML library. Filter la (in figure 17) 
shows the liver cDNA identifying albumin clones, and 2a shows liver cDNA hybridis-
ing to albumin clones and CML clones. The CML cDNA however, does not hybridise 
to filter ic (albumin clones) or the albumin clones seeded into the library (filter 2c). 
Apart from the albumin clones, the pattern of hbridisation of the three cDNAs to the 
CML library are identical. Thus the liver specific albumin clones, when seeded 
artificially in the CML library, can be identified by differential screening. 
FIGURE 17 
Schematic representation of experiment to show that albumin can be isolated by 
differential screening. The autoradiograph shows the filters corresponding to the filters 
in the diagram. Filters are aligned in the same orientation. Filters la-id are albumin 
cDNA containing phage, only. Filters 2a-2d are CML cDNA clones, seeded with albu-
min cDNA clones. Filters 3a-3d are CML cDNA clones. Filters with the same numbers 
are taken from the same agar plate. Filters la, 2a and 3a were hybridised with human 
liver cDNA. Filters lb. 2b and 3b were hybridised with nick translated mouse albumin 
cDNA clone. Filters ic, 2c, and 3c were hybridised with CML cDNA. Filters id, 2d, 
and 3d were hybridised with Daudi cDNA. Filters ic and id are completely negative, 
the radioactive marks on them which appear to resemble positive plaques are due to 
orientation holes in the filters, and can therefore be discounted as artefacts. The albu-
min plaques, are positive on filters la, lb, 2a, and 2b. They are the only positive 
clones on filters la, lb, 2b, and are therefore easily visible. They are smaller and 
fainter clones than the cDNA CML clones because the CML clones are in the phage 
A.gtlO, while the albumin clones are in Xgt11. XgtlO gives larger plaques than ?tll and 
therefore the albumin positive plaques are difficult to visualize in the photograph of 2a, 
as the radioactive signal from the Xgt 10 positive plaques tends to obscure that from 
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6. Randomly Primed cDNA 
In all the previous experiments the cDNA was synthesised from the mRNA, using 
oligo (dT) 1218  as a primer. It has been demonstrated that highly repeated sequences 
such as those which would be detected with Si nuclease treated genomic DNA are not 
responsible for the lack of identification of tissue specific clones. However if a repeat 
element present at an abundance below the resolution of Si nuclease treated DNA is 
responsible, and that element is in the 3' region of the mRNA, then it will generally be 
represented if the oligo (dT) method of cDNA synthesis is used. The primer anneals to 
the poly(A) tail of the rnRNA and so cDNA is synthesised from this region and in 
theory all cDNA molecules should have the 3' region and extend variable distances 5' 
into the mRNA sequence. If the cDNA is of small size, then the 3' untranslated 
regions of the mRNA will be highly represented in the cDNA mix. To circumvent this 
problem and to get a better representation of the whole length of the mRNA 
molecules, it was decided to randomly prime the cDNA instead of using oligo (dT). 
Random priming uses 6 nucleotide stretches of single stranded DNA which will anneal 
to the mRNA at regions along the length of the molecules. cDNA primed in this way 
will thus represent the whole length of the mRNA as a mixed population. 
A liver Xgtl 1 cDNA library (Clontech) was screened with oligo (dT) primed 
cDNA and randomly primed cDNA synthesised from liver poly (A) RNA. Initially 
the library was used to compare the hybridisation patterns of oligo (dT) primed cDNA 
from CML, liver and Daudi poly (A). Identical patterns of hybridisation were 
obtained in each case. 
500 pfu of the liver cDNA library were then plated out, and replica filters were 
probed with oligo (dT) primed liver cDNA or S 1 nuclease treated DNA or randomly 
primed liver cDNA. 
RESULTS 
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25 (10%) of the plaques hybridised to the liver oligo (dT) primed liver cDNA. Of 
these, 10 plaques hybridised to Si nuclease treated genomic DNA and a further 17 
plaques hybridised exclusively to the Si nuclease DNA. The randomly primed cDNA 
gave a hybridisation pattern similar to the oligo (dT) primed pattern in that each 
plaque that was positive with the oligo (dT) primed eDNA was positive with the ran-
domly primed cDNA but there were 12 additional plaques which hybridised only to 
the randomly primed cDNA. These 12 plaques did not hybridise to the Si nuclease 
treated human DNA. 
These results indicate that the randomly primed cDNA hybridises to liver cDNA 
sequences which are not picked out by the oligo (dT) primed cDNA. We have not 
found any Xgti 1 liver cDNA plaques which hybridise to liver oligo (dT) primed 
cDNA and do not hybridise to oligo (dT) primed CML or Daudi cDNA. It is hoped 
that the additional plaques which hybridise over and above the oligo (dT) primed 
cDNA are liver specific. 
The experiment was repeated with the CML cDNA library being probed with ran-
domly primed and oligo (dT) primed CML cDNA and Si nuclease treated DNA. The 
result was the same as with the liver library in that the randomly primed cDNA gave 
6 more plaques in addition to the 50 plaques which hybridised in common with the 
oligo (dT) primed cDNA (see figure 18). The plaques unique to the randomly primed 
cDNA hybridisation pattern did not cross react with the Si nuclease treated DNA. 
5.4 Discussion 
It has been shown here that randomly primed liver cDNA and CML cDNA, when 
hybridised to replica filters from the liver cDNA library, gave a common background 
pattern and some liver specific plaques, hybridising only to the liver cDNA. treated 
cDNA. The problems initially encountered, may have lain partially in the properties of 
the reverse transcriptase used. A colleague found subsequently that using new reverse 
transcriptase (nbl enzymes) which gave a very high incorporation of dTTP into the first 
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strand (30% compared to 1-3% with the old reverse transcriptase (Boehringer 
Mannheim) seemed to improve the differential screening results. Oligo (dT) primed 
cDNA from liver and CML when hybridised to the liver cDNA library gave distinctly 
different patterns of hybridisation when the new reverse transcriptase was used. 
This work is incomplete as an oligonucleotide probe deduced from the amino acid 
sequence for CFAg became available. This meant that CFAg cDNA clones could be 
screened for directly and so differential screening for CML specific clones became 
redundant. The fact that randomly primed cDNA hybridises to more plaques than con-
ventionally primed cDNA needs to be further investigated. The plaques which hybri-
dise exclusively to the randomly primed cDNA need to be isolated and rechecked for 
their tissue specificity. There is no evidence that repeats are the reason for this result 
and the experiments with S1 nuclease treated human DNA indicate that it is not mid-
repetitive sequences which are influencing the hybridisation pattern. The possibility 
exists that it could be repetitive elements of an abundance below the resolution of the 
Si nuclease-treated DNA. This might possibly explain the different hybridisation pat-
terns seen. If the CML cDNA hybridises to the CML library by virtue of homology 
with tissue specific sequence in that DNA sequence, then the liver cDNA should not 
hybridise unless the insert DNA also contains sequence which is not tissue specific and 
will hybridise to a population of the liver cDNA with homology to this piece of the 
sequence. This non tissue specific piece of sequence would necessarily be in the 3' 
untranslated region of the mRNA and would perhaps explain why more efficient 
reverse transcriptase extending further into the mRNA molecules would obviate the 
problem. This does not explain why the experiment where albumin was seeded into the 
CML library worked so successfully. As albumin was detected immunologically to be 
in the ?gt11 liver library at 5% of the clones, when J.Maule screened with liver 
versus CML cDNA at least 1 in 20 clones should have been liver specific! 
Had I continued on this line of work, the next step that I should have taken 
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would have been to attempt subtractive hybridisation. This is a technique which has 
been used very successfully by Littman et al (1985) where the gene encoding the T 8 
cell surface glycoprotein was isolated. Basically the strategy was to produce mouse L 
cell cotransformants which expressed the human T 8 cell surface marker. cDNA was 
synthesised to the rnRNA from the cells and hybridised to a vast excess of mRNA iso-
lated from nontransformed mouse L cells. The resultant probe, highly enriched for T 8 
sequences, was then used to screen a cDNA library of human peripheral T cells and 
the relevant cDNA was isolated. However in this instance, Littman et al (1985) have a 
highly expressed gene and the non transformed cells provide the perfect source of 
cDNA to remove the non specific sequences. 
I feel that the " repeat problem " could be removed from our experiments by 
absorbing out the molecules containing repeat elements from the labelled first strand 
cDNA. This could be accomplished by hybridising with an excess of "cold' total 
human DNA (Sealy et al 1985) before screening the library. 
Another possibility which could account for the anomalous results obtained is the 
presence of mitochondrial mRNA in poly (A) preparations from most tissues. The 
abundance of the mitochondrial mRNA in the library and in the various tissue cDNAs 
determines how tissue specific the initial overall pattern will appear. This does not 
explain the difference between random and oligo (dT) primed cDNA hybridisation pat-
terns. The presence of mitochondrial cDNA sequences could be quantified by probing 
the CML cDNA library with mitochondrial specific probes. 
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FIGURE 18 
Photograph of autoradiographs of replica filters from XgtlO CML cDNA library probed 
with a) oligo (dT) primed CML cDNA 	 b) randomly primed CML cDNA 
c) Si nuclease treated human DNA nick translated. 
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CHAPTER 6 
ISOLATION OF THE cDNA FOR CFAg 
6.1.a Design of oligonucleotide probes to screen the XgtlO CML eDNA library. 
As described in the introduction, several IgG monoclonal antibodies (McAbs) 
were raised against CFAg (Hayward et a! 1986) from CML lysate. The McAbs fell 
into two classes which recognised different epitopes on the antigen. C557, the lowest 
affinity McAb, was used in the imrnunopurification of the antigen (Novak et a! 1987). 
The antibody was coupled to CNBr-activated Sepharose and used to purify CFAg from 
the plasma of CF patients, lysate of CML cells, and lysate from DMSO stimulated 
HL-60 cells. The CFAg purified from all these sources was compared by N-terminal 
amino acid sequence determination, SDS PAGE immunoblotting, and Ouchterlony 
double diffusion using the anti-CML antiserum. By all these criteria, the antigen 
appeared to be identical from whichever source it was purified. The greatest length of 
amino acid sequence was obtained from antigen purified from normal granulocytes. In 
this instance 53 amino acids were sequenced. The partial sequencing of the first 30 
residues of the antigen from CML cells, enabled the corresponding coding sequence to 
be searched for a suitable oligonucleotide sequence. Owing to the redundancy of the 
genetic code, most amino acids are encoded by four different codon triplets and three 
of the commonest amino acids each have a total of 6 different codons. Thus a happy 
medium between length of oligomer (the longer the more specific) and the number of 
alternative probes required to cover all codon possibilities must be reached. Oligonu-
cleotide mixes of 4 (Stetler et al 1982); 8 (Sood et al 1981); 12 (Breslow et a! 1982); 
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64 (Orkin et al 1983); and 384 (Whitehead et a! 1983) have been successfully used. In 
this case 2 probes were designed as shown below: one of 15 nucleotides with 144 vari-
ations and one of 17 nucleotides with 64 variations. 




5' AUU AUU 
C C 
A A 
14 15 16 
DV Y 
GAU GUU UAU 3' 
C C C 
A 
G 
Anti-sense sequence used 
SY-284 
15mer Mix 144 
5' ATA AAC ATC AAT AAT 3' 
G G G G G 
T 	T T 
C 
Predicted mRNA sequence from protein sequence 
Amino acid 	23 24 25 26 27 28 
K G N F K A 
5' AAA GGU AAU UUU AAA GC 3' 
G C C C G 
A 
G 
Antisense sequence used 
SY-312 
17mer Mix 64 
5' GC TTT AAA ATT ACC TTT 3' 
C G G G C 
T 
C 
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6.1.b Screening the XgtlO CML eDNA library with oligonucleotide probes. 
The oligonucleotide mixes were end-labelled (section 2.2) with 200 p.Ci (y- 32P 
ATP) per reaction and 5pmoles of 5' ends. For a 17 nucleotide probe (assuming the 
average molecular weight of a base to be 300), the molecular weight of the probe is 
300 x 17 = 5,100. Thus 1 mole, or 6.2 x 1023 molecules weighs 5,100g. 14g therefore 
= 1.2 x iO'4 molecules. 1.2 x 1014  molecules = (1/6.2 x 1023)  x 1.2 x 1014 = 1.9 x 
10- 10  moles (196 pmoles). Therefore, 5 pmoles of 5' ends = 25.5ng of l7mer DNA. 
100,000 plaques over 10 plates were screened in duplicate with each oligo mix (sec-
tion 2.23). The optimum temperature at which nitrocellulose filters are hybridised with 
an oligonucleotide probe, can be calculated as follows. The ideal temperature for 
hybridisation to an oligonucleotide probe is where perfect hybrids are stable, but 
mismatched hybrids are not. This is usually 5°C below the temperature (Td) at which a 
perfectly-matched hybrid will be half-dissociated (Suggs et a! 1981). Td = 4 0C per GC 
base pair + 20C per AT base pair. For an oligonucleotide mix, the lowest calculable 
Td is used i.e hybridisation is at 5 °C below the lowest Td. For SY 284, this tempera-
ture was 31 °C and for SY 312 it was 37 °C. A final wash was given at the Td tem-
perature. 
Seven plaques were positive on duplicate filters for the 15mer SY-284 but none 
of these were positive with SY-312. There were no plaques positive on duplicate filters 
for SY-312. This was somewhat disturbing at the time, because the position of SY-312 
was only 18bp from SY-284 and was more 3' in the mRNA. It seemed unlikely that 
cDNA synthesised from the 3' end of the mRNA should contain sequence homologous 
to the oligonucleotide SY-284 and not have sequence homologous to SY-312. As 
SY-284 had such a varied sequence and was only 15 bp long there was some anxiety 
that just by chance there would be a sequence in the library that would match one of 
the oligomer variations. The fact that the other oligomer did not hybridise added 
emphasis to this worry. However the 7 positive clones were picked, replated and reiso- 
-118- 
lated until the plaques were all positive. It was subsequently discovered by M. Novak 
that the amino acid sequence to which the oligomer SY-312 had been made was 
incorrect and the residue at position 27 was histidine and not lysine. 
6.1.c Insert size of the lambda clones 
DNA was made from the 7 positive lambda clones (Section 2.24) using a 20x20 
cm clear plate lysate. The inserts were released from the lambda by restricting the 
DNA with Eco Ri, and visualised by running on 0.8% agarose gel. Clones 4 and 8, 
had inserts of 350bp. Clones 3-16, 3-14, A, B and C, had insert sizes of 250bp. The 
Eco Ri cut lambda gtlO cDNA clones 4, 8, 3-14, 3-16 A, B, C were then shotgun 
cloned (Section 2.30) into pUC-9 (Messing et a! 1982). The lambda arms are too 
large (32kb and 10kb) to be ligated into the plasmid and pUC-9 contains the 13-
lactamase gene and Col El origin of DNA replication of pBR322 ligated to a portion 
of the lacZ gene of E.coli. Introduced into lac minus E.coli, the plasmid will give rise 
to blue colonies when grown on the appropriate indicator plates. Cloning into the 
unique restriction sites within the lacZ gene fragment, inactivates the gene and gives 
rise to white colonies. 
Cloning into a plasmid enables large amounts of cloned DNA to be grown up and 
used as a probe, either labelled as the whole plasmid, or as insert DNA. pUC-9 is only 
2769bp whereas lambda gtlO is 43.34kb in size. A 300bp insert is thus - 10% of the 
plasmid DNA, but only 0.75% of the lambda gt10 genome. 
Clone 4 and 8 were successfully subcloned into pUC-9. Ligations and transforma-
tions were carried out as described in the materials and methods (section 2.30, 2.31). 
Transformed E.coli JM 83 were identified as ampicillin resistant bacteria. Bacteria car-
rying plasmid with insert DNA were white (non-blue) colonies when grown on X-gal. 
18 white colonies were picked from each experiment and small scale DNA prepara-
tions were done on imi cultures (section 2.32). Cutting these small scale preparations 
of plasmid DNA with Eco Ri, revealed that all of the samples contained insert DNA 
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of the correct size. ?gtlO cDNA clones 8 and 4 subclones in pUC-9, (8-9 and 4-7) 
were grown up in large scale plasmid preparations (section 2.33) and insert DNA was 
isolated from the plasmids (section 2.34) by cutting with Eco Ri and then excising the 
relevant band from a low melting point agarose gel and then carrying out phenol 
extractions (section 2.34). 
The insert fragments were used in Northern blots, to look for the abundance and 
tissue specificity of the mRNA homologous to CFAg cDNA. In order to verify the fact 
that the isolated cDNA clones were identical, the insert DNA of clone 8-9 was used to 
probe Eco RI lambda gtlO digests of the other 6 clones (3-1, 3-2, 4-7, A, B, Q. Clone 
8-9 hybridised with all the other clones' insert DNA, but not with the lambda vector's 
arms. Therefore all the clones isolated, were probably from the same cDNA. As clone 
8-9 was the largest clone, this was used in the further characterisation. 
6.1.d Verification of clone 8-9 being cDNA for CFAg. 
Initial evidence of the identity of clone 8-9 was present in Northern blot data. 
When various tissues were probed with insert DNA from clone 8-9, hybridisation sig-
nal was only seen with mRNA samples from CML cells and induced but not unin-
duced HL-60. Further, there was hybridisation with RNA extracted from a somatic cell 
hybrid expressing CFAg but not with another hybrid which did not express CFAg. 
This evidence is an indication of the identity of clone 8-9 but is somewhat circumstan-
tial (see later for Northern blot data in detail). The chromosomal location of the clone, 
also provided circumstantial evidence as to the identity of clone 8-9 (see later for chro-
mosomal mapping data). Sequencing the DNA of clone 8-9 however, provided uneqi-
vocal evidence that the cDNA for CFAg had been cloned. 
6.2 Sequencing data 
In order to sequence clone 8-9, the insert fragment was cloned into the Eco RI 
site of M13 mp9. The M13 lifecycle can be exploited for the preparation of single 
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stranded recombinant DNA which then lends itself to sequencing using the Sanger 
dideoxy sequencing method. The general protocol is as follows (for experimental 
details see section 4.8). In its replicative form, M13 exists as a double stranded 
species. This enables foreign DNA to be cloned into a suitable restriction site. The 
M13 can then be introduced into a competent bacterial host by a transfomation step. 
The phage will then produce both double stranded replicative forms and single 
stranded mature virus forms. Large fragments of DNA can be cloned in M13 because 
it is a filamentous phage and has no constraints on the size of molecule due to packag-
ing restrictions. However 300-900bp inserts appear to be most successful in practice. 
M13 does not lyse the host cell but it does retard the growth so that infected cells 
appear as turbid plaques on a lawn of uninfected cells. In order to identify recom-
binants from nonrecombinants the Messing and Vieria (1982) M13 vectors have been 
designed to incorporate the E.coli lacZ gene under the control of the lac operon. The 
unique cloning sites are located within the lacZ gene and in the presence of the gratui-
tous inducer 1PTG only nonrecombinant phage will give a blue colour when plated on 
the colourimetric substrate X-gal. This is because the lacZ gene product will only be 
functional, and able to hydrolyse X-gal when it is not interrupted by the insertion of 
foreign DNA. The recombinant phage having been identified, are amplified in small 
cultures and the protein coat removed by phenol treatment. The single stranded tem-
plate is now ready for sequencing. This is carried out by annealing a l7mer oligonu-
cleotide homologous to a region of the M13 genome adjacent to the insertion site. The 
primer is then extended in the 5' to 3' direction by the Klenow fragment of E.coli 
DNA polymerase I. This lacks the 5' to 3' exonuclease activity of the whole enzyme 
but still retains the polymerase activity and will incorporate a dideoxynucleoside 
instead of a deoxynucleotide although at reduced efficiency. In order to continue chain 
synthesis there must be a 3' hydroxyl group on the last nucleotide to use in the phos-
phodiester bond to the next nucleotide. Dideoxynucleosides lack a 3' hydroxyl group 
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so if one is incorporated into the growing DNA strand, termination will occur at that 
point. This is exploited in Sanger's sequencing method. Four reactions are carried out, 
each with one of the dideoxynucleosides (ddATP, ddGTP, ddCTP, or ddTTP), as well 
as dNTPs. In each reaction the enzyme will occasionally use a ddNTP and terminate 
the DNA synthesis of some growing strands but in most cases a dNTP will be incor-
porated and the DNA will be extended further. The result is a series of DNA frag-
ments terminated at different ddNTPs. This can be visualised by the incorporation of a 
radiolabelled dNTP into all the reactions and the denatured DNA then resolved on a 
polyacrylamide gel and autoradiographed. 
M13 clones were isolated with the 8-9 insert fragment in both orientations, which 
allowed the DNA to be sequenced in both directions. A 19mer oligonucleotide was 
synthesised to a region of the insert DNA from 142 to 160 in both the sense and anti-
sense so that clones of both orientations could be sequenced to verify the data. Figure 
19 shows an example of DNA sequencing by the Sanger dideoxy technique (Sanger et 
al 1977). The arrow indicates the Eco RI site of the M13, and the insert sequence is 
read from that point up the gel. The resulting 338bp sequence (see figure 20) was 
translated to protein sequence. The predicted amino acid sequence was found to agree 
almost exactly with the protein sequencing data obtained by M.Novak. The residue at 
position 27 was found to be histidine and not lysine which explained why the oligomer 
SY-312 had not hybridised. At amino acid 42 the protein sequencing revealed a 
threonine where the DNA sequence predicted a cysteine and at position 50 the protein 
analysis identified a threonine where the DNA sequence indicated a glycine. These 
differences were resolved on subsequent protein sequencing and the deduced sequence 
was correct. 
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FIGURE 19 
Autoradiograph to show an example of Sanger dideoxy sequencing. The method 
was carried out as described in section 2.35. The arrow indicates the Eco Ri site in the 
Eco Ri linker. The letters at the top of the tracks, indicate which dideoxy NTP was 
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The sequence of clone 8-9 (figure 20) includes an open reading frame of 249bp 
which encodes 83 amino acids stretching from the first amino acid used for construc-
tion of the oligonucleotide probe to the carboxyterminal residue before the chain termi-
nation codon. The sequence encoding the first 11 N-terminal amino acids known from 
the protein sequencing data and the 5' untranslated region is missing from the clone. 
The molecular weight of the protein calculated from this deduced sequence is 10,938 
kDa and this is in approximate agreement with the observed molecular weight from the 
immunoprecipitation of the antigen. There do not appear to be any N-glycosylation 
sites (N X S, N X T) in CFAg from the predicted sequence and there is no evidence 
that CFAg is a glycoprotein. The predicted protein is rich in lysine residues (14%) 
and leucine (10.5%). 
TATCATCGACGTCTACCACAAGTACTCCC 
[M L T E L E K A L N S I I D V Y I 	1K Y S 
30 
TGATAGGGGAATTTCCATGCCGTCTACAGGGATGACCTGAAGAAATTGC TAGAGACCG 
L I K G N F H A V Y R D D L K K L L E T 
90 
AGTGTCC TCAGTATATCAGGAAAAAGGGTGCAGACGTCTGGTTCAAAGAGT TGGATATCA 
F C P Q Y IRK K GAD VI 	F K EL DI 
IL 5 0 
ACACTGATGGTGCAGTTAACTTCCAGGAGTTCCTCATTCTGGTGATAAAGATGGCGTGGC 
N T C C A V N F Q E F L I L V I K M A W 
AGCCCAC GCCATGGGCCACGAGTAGCTGAGTTACTGCCCAGAGGC 
J) P T K K A M K K A T K S S 
TCGCCCCCTGACATGTACCTGCACTTGTCATCTACCTC (polyA) 
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FIGURE 20 
Nucleotide sequence of the cDNA clone 8-9 with the predicted amino acid 
sequence. The amino acid sequence determined by protein sequencing (Novak et al 
1987) is enclosed in brackets. The asterisks mark the position of the oligonucleotide 
used to isolate the clone. The putative polyadenylation site is underlined. 
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M. Novak used a modification of the method of Hamlyn et al (1978) to sequence 
a region of the mRNA of CFAg 5' to that present in clone 8-9. Initially oligomer 
SY-284 was used to prime cDNA synthesis from DMSO induced HL-60 cells as a 
source of CFAg mRNA. This enabled us to design a unique 24bp oligomer to a 
region 8bp 5' to the start of the sequence present in clone 8-9. This was then used as a 
primer and enabled M.Novak to complete the sequencing of the 5' region of CFAg 
cDNA. The new oligonucleotide was also used to screen the lambda clones 4-7, 3-1-
14, 3-1-16, A,B,and C. Unfortunately none of these clones hybridised to the oligonu-
cleotide and so it was assumed that they contained only insert sequence already 
represented by clone 8-9. Combining the two sources of sequence, we could compile 




1 	 G*************** 	 60 
ATGTTGACCGAGCTGGAGAAAGCCTTGAACTCTATCATCGACGTCTACCACGTACTCC 




L 	KG N F H A V Y RD DL K K L LET 
180 
GAGTGTCCTCAGTATATCAGGAGGGTGCAGACGTCTGGTTCJGAGTTGGATATC 
E C P Q Y IRK K GAD VI  F K EL DI 
240 
AACACTGATGGTGCAGTTAACTTCCAGGAGTTCCTCATTCTGGTGATAJGATGGCGTGG 
NT D GA V N F Q E F L 	L V I K MAW 
300 
CAGCCCACAAAAAAGCCATGAAGGCCACAJGAGTAGCTGAGTTACTGCCCAGAGG 
Q PT K K AM K K AT K S S 
CTGGGCCCCTGACATGTACCTGCAGAATTGTCATCTACCTC (polyA) 
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FIGURE 21 
Nucleotide and corresponding amino acid sequence of the cDNA clone CFA 8-9. 
The probable polyadenylation signal of the rnRNA is underlined. The asterisks mark 
the position of the oligonucleotide used to isolate the clone. Brackets enclose the N-
terminal amino acids determined by protein sequencing (Novak et al 1987). The 
nucleotide sequence from -51 to +33 was determined by reverse transcriptase primer 
extension using induced HL-60 cell mRNA as a template. 
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Figure 22. 
The restriction map of CFAg clone 8-9, showing relative positions of common restric-
tion enzyme sites. 1cm represents 20 base pairs. 
5' 
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6.3 Tissue distribution, transcript size and abundance of CFAg mRNA 
The CML cDNA library was rescreened with the insert DNA from clone 8-9 and 
it was found that approximately 0.5% of the recombinants were positive. This reflects 
the abundance of the mRNA for CFAg in CML cells. Replica filters were screened 
with the 24mer N-terminal oligomer and 30% of the clones positive with 8-9 were also 
positive with the N terminal oligomer. 
6.3.a Tissue distribution 
The insert 8-9 DNA was used in Northern blot analysis to examine the tissue dis-
tribution of the mRNA, (figure 23a and 23b). RNA was prepared from a variety of tis-
sues and cell lines (section 2.14). Hep G2 is a hepatoma cell line which expresses the 
majority of liver functions (Aden et al 1979). EMBK is an embryonic kidney cell line 
(ATCC No. CRL 1573). MNNG-HOS is an osteosarcoma cell line (ATCC No. CRL 
1547). Daudi is a Burkitt lymphoma derived B-lymphoblastoid line (Klein et al 1968). 
CML #1 and #2 are RNA samples from CML cells from two different leukophoresis 
samples. The mouse myeloid stem cell WEHI-TG (Geurts van Kessel et al 1983) was 
used to fuse with CML cells from different patients and the resulting hybrids were 
analysed to see which chromosomes segregated with CFAg (van Heyningen et al 
1985). WEH 3127.1.9 contains the human chromosomes 1,9,14, and 21. It expresses 
immunologically detectable amounts of CFAg. WEP 1342.2.4 contains human chromo-
somes 7,10,13, and 20 and does not express immunologically detectable levels of 
CFAg. 
The blot in figure 23a demonstrates that clone 8-9 hybridises to RNA from CML 
cells, induced but not uninduced HL-60, and the CFAg expressing hybrid (WEH 
3127.1.9). There is weak hybridisation with poly(A) RNA isolated from normal liver. 
This is attributed to blood contamination of the tissue since it has been demonstrated 
that there is turnover of CFAg in normal peripheral granulocytes and immunohisto-
chemistry of liver sections with anti-CFAg monoclonal antibodies reveals antigen only 
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in granulocytes and not in hepatocytes. Further, there is no signal with Hep G2 cells 
which express the majority of liver functions, and there is no hybridisation with hepa-
toma sample RNA isolated from a sample which was relatively free from blood con-
tamination. 
6.3.b Transcript size 
Figure 23b shows that in CML and HL-60 mRNA probed with CFAg cDNA 
clone 8-9, there is a major transcript of - 550bp and a minor transcript of 1kb. The 
Southern blotting data indicates that there is probably only one gene for CFAg, and 
therefore the two bands may be due to post transcriptional processing, although there 
is no evidence for this. The size of the transcripts was determined using size markers 
provided by the cutting the phage phi X174 with the restriction enzyme Hae III, dena-
turing, and running the digest on the gel. The Northern blot was probed with a mixture 
of radiolabelled phi X174 and clone 8-9. 
6.3.c Abundance of CFAg mRNA in myeloid tissues. 
The Northern blot in figure 23b, compares the abundance of CFAg mRNA from 
HL-60 cells treated with DMSO for 5 days, with HL-60 cells induced for 2 days with 
RA, and with CML cell RNA. The blot was reprobed with a mouse actin probe (Minty 
et al 1981) to ensure that equal amounts of mRNA were loaded in each case and to 
check that the RNA was not degraded. The actin hybridisation intensity (figure 23b) 
indicates that the RNA amounts were roughly equal and this is also the case in figure 
23c although the actin dat for this blot is not shown. The signal obtained with clone 
8-9 (figure 23c) hybridised to HL-60 induced with DMSO indicates that the abundance 
of the mRNA for CFAg is high (equal to the abundance in CML) whereas in HL-60 
induced for 2 days with RA it is relatively low (figure 23b). There was no detectable 
signal observed when clone 8-9 was hybridised to uninduced HL-60 (figure 23c). Th 
data agree with the protein data in Chapter 3 i.e CFAg is abundantly expressed in 
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CML cells, expressed at a lower level in HL-60 cells induced for 2 days with RA, and 
is undetectable in uninduced HL-60 cells grown in serum free medium. 
It is not clear why HL-60 induced with DMSO gives such an increased expres-
sion of antigen compared to RA-induced HL-60. It may be related to the degree of 
maturation that the cells attain with the two different chemicals. After 5 days of RA 
treatment 30% of the cells can be identified as mature granulocytes whereas among 
DMSO treated cells, only 10% are recognisable as mature cells. The remaining cells in 
the population are at varying stages from promyelocytes to metamyelocytes (Breitman 
et al 1980; Ferrero et al 1983). Thus at day 2 of RA treatment the HL-60 cells may be 
at the optimum stage of differentiation for antigen production and this stage is attained 
at day 5 of DMSO stimulation. The difference in message abundance may be ascribed 
to more cells of the optimal maturation stage for CFAg expression being present in the 
DMSO-treated cells at 5 days than in the RA-treated cells at 2 days. 
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FIGURES 23a and 23b 
RNA (Northern) blot analysis of various human cell lines and tissues. Lane a, 
Hep G2(hepatoma) (38); b, EMBK (embryonic kidney, ATCC No. CRL 1573); c, 
MNNG-HOS (osteosarcoma, ATCC No. CRL 1547); d, Daudi (Burkitt lymphoma 
derived B-lymphoblastoid line)(39); e, hepatoma; f, CML #1; g, CML #2; h, unin-
duced HL60; i, HL60 induced (2 days RA); j, normal liver; k, WEHI TG (mouse 
myeloid stem cell) (13); 1, WEP 1342.2.4 (mouse x human myeloid cell hybrid con-
taining human chromosomes 7,10,13,20) (2); m, WEH 3127.1.9 (myeloid cell hybrid 
containing human chromosomes 1,9,14,21 and expressing CFAg) (2). 
Lane 1, CML #1; 2, HL60 induced (2 days RA); 3, HL60 induced (5 days 
DMSO); 4, CML #2. Both blots were reprobed with mouse actin to ensure compar-
able sample loading (shown only in lanes 1-4). 
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FIGURE 23c 
RNA blot analysis to show the relative abundance of CFAg mRNA in equal 
amounts of RNA from different myeloid tissues. Lanes 1 to 4 contain 1pg of poly 
(A) RNA from various tissues. lane 1, CML #2; lane 2, HL-60 induced 5 days with 
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6.4 Southern blot analysis of genomic DNA with CFAg cDNA clone 8-9 
Isolation and digestion of high molecular weight DNA, and Southern analysis 
were carried out as described in sections 2.36, 2.28 and 2.37. Genomic DNA from 
two CML patients (including the patient from whom the cDNA library had been made) 
and a normal male and female were digested with the following enzymes- Eco RI, Pst 
I, Barn Hi, Hind III, and Bgl II. The first four enzymes gave single bands of the fol-
lowing sizes 
EcoRl 12.5Kb 
Pst I 4.5 Kb 
Barn HI 8.5 Kb 
Hind III 18 Kb 
Bgl II gives three bands of sizes 3.9, 4.4, 5.2 Kb. 
This is consistent with a single gene for CFAg. It would be necessary for the gene to 
contain two Bgl II sites within introns for the model to be correct. 
Further evidence that the gene is single copy is that, when the cDNA clone 8-9 
was used to screen a Barn Hi EMBL 3 genomic library, only one positive plaque was 
obtained in screening 600,000 plaques. This genomic clone has been isolated and its 
identity verified by its reactivity with the oligomers to the CFAg DNA sequence which 
are available. It has not been used for mapping intron/exon organisation as yet. 
6.5 Conservation of CFAg between species 
In order to examine how conserved the cDNA sequence was, clone 8-9 was used 
to probe genomic DNA from various species. In Southern blot analysis under very low 
stringency conditions (5xSSC and 55 0C hybridisation conditions; and 2xSSC and 550C 
washes) a hybridisation signal was only observed with mouse and human and not with 
equivalent amounts of DNA from chick, trout, xenopus or yeast. Even at this low 
stringency, only one hybridising band was seen with the human and mouse genomic 
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DNAs. Blots hybridised with human CFAg cDNA clone 8-9 could also be washed at 
680C in 2xSSC and rodent bands were as strongly hybridising as human bands. 
6.6 Chromosomal localisation of the gene for CFAg 
The gene for CFAg has already been mapped to human chromosome 1 by 
somatic cell genetics (van Heyningen et at 1985). Owing to the availability of rodent x 
human somatic cell hybrids it was possible to map the CFAg gene to a small region on 
chromosome 1. This was not previously possible because the detection of the gene 
relied on the expression of CFAg and its immunological detection. The somatic cell 
hybrids used by van Heyningen et al consisted of a mouse myeloid parent cell fused to 
human CML cells. The fact that the mouse parental cell was of myeloid origin was 
important because it allowed the the continued expression of the granulocyte specific 
protein. The hybrid cells which were used to map the gene using the cDNA clone did 
not require expression of the gene and so the fact that the parental rodent cells were 
fibroblast cells was unimportant. 
The first important step was to confirm that CFAg gene was located on chromo-
some 1. This was done by using a mouse x human hybrid WEH 3127.1.9 which con-
tained human chromosomes 1, 9 and 14. This hybrid was then FACS sorted for the 
expression and non-expression of a chromosome 1 encoded cell surface marker 
(Andrews et a! 1985). The hybrid was provided by V van Heyningen and the FACS 
sorting and chromosome analysis was kindly carried out by J. Fletcher. After the 
FACS sorting was completed, chromosome analysis showed that the clone WEH 
3127.1.9 T7 contained the human chromosomes 1,9,14; and the clone WEH 3127.1.9 
T8 contained the human chromosomes 9 and 14. It could be shown in Southern 
analysis that the cDNA clone 8-9 hybridised to genomic DNA from both clones but a 
human specific band was only seen in the clone WEH 3127.1.9 T7 (Figure 24a). 
A series of somatic cell hybrids were then used which have different fragments of 
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chromosome 1 contained in them. In the case of NYX 5.6 and NYX 5.6.11 only the 
chromosome 1 fragments have been analysed and data for the remaining human chro-
mosomes urt not available. The hybrid NYX 5.6.11 is a subclone of NYX 5.6 but the 
chromosome 1 has broken in the process of subcloning. Table 1 summarises the chro-
mosome data on the various hybrids and shows that the human specific bands hybridis-
ing to clone 8-9 are only present when the region of chromosome 1 from q12 to q21 is 
also present. Figure 24a and 24b show the Southern blot analysis used to determine 
the presence or absence of the CFAg gene in various hybrids. Hybrids, Rag J8, NYX 
5.6, NYX 5.6.11 and WEH 3127.1.9 T7,8, are mouse/human hybrids. SK 81 and 82 
are chinese hamster/human hybrids. The hybrid Rag J8, contains the short arm of the 
human chromosome 1 and a region of the long arm from the centromere to q2 1. This 
hybrid contains DNA which gives the human band size with CFAg. SK 82 however, 
contains the short arm of the human chromosome 1, but the region of the long arm 
from the centromere to q12. This hybrid does not appear to contain human DNA 
which hybridises to CFAg. These results imply that CFAg lies in the region q12 to 
q22 on human chromosome 1. 
It should be noticed that no reaction has ever been observed with the guinea pig 
antiserum raised against CFAg and any mouse tissue. The human CFAg cDNA clone 
does not hybridise even under very low stringency washes to mRNA from a mouse 
myeloid cell (WEHT-TG) however a mouse specific hybridising band is observed in 
genomic DNA blots, probed with clone 8-9, and the mouse myeloid cell line (WEHI-
TG) does allow expression of human CFAg in somatic cell hybrids. In order to verify 
the chromosomal assignment further, in Situ hybridisation was attempted by J.Gosden 
using the CFAg cDNA clone but no specific region to which the clone hybridised was 
identified. This was probably due to the small size of the clone, and will be repeated 
with the genomic clone. 
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FIGURE 24a 
Southern blot analysis to illustrate mapping of CFA 8-9 in rodent/human somatic 
cell hybrids. Chromosome analysis is shown in Table 1. 104g of genomic DNA dig-
ested with Bgl II was loaded in each case. Lambda DNA cut with Hind III is also 
shown with the size of the bands indicated in kilobases. Lane 1, NYX5.6. 11; 2, F9.6 
3, NYX5.6 ; 4, CML#3; 5, WEH 3127.1.9 T7 ; 6, WEH 3127.1.9 T8; 7, WEH 
3127.1.9 T7; 8, WEH 3127.1.9 T8; 9, WEHI-TG. 
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FIGURE 24b 
Southern blot analysis to illustrate mapping of CFAg in rodent/human somatic 
cell hybrids. Chromosome analysis shown in Table 1. lO.tg of DNA was loaded in 
each case. DNA in lanes 1 to 8 are cut with Bgl II, while DNA in lanes 9 to 16 are 
cut with Eco R1.Lanes 1-8 Lanes 1 and 9 contain SK 81; lanes 2 and 10 contain 
WEFH-TG, lanes 3 and 11 contain CML #1; lanes 4 and 12 contain SK 82; lanes 5 
and 13 contain RAG J8; lanes 6 and 14 contain WEHI-TG; lanes 7 and 15 contain 
CML #2; and lanes 8 and 16 contain chinese hamster DNA. 
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CHROMOSOMAL LOCALIZATION OF THE GENE FOR CFAg. 
Fragment of 1 2 3 4 5 	6 7 8 9 10 1112 [13 [14 [15 6 17118119120 211221  X Y CFAg 
Rag J8 pter-q21 I + 
SK82 pter-q12 
- I -  - 
SK81 pterp31  
NYX 5.6 complete not fully characterised - + 
NYX 5.6.11 pter-q23 not fully characterised + 
F9.6 complete 111=11111*1 ililIllil _+ 
WEH 31 27.1 .9 T7 complete I + 
WEH 31 27.1 .9 T8 absent f - 
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TABLE 1 
Segregation of the CFA 8-9 hybridising, human specific restriction fragment with chro-
mosome 1 or fragments of it. 
WEH 3 127.1.9 T7 and T8 (van Heyningen et al 1985) are subclones of the same 
hybrid FACS sorted for expression and non-expression respectively of a chromosome 1 
encoded cell surface marker (Andrews et al 1985). Black squares denote the presence 
of chromosomes in >50% of cells scored. The restriction fragments corresponding to 
the human gene for CFA 8-9 are seen whenever the entire chromosome 1 is present 
and also in hybrid RAG J8 with human chromosome 1 from the tip of the short arm 
to band q21 on the long arm (pter-q21) present. No human bands are present in 
hybrid SK 82 containing only region pter-q12 of chromosome 1. The gene must there-
fore lie between bands q12 and q22 on chromosome 1. Other hybrid cell data support 
this result. 
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6.7 Conclusion 
The full cDNA sequence of CFAg has been determined by combining the 
sequence data from the cDNA clone isolated from the CML cDNA library and cDNA 
synthesised from DMSO induced HL-60 mRNA template. The total length of the 
cDNA is 404 bp which agrees with the size of the mRNA visualised on agarose gels 
(550bp) assuming a poly (A) tail of 150-200bp. The open reading frame is 282bp 
long stretching from the ATG start codon to the base pair at position 252 (see figure 
20) preceeding the TGA stop codon. The size of the protein from the deduced amino 
acid sequence is 10,938 kDa, which is in approximate agreement with the size 
observed on SDS PAGE (Novak et al 1987). Deduced protein sequence data for clone 
8-9 and the protein sequence of the immunopurified CFAg (Novak et a! 1987) agree 
completely and verify the identity of the clone. The results of Northern blot analysis 
with CFAg clone 8-9, establishes the expression of CFAg in myeloid tissue which 
agrees with the immunohistochemical data available for CFAg (Wilkinson et a! 1986). 
Furthermore, using Southern analysis of genomic DNA from somatic cell hybrids it 
was possible to assign the location of CFAg clone 8-9 to chromosome 1 which agrees 
with the chromosomal assignment of CFAg using immunological detection of expres-
sion in a panel of somatic cell hybrids by van Heyningen et al (1985). The availability 
of hybrids containing fragments of chromosome 1 enabled CFAg to be mapped to the 
region q12-q22. 
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CHAPTER 7 
Comparison of CFAg Deduced Sequence to other Protein Sequences. 
7.1 Introduction 
The protein sequence deduced from the nucleotide sequence of clone 8-9 (includ-
ing the 11 amino acids missing from the sequence but identified by protein sequenc-
ing) was compared with all the sequences in the National Biomedical Research Foun-
dation library (NBRF) data base (version 8, 809,386 residues) by a method which 
allows high stringency comparison with all the sequences present (Coulson et al 1986). 
Coulson, Lyall and Collins at Edinburgh University, Department of Molecular Biology 
kindly analysed our deduced protein sequence using an algorithm which exhaustively 
searched the data base for similarities. Normally the assessment of significance of 
detected similarities relies upon the statistical behaviour of randomly compiled implau-
sible sequences, because the best exhaustive algorithms (Needleman-Wunsch-Sellers; 
(Collins and Coulson 1986)) cannot be efficiently used due to the large number of 
known protein sequences. The exhaustive searches necessary to discriminate genuinely 
similar proteins, run on conventional serial mainframe computers are impracticably 
slow and, consequently, most searches are carried out initially at a superficial level. 
For strong similarities approximate methods eg FASTP (Lipmann and Pearson 1985) 
should reveal the same alignments as an exhaustive search. However, more distantly 
related proteins require a more thorough search. In our case, the best local similarity 
alignment of Smith and Waterman (1981) was used in conjunction with the I.C.L. 
4096 distributed array processor (DAP). The full potential of the multi processor 
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machine is exploited and the program takes 1-2 seconds per residue of test sequence to 
search the entire protein database. The score for each amino acid pairing was assigned 
and log odds tables for a range of evolutionary distances were used. Indels (insertions 
or deletions) were scored as a single fixed value penalty. An inbuilt measure of 
significance is the expected number of alignments with a certain score when compared 
to the vast majority of unrelated proteins in the database. The log of the frequency of a 
particular score declines linearly with the score itself, i.e the greater the score the less 
is the expected frequency of alignments. Alignments with scores expected less than 
once require examination, and closely related sequences will produce alignments with 
scores expected to occur many orders of magnitude less often. 
7.2 Proteins with sequence similarity to CFAg 
The database search with the clone 8-9 protein sequence was carried out using 
each reading frame separately, and reading through stop codons in case the sequencing 
had been incorrect. Only one reading frame produced significant alignments and this 
corresponded to the CFAg sequence from protein sequencing. The four alignments 
were :- 
Bovine Intestinal calcium binding protein (ICaBP).....Expected frequency 1.1x10 5 . 
Porcine Intestinal calcium binding protein..........Expected frequency 2.8x 1O. 
Bovine S-lOU a protein alpha chain................Expected frequency 5.8x10 4 . 
Bovine S-lOO P protein beta chain................Expected frequency 1.4x10 3 . 
The search was repeated using scoring tables for 5 evolutionary distances. 
Depending on the evolutionary distance one sequence is from another, the scores 
assigned to particular residue changes must also change. Dayhoff, (Dayhoff 1978) 
compiled score tables for amino acid changes at different PAMs (accepted number of 
point mutations per 100 residues), where the PAM is a measure of evolutionary dis- 
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tance between two protein sequences. The scores and expected frequencies are shown 
below for the best four local similarity alignments using the 80 PAM similarity table. 
Indels were scored -10. 
Bovine S-100a protein alpha chain.......score 189......Exp Freq 1.7x10 1° 
Bovine ICaBP...........................Score 167......Exp Freq 1.2x10 8 
Bovine S-100b protein beta chain........score 163......Exp Freq 2.6x10 8 
Porcine ICaBP...........................Score 153......Exp Freq 1.8 x10 7 
The best alignment of CFAg and S-100a protein is shown below. * indicates resi-
due identity and . indicates pairs of residues with a positive score in the similarity 
table. There is 43% homology over a stretch of 72 amino acids. CFAg sequence is 
given below the S-100a protein sequence. 
SELETAMETLINVFHAH SGKEGDKYK_LSKELKELLQTELSGFLDAQKDAKWLDEDGDG 
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The database search revealed that CFAg had significant homology to S-lOU a and 
P chains and ICaBPs from the rat, cow and pig. These proteins are all members of the 
troponin C super family characterized by a relatively low molecular mass and the abil-
ity to bind calcium . Twenty four of the top twenty five alignments in the search 
involved calcium-binding proteins such as calmodulin and troponin C. 
7.3 Calcium-binding proteins 
The proteins with the highest significant similarity to CFAg are calcium-binding 
proteins. No physiological function has been assignd to any of these proteins, but the 
intestinal CaBP are known to be vitamin D inducible (Thomasset et al 1979), and may 
be involved in the absorption of calcium across the gut. The bovine S-lOO a and 13 
proteins are predominantly located in the brain (Eldik et a! 1982), as are the human 
forms (Donato 1986). Bovine ICaBP has not been cloned, but the protein has been iso-
lated and sequenced (Hofmann et al 1979, Fullmer and Wasserman 1981. cDNA 
clones encoding the rat and chicken ICaBP have been isolated and sequence data pub-
lished (Desplan et al 1983, Desplan et al 1983a, Wilson et al 1985,). The three dimen-
sional structure of the minor A form (i.e the form lacking the first two N-terminal 
amino acids of the native protein) of bovine ICaBP has been determined by X-ray 
crystallography (Szebenyi et a! 1981). H  NMR studies have also been performed on 
the minor A form of bovine ICaBP (Dalgamo et a! 1983) as well as the native porcine 
protein (Shelling et al 1983). Recently a synthetic gene encoding the known amino 
acid sequence of bovine ICaBP has been cloned into an expression vector in E.coli in 
an attempt to examine and define the domains important in the structure and function 
of the protein (Brodin et al 1986). The ICaBPs belong to a larger family of calcium-
binding proteins (see discussion) including parvalbumin, troponin c, and calmodulin. 
They all contain the same helix-loop-helix structure of their calcium-binding sites, the 
so called EF-hand structure (Kretsinger 1980). Parvalbumin (Kretsinger 1973), bovine 
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ICaBP (Szebenyi et al 1981), troponin C (Herzberg and James 1985; Sundaralingham 
et al 1985) and calmodulin (Babu et al 1985) have all been characterized by X-ray 
crystallography. It was from the amino acid sequence and crystallographic structure of 
parvalbumin that Kretsinger (1980) stated the essential features of the EF-hand 
calcium-binding region. Parvalbumin consists of a loop-helix structure and it is helix 5 
and 6 or E and F which are involved in the calcium binding together with the 
interhelix loop which contains the oxygen atoms to ligand the calcium ion. This model 
can be demonstrated with an outstretched forefinger, thumb and clenched middle finger 
leading to the term "EF-hand". 
For a region to satisfy the constraints of an EF-hand certain amino acids must 
have oxygen atoms in their side chains available to ligand the calcium ion. 
Residue 10, 12, 14, 18, 21 supply side chain oxygens and residue 16 uses a pep-
tide oxygen. The putative EF-hand domain for CFAg determined by amino acid 
sequence comparison to the other calcium-binding proteins is shown below. Number-
ing the residues with the standard domain numbering scheme devised for parvaibumin, 
it can be seen that the residues 10, 12, 14, 18, 21 all have side chain oxygen 
molecules. According to Kretsinger's model, residues 2, 5, 6, 9, 22, 25, 26 and 29 
must have hydrophobic side chains as these positions are on the inside of the 
molecule. Asp, Asn, Glu, Gin, Ser or Thr must occupy positions 10, 12, 14, 18, and 
21. CFAg obeys these rules also. Finally the conformation and packaging of the loops 
imposes two constraints. Firstly the bend at residue 15 is so tight that only Gly can 
assume the accquired angle and residue 17 must be able to anchor the loop to the 
hydrophobic core of the molecule. 
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Calmodulin, troponin C and parvalbumin contain only EF-hand type of calcium 
binding domain whereas S-100 and ICaBPs have one EF-hand region and another dis-
tinct calcium binding structure at a more N-terminal position in the protein. The puta-
tive EF-hand region of CFAg shows significant similarity to the EF hand region of 
various calmodulins, but the other, non EF-hand, calcium-binding region of CFAg is 
not significantly similar to any region of calmodulin. This supports the theory that, 
like S-100 and ICaBP, CFAg contains one EF-hand type calcium binding region and 
another distinct calcium binding structure. The constraints of this region have not been 
defined, and the calcium ion uses oxygen atoms from the peptide backbone as ligands 
(van Eldik 1982). The mammalian ICaBPs bind calcium with different affinity to their 
two types of site (Bryant and Andrews 1984). 
Very recently, the human cDNA sequence for a growth factor inducible gene has 
been determined (Calabretta et al 1986). It is 434 nucleotides in length and has an 
open reading frame of 270 nucleotides coding for a putative polypeptide of 90 amino 
acids. The closest homology at the nucleotide level of this protein 2A9, is to the S-100 
protein with 55% homology in the coding region. At the amino acid level the 
homology is most noticeable in the calcium-binding regions of S-100. In the first (non 
EF-hand site) the homology is 88% and at the second (EF-hand site) the homology is 
61% to the S-100 a subunit. 
The EF-hand calcium binding motif is the most highly conserved region between 
CFAg, S-100, ICaBP,and 2A9. Over the whole length of the 2A9 predicted protein the 
homology to CFAg is 28.8%, but over the 30 amino acids involved in the EF-hand, 
the homology is 40%. For S-lOOa and bovine ICaBP the homology in this region is 
50%. 
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The function of 2A9 has not yet been elucidated and the protein has not yet been 
isolated. However Calabretta et a! (1986) believe it may be involved in cell prolifera-
tion as the mRNA corresponding to the cDNA clone is induced in quiescent fibroblasts 
by various growth factors. 
S- 100 has been reported to be closely related to p11 (Gerke and Weber 1985) p11 
is an 11 kDa protein, whose function appears to be as a regulatory subunit of a larger 
molecule p36. This 36 kDa protein is the major cytoplasmic target of avian sarcoma 
virus, tyrosine-specific protein kinases (Greenberg et al 1984), and has moderate cal-
cium binding capacity. The cellular function of p36 is unknown but it may be involved 
in microfilament association and binding to lipids and membranes. In some cell types, 
such as intestine, p36 exists as a heterodimer in association with the small p1  1 subunit 
(Gerke and Weber 1985). In human epidermal cells, the analagous protein p35 exists 
mainly as a monomer and in vitro phosphorylation seems to occur preferentially on 
this form. This has led to the proposition that p11 is a regulatory element (Gerke and 
Weber 1985). 
p11 has a lower observed similarity to ICaBP than to S-100 and no calcium bind-
ing has been shown for p11 although attempts have been made to show this (Gerke 
and Weber 1985). The introduction of a gap of 3 consecutive residues in the p11  95 
amino acid residues allows for 43 identically placed residues when comparing to the 
S-100 a subunit, plus 15 highly conserved amino acid changes. The 3 deleted residues 
however lie within the non EF-hand calcium binding site. The EF-hand region of p1  1 
also differs from true calcium binding site as defined by Kretsinger (1980). The possi-
bility exists that S-100 may have a regulatory function similar to that proposed for 
p 11 . 
Comparing CFAg to p1  1 there are 23 conserved amino acids over a stretch of 94 
amino acids, the most striking homology being in the proposed EF-hand region of cal-
cium binding (36%). Calabretta et al (1986) postulate that as calcium and tyrosine 
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kinases have an important role in cellular proliferation, perhaps 2A9 mediates this 
regulation in fibroblasts by calcium-binding and interaction with a cellular substrate for 
tyrosine kinase in a similar way to p11 regulation of p36. 
S-100 and p11 both exist as dimers but S-100 has been shown to bind 2 moles of 
calcium whereas no calcium binding has been detected for p11. Further, the analagous 
sites for calcium binding in p11 appear to be altered. It is possible that S-100 has a 
protein ligand related to p36. CFAg on native gel Western blotting appears to exist 
predominantly as a dimer. 
Figure 25 shows the alignment of ICaBPs from pig, rat and cow and bovine S-
lOOa and P subunits, human 2A9 and porcine p11 with CFAg protein sequence. Con-
served amino acids are boxed and the calcium binding ligands for bovine ICaBP are 
marked. 
p11 	 P s Q!JH  A M E T M M F T F - - - G D K G Y L T K E D L R VRM 
2A9 	 A C 1IJLID Q A I G L L V A I F 	 G R S G D K H T L S K K H L K £ L  
S-lOOp-chain 	
SIELEKAVVALIIDVF GREGDKHKLKKSELKEL[ 
IG S-100 ,-chain 	G SIE L E[]A M E T U I[JV F 	K H G D K Y K U S K K E L K E U U 
CFAg 	MLT[EKALNS iii_DVYHKYS LIKGNFHAVYRDDLKKLL 
Bovine lCaBP 	 KS? EEL KG I FE KY A A K H GD? N Q L S KEEL K L L L 
PigICaBP 	 S A Q K SPA ELKS I FE KY A A K H G  P N Q L S K H E U K Q LI 
RatICaBP 	 K S I F Q K 	AAKEGDPNQLSKEELKLLI 
p11 -El  K E F P N G F L E Q k......D 	I K D P L V KM K D L D Q C RD G K V G F Q S F F S I A 
2A9 QKELT5KLQAEIAR 
IC 	D L B 
_MIFLDRNKDGEVNFQEYVTF 
S-100f-chain N N S L S H F L El K EEV KM - E L D S D G D G E C D F Q S F M A F VA 
S-100-chain QTELSGFLDQKDADVKMKELDEDGDGEVDFQEYVVLVV 
CFAg S T E C P Q Y I R K K G A D V W F K S L D I N T D G A V N F Q E F L I L V I 
BovinelcaBP QTEFPSLLKGPSTDELFEELDKNGDGEVSFEEFQVLVK 
PigICaBP Q A E F P 
L 
S L L KG PR T D DL F Q EL D K N G N GE VS FEE F Q V L  K 
RatICaBP 0 SE F P 
L 
N L L K A S ST D N L FEEL D K ND D GE VS YE E  H V F F K 
p11 	 G L T I A C N D Y F V V H M K Q K 
2A9 	 L GL A - - - L I Y N EJ1LG 
S-100,ichain 
M lIT T A C H E F F E H Ef 
S-10091,-chajn ALITvACNNFFWENIs 
CFAg 	K MJW Q P T K K A M K KT K S S 
Bovine ICaBP K I S 
P1gICaBP 	K I S 
Rat ICaBP 	K US Q 
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FIGURE 25 
Alignment of amino acid sequences of ICaBP from rat, pig and cow, and bovine 
S-lOOa and P subunits, human 2A9 and porcine p11 with CFAg protein sequence. 
Amino acids which occur in CFAg and one other sequence are boxed. The standard 
one letter code is used to abbreviate the amino acids. Calcium binding ligands as 
determined by X-ray crystallography for the EF-hand region of bovine ICaBP (Krets-
inger 1980), are marked with 'i'.  The calcium binding ligands for the second distinct 
region are marked 
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CHAPTER 8 
DISCUSSION 
This thesis describes the isolation of cDNA clones for CFAg from a CML library. 
The identity of the clone has been established by comparing the predicted amino acid 
sequence deduced from the DNA sequence of the clone with the 53 amino acid 
sequence obtained for the immunopurified protein (Novak et al 1986). The cDNA 
clone has been used to demonstrate that the major mRNA transcript in CML cells is an 
abundant species of - 550bp in size. The CFAg protein can be induced in HL-60 cells 
with RA and to a greater extent by DMSO. Both these chemicals induce the cells to 
differentiate towards myeloid cells. 
Using Southern blot analysis with the cDNA clone for CFAg, there appears to be 
only one gene. Using very low stringency conditions the gene will only hybridise to 
mouse and human DNA and not to bird, fish, amphibian or yeast DNA. 
The location of the gene for CFAg has been confirmed to be on chromosome 1 
and sublocalized to the region q12-q22. 
The predicted amino acid sequence for CFAg was compared to other known pro-
tein sequences in the NBRF database and was found to have significant homology to 
calcium binding proteins from mammalian intestine and the S-lOOa and S-1003 subun-
its which are most abundant in brain. Similarity to the predicted amino acid sequence 
of the human cDNA clone, 2A9 (Calabretta et al 1986) and to the porcine p11 protein 
has also been established. These latter protein sequences were not present in the data-
base due to their recent identification. In order to postulate a function for CFAg it is 
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useful to examine the function of these homologous proteins. 
CFAg has significant homology to a family of calcium-binding proteins whose 
functional importance is not completely understood. Baba et at (1984) established a 
phylogenetic reconstruction where all 50 proteins of the calmodutin family protein 
members could be divided into 7 lineages established during more than 1 billion years 
of evolution. The lineages originate from a one domain polypeptide of 36-40 amino 
acid residues with a central 12 amino acid calcium binding site, and a series of tandem 
duplications result in the various family members. 
Troponin C, calmodulin, parvalbumin, myosin light chains, S-lOO and intestinal 
calcium binding proteins are all members of different classes of calcium modulated 
proteins (van Eldick et at 1982). Troponin C and calmodulin both bind 4 calcium ions 
per molecule while parvalbumin binds only 2. The type of calcium binding region in 
these proteins has been termed EF-hand structure and was first characterised by Krets-
inger (1975) for parvalbumin (1975a). Calmodulin has four such regions as does tropo-
nm C. S-lOO and ICaBPs however (although they bind two calcium ions each) have 
only one region which satisfies the constraints of the EF hand model. Bovine ICaBP, 
which has the second highest homology to the CFAg predicted sequence, has been 
examined by X-ray crystallography (Szebenyi et at 1981) to reveal the different bind-
ing regions. The porcine ICaBP has been studied using NMR (Shelling et at 1985) and 
the two binding sites appear to have random binding with equivalent association con-
stants. 
8.1 Calmodulin 
Calmodulin is the best characterised calcium modulated protein, and has homol-
ogy to CFAg in the EF hand region of calcium binding. Calmodulin is a highly con-
served, ubiquitous protein contained mainly but not exclusively in the soluble fraction 
of cells. It is not necessarily advantageous to look at specific functions of calmodulin 
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when attempting to assign a putative function to CFAg, but a general idea of the types 
of function calmodulin fulfills may be of some help. No definite function has been 
assigned to the calcium binding-proteins to which CFAg is most significantly homolo-
gous. 
Calmodulin itself is not active but when complexed to calcium it becomes an 
active species (Cheung 1980). Although it has no demonstrable enzyme activity it has 
phosphodiesterase activator activity including the calcium-dependent stimulation of 
cyclic nucleotide phosphodiesterase, adenylate cyclase, myosin light chain kinase, 
skeletal muscle phosphorylase kinase and other protein kinases (Kennedy et al 1981). 
However not all of these functions are necessarily calmodulin specific as many 
preparations are impure and calmodulin can, for example, substitute for troponin C and 
activate actinomyosin ATPase in vitro (Dedman et al 1977). However Hathaway et al 
(1981) have shown a physiological role for calmodulin in the regulation of the myosin 
light chain kinase and Pichard et al (1981) have shown muscle phosphorylase kinase 
regulation by using purified protein. Calmodulin is highly conserved throughout evolu-
tion and the recently cloned yeast homologue has 60% homology to the bovine coun-
terpart (Davis et al 1986). 
8.2 Intestinal calcium-binding proteins 
The biosynthesis of these proteins which have been found in the small intestine of 
cow, pig, rat and chicken is dependent on vitamin D. They are soluble species and 
appear to be of two major types: type I proteins with MW of - 28,000 and type II pro-
teins with a molecular weight of - 10,000. The type II proteins to which CFAg has 
been found to be homologous have only been detected so far in mammalian species. 
Figure 25 shows the calcium-binding sites and Syebenyi et a! (1981) determined that 
there were 4 alpha helices. Two of the helices III and IV and the calcium binding 
loop connecting them form a calcium-binding structure similar to the EF hand structure 
of parvalbumin. The explanation of these binding structures is in Chapter 7. The III 
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and IV site calcium (EF hand) appears to more readily removed than the I and II site 
calcium. Syzebenyi suggests that the I, II site may be permanently saturated with cal-
cium whereas the III, IV site is a candidate for a regulatory site which could easily 
bind and release calcium in the same way that has been demonstrated for calmodulin. 
Antibodies have been raised against mammalian type I and type H ICaBP and chick 
type I proteins. The two types are immunologically distinct and although chick ICaBP 
will cross react with mammalian type I ICaBP from kidney and brain, mammalian type 
H proteins appear to be species specific (Wasserman et al 1977). When vitamin D is 
given to rachitic rats an immediate response is observed in the increase in intestinal 
absorption of calcium followed by a delay of several hours and the production of 
ICaBP (Thomasset et al 1979). 
8.3S-100 
Another class of calcium-binding proteins, separate from those regulated by vita-
min D, is a group of closely related small acidic proteins. S-100 are members of this 
group and are so called because of their solubility in 100% ammonium sulphate 
(Moore 1968). The S-100 proteins are dimers composed of the a chain and the 3 chain 
(S-100a protein) or two a chain (S-lOOaO protein) or two P chain (S-100b) subunits. 
S-100 is the overall term used for these proteins which are abundant in the brain and 
contained in well defined cell types of both neuronal and non-neuroectodermal origin. 
In the mammalian brain S-100a and S-100b are confined to glial cells while S-lOOaO is 
neuronal in localization (Donato 1986). Norepinephrine and dibutrylcyclic AMP 
increase the level of S-100 in C6 rat glioma cells both by stimulation of synthesis and 
inhibition of degradation of S-100 (Labourette et al 1980). Taubuchi et al (1982) 
showed that forskolin and prostaglandin E plus theofilhin known to activate adenylate 
cyclase, also induces an increase in the S-100 content of rat glioma cells and therefore 
S-100 may be regulated by cAMP (Higashida et al 1985). S-100 a and b proteins pos-
sess two types of calcium binding site. An EF hand conventional site in the carboxy 
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terminus and an unconventional calcium binding site in the N terminal part of the 
polypeptide chain. This site has a lower calcium binding affinity due to the high con-
tent of basic amino acids (Baudier et al 1983). The rat, human, (Kuwano et al 1984) 
and bovine (Isobe et a! 1978) protein sequences are homologous except for 4 residues. 
Although S-100 appeais to be mainly present in the soluble fraction of glial cells in 
vitro it appears to interact, with high affinity, with several natural membranes isolated 
from brain, including synaptic vesicles and nuclear membranes (Donato et al 1986). 
Natural membranes possess high and low (Kd=7nM and Kd =0.4pM) affinity binding 
sites for S-100, the high affinity binding site requiring the presence of calcium (Donato 
1986). S-100 has been detected immunologically in human glial cells of the central 
nervous system, some neurons, Schwann cells of the peripheral nervous system, 
melanocytes, Langerhans cells of the epidermis, sweat glands and ducts of the skin, 
myoepithelial cells and occasional ducts of salivary glands and breast, serous glands, 
and hyaline cartlidge of bronchi and the larynx (Kahn et al 1983). The presence of S-
100 can also be used as a marker for malignant melanoma and neoplasms derived from 
Schwann cells (Donato 1986). Thus S-100 proteins are clearly important and more 
widely distributed than previously thought, although not ubiquitous like calmodulin. 
The function of S-100 remains far from clear, the majority of evidence being related to 
the acquisition of behavior patterns (Hyden et a! 1970). It potentiates the microtubule 
disassembling affect of high calcium concentrations (Donato 1986) and also interacts 
in vitro with some of the proteins known to be a target of calmodulin (Burgess et al 
1984). It has been shown to be phosphorylated by brain nuclear kinases and inhibits 
the phosphorylation of a 73 kDa cytoplasmic polypeptide of brain in a calcium depen-
dent way (Patel et al 1982). S-100 has also been reported to bind zinc very tightly and 
in a calcium independent manner (Baudier et al 1983). 
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8.4 p1! 
As mentioned in chapter 7, S- 100a and b subunits have homology to p11, a regu-
latory subunit of p36, the substrate for tyrosine specific protein kinases . p11 exists as 
a dimer as does S-100. Calcium binding was searched for in unsucessfully in p11 and 
although the homology of p11 to S- 100 a chain is significant, the region of p11 homo-
logous to the first calcium-binding region of S-lOU a lacks 3 residues, and the EF-
hand region has two amino acids which are not conserved and may affect calcium 
binding. The possibility of zinc binding for p1  1 is being examined, as is the possibility 
of a larger subunit to complex with S-100 (Gerke and Weber 1985). 
8.5 2A9 
We have also noted that CFAg has sequence similarity to the predicted protein 
sequence of the cDNA clone 2A9 The 2A9 cDNA clone was isolated by screening 
transformed human fibroblasts with a hamster homologue, which itself was isolated by 
differential screening for cell cycle variable messenger RNAs. The human clone was 
overexpressed in human acute myeloid leukaemia cells. The protein equivalent to the 
2A9 cDNA has not been isolated. The homology of 2A9 to S-100 is particularly 
remarkable in the putative calcium binding regions. The mRNA transcript size of 2A9 
is 0.6kb and the transcript becomes apparent in rat, mouse, and human diploid fibrob-
lasts only when these are stimulated with various growth factors. It is not detectable in 
Go cells. 2A9 is detectable in human bone marrow cells and cells from acute and 
myeloid leukaemias (Calabretta et al 1985; 1986). Its inducibility is not affected by 
inhibition of protein synthesis and Calabretta et a! (1986) postulate that 2A9 may have 
a role in cell cycle regulation. Calcium is required for growth of cells in culture, espe-
cially fibroblasts, and levels of intracellular free calcium are markedly increased when 
quiescent fibroblasts are stimulated to proliferate by platelet derived growth factor 
(PDGF) and epidermal growth factor (EGF) but not when stimulation is by insulin. 
2A9 is induced by PDGF and EGF but not by insulin. Further, the 2A9 predicted 
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amino acid sequence has significant homology to p11 which is part of a complex 
which is a substrate for tyrosine kinases. Tyrosine kinases are also involved in the cel-
lular response to growth factors (Cooper et al 1982). Wilkinson et a! (personal com-
munication) have shown that the only normal cells in which CFAg can be detected 
immunologically are non keratinised squamous epithelial cells of the tongue, oeso-
phagus and cervix. However squamous cell carcinoma of the skin and lung are 
strongly positive. This may indicate some involvement of CFAg in cell cycle control 
and when these cells are rapidly proliferating CFAg levels increase. However it may 
reflect an expansion of the particular cell type in which CFAg is present. 
8.6 CFAg as calcium-binding protein 
The predicted sequence of CFAg from the cDNA data indicates that it is a cal-
cium binding protein. Results of experiments using radiolabelled calcium by 
C.Hayward and M.Novak indicate that CFAg does bind calcium. ICaBPs are not 
directly involved in the uptake of calcium but are associated with this process (Corra-
dino R et a! 1976). The control of intracellular calcium levels is extremely important 
and although no clear function has been assigned to these calcium modulating proteins 
they may be involved in controlling the level and hence in transducing calcium signals 
(van Eldvik 1982). A rise in calcium levels may result in calcium binding to these 
proteins and in turn activate enzymes in a way similar to that for calmodulin. However 
the tissue distribution of this family of proteins suggests a more restricted role than 
that of the ubiquitous calmodulin. 
8.7 Signal transduction 
a) cAMP acts as a second messenger in mammalian cells. Regulated by adenylate 
cyclase levels, an increase in cAMP (generated from ATP) will result in the activation 
of protein kinases. The activation of protein kinases can be calcium dependent or 
independent. The stimulation of the adenylate cyclase occurs by the binding of an 
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agonist to the cell membrane receptor which then is coupled to a G protein which 
binds GTP when activated. 
The multiple steps in the 3-adrenergic system permit other signals to activate the 
cascade at many different points. Some protein kinases e.g glycogen phosphorylase 
kinase, are activated both by phosphorylation and calcium. The phosphorylation is 
mediated by the cAMP-dependent protein kinase and phosphorylation increases the 
affinity of the calcium-binding subunit (calmodulin) for calcium. In fact, independently 
of cAMP signalling, a sufficient increase in calcium will result in an unphosphorylated 
and yet active enzyme (Lodish et al 1986). 
Calcium-binding proteins may inter-relate with the cAMP second messenger path-
way at the level of protein kinases or at other points in the cascade. Calmodulin for 
example is involved in regulation of the cAMP response. The calcium-calmodulin 
complex binds to and activates phosphodieste rase which converts cAMP to AMP and 
thus terminates the effect of the agonist. 
b) The phosphoinositol pathway is responsible for the release of calcium (trigger 
calcium) into the cytosol from stores in the endoplasmic reticulum (ER) (Berridge et at 
1984). External agonists eg vasopressin, glucagon, neurotransmitters bind to receptor 
and stimulate two second messengers (Higoshida et a! 1986). Phosphatidyl(4,5)bisphos-
phate, a precursor lipid, is located within the inner leaflet of the plasma membrane and 
is cleaved in response to agonists which stimulate phosphodiesterase (phospholipase c). 
This yields the second messengers diacylglycerol and inos itol (1 ,4,5 )triphosphate. Dia-
cyiglycerol activates protein kinase c, while phosphatidylinisitol is converted to phos-
phatidylinisotol (4) phosphate and then to phosphatidyl (4,5) bisphosphate which is 
cleaved to inositol (1,4,5) triphosphate and thus mobilizes calcium. Protein kinase c 
phosphorylates one set of proteins while inositol trisphosphate elevates calcium to 
activate calmodulin-dependent protein phosphorylation and other calmodulin-dependent 
reactions. It may be that S-lOO,and ICaBPs are activated by this system and regulate 
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enzymes in a similar way to calmodulin but in a more defined manner suggested by 
their tissue specificity. 
8.8 Relationship of CFAg to the gene defect in CF 
The relationship of CFAg to the basic gene defect in CF is as yet unknown. The 
recent data, which indicate the biochemical fault lies in control of chloride ion per-
meability in various exocrine tissues may indicate the metabolic pathway in which the 
two gene products (on chromosome 1 and 7 ) must inter-relate. The 3-adrenergic 
response in CF exocrine tissue appears to be somehow defective (Welsh and Liedtke 
1986; Frizzel et al 1986; Sato and Sato 1984; MacPherson et al 1986) and f3-agonists 
stimulate chloride channel activity in normal, but not CF epithelial cells (Welsh and 
Liedtke 1986; Frizzel et al 1986). This does not however preclude inositol trisphos-
phate or diacyiglycerol also being involved. 
8.9 Defective chloride channel activity in CF 
The most recent results obtained independently by Welsh and Liedtke (1986) and 
Frizzel et al (1986) using patch clamp techniques, on trachea epithelial cells indicate 
that 
The activity of isolated chloride channels is equivalent in normal and CF samples. 
Whole cells stimulated with 3-adrenergic agonists demonstrate chloride channel 
activity only in samples from normals and not in CF individuals. 
Whole cells stimulated with 8-bromo-cAMP (cAMP analogue) or forskolin (activa-
tor of adenylate cyclase) only demonstrate chloride channel activity in normal and not 
CF samples. 
cAMP accumulation in response to J3-adrenergic agonists is normal in CF nasal and 
tracheal epithelial cells. 
This places the defect in CF chloride ion reabsorption at a point distal to cAMP accu- 
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mulation but not intrinsic in the channel itself. However this does not rule out the pos-
sibility that it could be a defect in the phosphorylation of an important site on the 
cytoplasmic side of the channel for example. Sato and Sato (1983) also found normal 
cAMP regulation in sweat glands from CF individuals although sweat secretion was 
only stimulated by isoproterenol in normals. McPherson et a! (1985, 1984) reported a 
decreased stimulation of CF submandibular glands in CF patients by 3-adrenergic 
agonists, measured by a lack of mucin or amylase secretion from CF exocrine acinar 
cells. However noradrenaline (a mixed (x and 3-agonist) did stimulate CF cells to 
secrete mucin and amylase. They observed however that cAMP was increased to the 
same amount in normal and CF n-agonist stimulated tissues. 
Davis et al (1983), reported that intact leukocytes from patients with CF produce 
significantly less cAMP than normal lymphocytes and granulocytes in response to 
isoproterenol. Prostaglandin E however produces a normal response in CF white cells 
and the basal level of cAMP is normal. In opposition to their results Galan et al (1981) 
had shown that whole granulocytes from patients with CF had reduced numbers of 
beta-adrenergic receptors, and heterozygotes had normal numbers of receptors although 
they also displayed a reduced response to isoproterenol 
If the defect in CF is in the control of anion channel function, this also explains 
the reduced HCO 3  secretion from CF pancreatic ducts. Previous theories involving the 
chloride channel being intrinsically faulty in CF individuals did not explain this obser-
vation. 
However as has been recently demonstrated by Wakelam et a! (1986), in the case 
of glucagon it is not always clear whether only one pathway is involved in eliciting a 
hormonal response. A wealth of data accumulated to show that glucagon increased the 
cAMP levels via adenylate cyclase stimulation and caused glycogen breakdown , prob-
ably mediated by increased Ca levels. \Vakelam et al used a glucagon analogue 
(TH-glucagon), which does not activate adenylate cyclase or increase cAMP, to show 
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that there was still gluconeogenesis, glycogenolysis, and urea synthesis stimulation, 
and the production of inositol phosphates occured with this analogue. This has been 
shown for other signal hormones including vasopressin (which acts through Vi and V2 
receptors (Creba et al 1983)), and has been reported to be the case for secretin in pan-
creatic acinar cells (Peterson and Bear 1986). Consequently it may be too rash to attri-
bute chloride secretion stimulation completely to a cAMP mediated pathway. Further, 
these two systems are not autonomous, and it appears that in the case of glucagon 
(Wakelam et al 1986) adenylate cyclase activation can inhibit inositol phosphate pro-
duction, and similarly, activation of protein kinase C desensitises the glucagon-
stimulated cAMP pathway. 
8.10 Evidence for the involvment of a calcium-binding protein in CF 
McPherson et a! (1985;1984;1986b) discovered that the phosphodiesterase inhibi-
tor 3,isobutyl- 1 -methyl-xanthine partially restored the defective 3-adrenergic response 
in the CF submandibular glands. McPherson believes that in the CF exocrine acinar 
cells the mucin and amylase secretion has switched from 13 to a adrenergic function. 
In a scientific correspondance to Nature (1986a) McPherson et al postulate that as 
cAMP phosphodiesterase represents a point of interaction between cAJ\'IP and the cal-
cium regulatory pathway it may be a Ca 2+  dependent regulatory protein such as calmo-
dulin which is affected in CF. An overactivity of phosphodiesterase (which is responsi-
ble for the hydrolysis of cAMP to AMP) could be the result of an alteration in a 
calcium-dependent regulatory protein. Mangos (1981) also observed increased 13-
adreriergic secretory responses in CF parotid acinar cells in the presence of a phospho-
diesterase inhibitor. Gnegy et al (1981) have found that CF fibroblasts have an 
increased ability to stimulate phosphodiesterase activity and by inference have 
increased calmodulin levels. Vladutiu (1984) screened CF patients, their parents and 
normals by measuring the calmodulin concentration in dried blood spots in a radioim-
munoassay. He found a significant elevation of calmodulin levels in both CF and 
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heterozygotes compared to controls. However the study was small (7 CF and 7 hetero-
zygotes) and the overlaps between groups did not allow diagnosis based on the results. 
A more recent study carried out by McPherson et al (1986b) showed that calmodulin 
from CF and normal submandibular glands appeared identical when analysed on 
reverse phase high pressure liquid chromatography. Therefore the possible calcium 
-binding regulator does not appear to be calmodulin, although calmodulin activation of 
cAMP phosphodiesterase by crude extracts from CF cells is increased relative to con-
trol extracts. MacPherson (1986) postulates the alteration of a specific modulator of 
calmodulin function in CF cells 
Banschbach et al 1978 discovered that a two fold increase in 45Ca2 labelling 
was observed when normal human leukocytes were incubated in the presence of serum 
from CF patients. The degree of calcium labelling of patients' leukocytes was 
significantly greater than that observed for normal leukocytes. This experiment showed 
that high levels of intracellular calcium may be responsible for the reduced cAlvIIP 
stimulation seen by Davis et al (1983). Rasmussen et al (1975) and Shapiro et al(1978) 
had already reported that CF fibroblasts take up significantly more 45Ca21  than do nor-
mal fibroblasts. 
8.11 CFAg 
How does CFAg fit into t- 	data? Clearly intracellular calcium levels are impor- 
tant in mediating second messenger pathways, both in cAMP and inositol phosphate 
stimulation as already discussed. If CFAg is shown physiologically to be a calcium-
binding protein (and there is some unpublished data to support this (C.Hayward pers 
comm)) then it could act to regulate either one of these systems by directly controlling 
Ca 2+  levels or binding calcium and specifically activating a protein. The major tissue 
for CFAg is granulocytes, and this cell type is the most likely source of CFAg when it 
is present in serum. 
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The aberrant gene for CF having been located on chromosome 7, means that 
CFAg cannot be the mutant gene product. However the gene product of the chromo-
some 7 gene might interact directly with CFAg. The mutation in the CF gene may 
result in lack of function of its protein product, and as a consequence CFAg levels 
alone or together with levels of other proteins may then become elevated in serum. 
The level of CFAg in serum may be raised as a consequence of the CF gene mutation 
by :- 
Affecting the localisation of CFAg. 
In I-cell disease, fibroblast acid hydrolases become elevated in the plasma due to 
inappropriate localisation, the enzymes become extracellular rather than intralysosomal. 
In the same way, CFAg may be mislocalised due to the deficiency of the CF gene pro-
duct in CF individuals. 
The CF gene may affect the granulocyte membrane in some way and increase the 
level of CFAg in the serum of CF patients due either to leakage of the protein out of 
the cells or perhaps increased cell fragility. 
Alternatively the chromosome 7 gene product may have a control function and the 
aberration of this function in CF, results in misregulation of CFAg. 
It is possible that mislocalisation or misregulation of CFAg may result in the disr-
uption of a calcium mediated signal involved in anion channel control. Alternatively, 
the abnormal accumulation of CFAg in CF patients may be a secondary symptom of 
the perturbation in ion channel control, or may be an indirectly produced cause of 
abnormal channel regulation. 
8.12 Use of CFAg in heterozygote detection 
Hayward et al (1987), have assessed the serum concentrations of CFAg in cystic 
fibrosis patients and normals, using monoclonal antibodies against CFAg in a sensitive, 
two-site immunoassay. Unfortunately, although the median values of the serum 
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concentration of CFAg in homozygotes was significantly higher than heterozygotes, 
and heterozygotes higher than normals, there was an unacceptable degree of overlap 
between the different ranges of values. Because CFAg can also be found at high con-
centration in the serum of patients with myeloproliferative disorders such as CML, the 
possibility that CFAg presence in serum is due to granulocyte proliferation was investi-
gated. Inividuals with CF have chronic respiratory infections and so it is conceivable 
that they might have increased granulocyte turnover. This is not true however of CF 
heterozygotes. Hayward et al (1987) tried to answer this point and improve the hetero-
zygote test by measuring serum levels of another granulocyte protein (lactoferrin) to 
control for increased granulocyte number or damage, and C-reactive protein to obtain a 
measure of inflammation. The results could not improve the separation of the three CF 
genotypes and raised the question whether CFAg has any direct relevance to the CF 
gene or can be attributed to increased granulocyte proliferation and active tissue dam-
age. However, CFAg is significantly raised in the serum of CF heterozygotes compared 
to normals but lactoferrin and C-reactive protein are not. Disease controls have raised 
serum CFAg levels but also have significantly raised lactoferrin and C-reactive protein 
levels. Hayward et al conclude that the elevated levels of CFAg in the serum of CF 
heterozygotes is due to the presence of a single copy of the CF gene, while in CF 
homozygotes there are two elements contributing to the raised level of CFAg. One ele-
ment due specifically to the CF genotype of the individual and the other resulting from 
increased granulocyte turnover found in active inflammation. However, as the test 
stands at the moment, it regretfully cannot be used in heterozygote detection. 
8.13 Granulocytes as an affected tissue 
Granulocytes have not been closely examined as an affected tissue. Davis et al 
(1983) has shown that there is reduced j3-adrenergic response in granulocytes from CF 
and heterozygotes. The activity of chloride channels in CF granulocytes has not been 
examined and, as the tissue is easily available, this seems to be an obvious step to 
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take. The availability of peripheral blood means that if granulocytes were identified as 
an affected tissue, physiological studies could be carried out on virtually unlimited 
supplies of tissue. Samples would be readily available from CF patients, heterozygotes 
and normals, and would allow clearer analysis of disease associated changes. Further-
more if granulocytes expressed the CF gene defect then the possibility of designing a 
heterozygote test using these cells would be feasible. 
von Tscharner et al (1986) have shown that receptor-agonist stimulated inositol 
triphosphate causes transient openings of calcium gated cation channels in neutrophils. 
Inositol trisphosphate triggers the release of calcium from neutrophil intracellular stores 
(Spat et al 1986) and when the cytosolic free calcium rises above 10 7M the ion chan-
nels examined by von Tscharner et al (1986) are opened. However, the channels are 
inactive when the free calcium concentration falls. It is thus possible to hypothesise 
that an increase in the level of a protein which binds available free calcium could 
damp down the calcium signal. 
It would be interesting to see if other calcium-binding proteins (possibly as yet 
undiscovered) have raised levels in other CF tissues, especially in the supposedly 
affected tissues, i.e pancreas, sweat gland, respiratory tract epithelia. S-100, for exam-
ple, is present in sweat glands and serous glands of normals (Kahn et al 1983). 
The function of CFAg requires further investigation. The HL-60 cell system pro-
vides an excellent cell culture system to examine the effect of manipulation of the 
gene, (overexpression, or absence of a functional protein). S-100 has been reported to 
associate with a variety of proteins in vitro and particularly those with which calmodu-
lin is known to bind. Discovery of specific proteins which bind CFAg may lead to a 
clear indication of the types of processes in which it is involved and by analogy eluci-
date the function of the other classes of calcium-binding proteins with sequence simi-
larity to CFAg. 
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S 100, is reported to be highly conserved between mammals and it would be 
interesting to isolate the rodent homologue of CFAg and determine the degree of 
species divergence for this gene. 
At present, we have not ascertained which tissue in the mouse expresses CFAg. 
One would predict that mouse myeloid tissue would express the gene because the 
mouse myeloid cell line WEHI-TG, allowed expression of the human gene in somatic 
cell hybrids (van Heyningen et al 1985). A variety of mouse tissue RNAs are being 
analysed by Northern blot at this time. 
We have information (Calabretta et al 1987 unpublished) that the gene for 2A9 is 
located on human chromosome 1, in the region q21-q25. This region overlaps the 
region in which CFAg lies. It seems very probable that CFAg, and 2A9 are members 
of the same gene family and could have arisen from an ancestral gene by tandem 
duplication at some point in evolution. This theory is supported by the fact that the 
two genes appear to be, physically, very close in the genome. It would be interesting 
to see if S-100, and the ICaBPs are also located within the centromere-proximal region 
of the chromosome 1 long arm. This would identify a cluster of genes coding for a 
group of ancestrally related calcium-binding proteins, and possibly facilitate isolation 
of other genes within the same family. 
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ABBREVIATIONS 
The following is a list of abbreviations used frequently or not explained fully within 
the text. 
AMP ............... ampicillin 
bp...................base pair 
°C ................... degrees centigrade 
Ca ....................calcium 
cAMP .............. adenosine 2':3' cyclic monophosphate 
eDNA .............. complementary DNA 
Ci.....................curie 
CF....................cystic fibrosis 
CFAg................cystic fibrosis antigen 
Cf..................chloride 
CML ............... chronic myeloid leukaemia 
cpm. ................ counts per minute 
dATP.............. deoxyadenosine 5' triphosphate 
dCTP .............. deoxycytidine 5' triphosphate 
dGTP .............. deoxyguanosine 5' triphosphate 
dNTP .............. deoxynucleoside 5' triphosphate 
DNA...............deoxyribonucleic acid 
dpm.................disintegrations per minute 
dTTP..............deoxythymidine 5, triphosphate 
E.coli ................ Escherichia coli 
EDTA..............ethidium diaminetetra-acetic acid 
g.....................grammes 
ITS ................. insulin, transferrin, sodium selenite 
kb..................kilobase 
kDa ................. kilodalton 
J.Ll ................... microlitres 
McAb..............monoclonal antibody 
mRNA .............. messenger ribonucleic acid 
f3-NAD ............... f3-nicotinamide adenine dinucleotide 
Na .................sodium 
poly(A) .............polyadenylated ribonucleic acid 
RA....................retinoic acid 
RNA.................ribonucleic acid 
SDS..................sodium dodecyl sulphate 
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Tris 	. tris (hydroxymethyl) aminomethane 
rpm................revolutions per minute 
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The metabolic basis of the autosomal recessive disease cystic 
fibrosis (CF) remains unidentified. Elevated levels of a 
serum protein In CF homozygotes and obligate heterozygotes have 
been described. As heterozygotes are clinically unaffected, any 
consistently observed abnormality in these individuals is a likely 
pointer to the aetiology of the disease. The gene for this serum 
protein, called cystic fibrosis (CF) antigen, has been mapped to 
chromosome 1 (ref. 2). It is not the gene that is mutant in CF 
because this has since been assigned to chromosome 7 by cosegrega-
tion of the disease with closely linked DNA markers in CF 
familles. Cl? antigen is a product of normal and leukaemic 
granulocytes2 and is inducible in the promyelocytic cell line HL60 
(M.N., J.D., C. Hayward, F. Northrop, D.J.H.B., J. Walker, V. 
van H. and DSS., manuscript in preparation). We have isolated 
cDNA clones for this protein from a library constructed with 
messenger RNA from chronic myeloid leukaemia (CML) cells. 
The complete nucleotide sequence was obtained from the cDNA 
clone and by primer extension of mRNA. We have confirmed that 
the gene encoding CF antigen is on chromosome 1 and have 
localized it to a particular region. RNA blot analysis shows a 
550-bp major transcript in CML cells and in induced HL60. The 
amino-acid sequence predicted from the nucleotide sequence shows 
significant homology with intestinal and brain calcium-binding 
proteins. Abnormal accumulation of such a protein in Cl? is a clue 
which must be pursued now that evidence is gathering that the 
basic defect In CF is in pathways controlling chloride channel 
activity 7. 
Quantification of serum levels of CF antigen by immunoassay 
shows that the three genotypes (CF homozygotes, heterozygotes 
and normals) fall into three overlapping classes. Monoclonal 
antibodies, recognizing two epitopes on this protein, have been 
produced8. These antibodies have now been used for 
immunopurification and sequence-comparison of the antigen 
from a variety of sources (M.N. et aL, in preparation). 
Partial amino-acid sequence analysis of the purified protein 
allowed us to synthesize a highly redundant oligonucleotide 
probe, corresponding to the region indicated in Fig. 1 (M.N. et 
aL, in preparation), which was used to isolate the cDNA clone 
CFA 8-9. The library screened was constructed in AgtlO, using 
mRNA prepared from CML cells. Antigen turnover had pre-
viously been demonstrated in such cells by the specific 
immunoprecipitation of labelled protein following 35S-
methionine incorporation. The identity of CFA 8-9 was 
confirmed by matching the predicted and known amino-acid 
sequence outside the oligonucleotide parent region. 
The nucleotide sequence of CFA 8-9 is shown in Fig. 1. The 
insert of 338 nucleotides includes an open reading frame of 250 
base pairs (bp) which encodes 83 amino acids stretching from 
the first amino acid used for the construction of the oligonucleo-
tide probe, to the C-terminal residue before the chain-termina-
tion codon. The sequence encoding the first 11 N-terminal amino 
acids, known from the protein sequence data, is also shown in 
Fig. 1. The nucleotide sequence for this and the 5'-untranslated 
region (Fig. 1) was determined by oligonucleotide primer-exten- 
* Permanent address: Institute of Virology 81703, Bratislava, Czechoslovakia. 
1 	 G*************** 60 
ATGTTGACCGAGCTGGAGAAAGCCTTGAACTCTATCATCGACGTCTACCACAAGTACTCC 




L 	KG N F H AV Y 	DD L K K L LET 
180 
GAGTGTCCTCAGIATATCAGGAAAAAGGGTGCAGACGTCTGGTTCAAAGAGTTGGATATC 
E C P Q Y IA K K GAD VIW F K EL DI 
240 
AACACTGATGGTGCAGTTAACTTCCAGGAGTTCCTCATTCTGGTGATAAAGATGGCGTGG 
NT D G A V N F Q E F L  L V I K MAW 
300 
CAGCCCACAAAAP.AAGCCATGAAGAAAGCCACAAAGAGTAGCTGAGTTACTGCCCAGAGG 
Q P1K K  MK K A TX S S 
CTGGGCCCCTGACATGTACCTGCAGAATAATAAAGTCATCAATACCTC (polyA) 
Fig. 1 Nucleotide and corresponding amino-acid sequence of the 
cDNA clone CFA 8-9. The probable polyadenylation signal of the 
mRNA is underlined. Asterisks, the oligonucleotide used to isolate 
the clone; !, termination codon; vertical bar, start of probe; 
brackets, N-terminal amino acids determined by protein sequenc-
ing (M.N. et aL, in preparation). The nucleotide sequence from 
—51 to +33 was determined by reverse transcriptase primer 
extension using induced HL-60 cell mRNA as a template. 
Methods. RNA was prepared 30  from 1011  CML cells collected by 
leukophoresis. Poly(A)' RNA was isolated 3 ' and used as a tem-
plate for cDNA synthesis 32. The resulting double-stranded cDNA 
was cloned in AgtlO by standard procedures 33 . Titration on 
Escherichia coli Hfi strain revealed a library of 70,000 independent 
recombinants. The amplified library was screened by the method 
of Benton and Davis'. The 144-fold redundant 15-mer oligo-
nucleotide probe was labelled with polynucleotide kinase using 
10 pmol of 5' ends and 200 I.Xi of [y- 32P]ATP per reaction 35. 
Filters were washed in 2 x SSC containing 0.1% SDS for 90 mm 
at 37 °C. Positive plaques were recloned repeatedly and then sub-
cloned into M13mp9 for sequencing. Both strands of the clone 
with the largest insert (CFA 8-9) were sequenced by the dideoxy 
chain termination method. Reverse transcriptase mediated primer 
extension and dideoxy sequencing of first strand cDNA was carried 
Out following Novak et at (manuscript in preparation). 
tion using mRNA from DMSO-induced HL-60 as template. The 
relative molecular mass (Mr) of 10,938 deduced for the complete 
sequence of 94 amino acids, is in agreement with the approxi-
mate subunit M observed for immunoprecipitated antigen 
(M.N. et at, in preparation). There are no N-glycosylation sites 
predicted from the amino-acid sequence and there is no evidence 
that CF antigen is a glycoprotein. The 3' untranslated region of 
the mRNA is unusually short. On re-screening the CIVIL cDNA 
library with CFA 8-9 as probe, approximately 0.5% of the 
recombinants were positive, suggesting that the gene product is 
relatively abundant in these cells. 
RNA blot analysis (Fig. 2) on a variety of tissues and cell 
lines was carried out to examine message size and abundance. 
In all cases where mRNA hybridizing to the CFA 8-9 insert was 
observed, two bands were seen. The major band of approxi-
mately 550 bp was of at least 20-fold higher intensity than the 
second 1 kilobase transcript. Total mRNA levels loaded were 
monitored by reprobing with an actin cDNA probe?. Poly(A) 
mA isolated from two CIVIL samples, one of which had been 
used for the construction of the cDNA library, contained very 
high levels of CFA 8-9 transcripts. Equivalent amounts of 
mRNA isolated from uninduced HL60 cells gave no detectable 
signal, whereas HL60 cells induced to differentiate along the 
myeloid pathway" possess both size transcripts. However, 
retinoic acid (RA) and dimethyl sulphoxide (DMSO) induce 
b 
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Fig. 2 RNA (Northern) blot analysis of various human cell lines 
and tissues: a, Hep G2(hepatoma) 37 ; b, EMBK (embryonic kidney, 
ATCC No. CR1 1573); c, MNNG-HOS (oesteosarcoma, ATCC 
No. CRL 1547); d, Daudi (Burkitt lymphoma derived B-lympho-
blastoid line)"; e, hepatoma; f, CML #1; g, CML #2; h, unin-
duced HL60; i, HL60 induced (2 days RA); j, normal liver; k, 
WEHI TG (mouse myeloid stem cell)' ;. I, WEP 1342.2.4 (mousex 
human myeloid cell hybrid containing human chromosomes 7, 10, 
13,20) 2; m, WEH 3 127.1.9 (myeloid cell hybrid containing human 
chromosomes 1, 9, 14, 21 and expressing CFAg) 2. Lane 1, CML 
#1; 2, HL60 induced (2 days RA); 3, HL60 induced (5 days 
DMSO); 4, CIVIL #2. Both blots were probed with CF antigen 
gene cDNA, and reprobed with mouse actin to ensure comparable 
sample loading (reprobe shown for lanes 1-4 only). 
Methods. Cells were grown in RPM! 1640 medium supplemented 
with 5% fetal calf serum, except for uninduced HL60 which was 
grown in serum-free medium supplemented with insulin, transfer- 
rin and selenite (ITS, Sigma). HL60 induction was by continuous 
culture with 1.2% (v/v) DMSO or 10_6 M RA. RNA was isolated 
as in Fig. 1. Then poly(A) RNA (2 p.g in lanes a, b, c, k, I, m), 
total RNA (20 p.g in lanes d-j) or poly(A) RNA (1 ILg in lanes 
1-4) was separated on a 1.2% agarose/formalcfehyde gel and 
transferred directly to nitrocellulose 35. Hybridization was at 68 °C 
with the insert from CFA 8-9 randomly primed with a mixed 
sequence hexadeoxynucleotide (Pharmacia), filled in using 
Kienow enzyme and radiolabelled with [a-32P]drrP. Filters were 









low and high relative message abundance respectively. A 
possible explanation for this may be that cells treated with RA 
and DMSO do not reach the same degree of maturation along 
the myeloid pathway. After equivalent treatment regimes only 
10% of DMSO-treated cells are recognizable as mature 
neutrophils' °", compared with 30% for RA treatment. 
Messenger RNA isolated from a variety of other malignant 
human cell lines (embryonic kidney, osteosarcoma, hepatoma 
and Burkitt's lymphoma) gave no detectable signal. Human liver 
mRNA gave a weak signal which we have assumed to be due 
to blood contamination of the original tissue, because we have 
demonstrated antigen turnover in normal granulocytes, and 
immunohistochemical analysis of liver sections reveals no anti-
gen in hepatocytes (V. van H. et aL, unpublished). No detectable 
signal was seen with mRNA from the mouse myeloid stem cell 
line WEHI-TG 12, or in somatic cell hybrids between WEHI-TG 
and human CML cells unless human chromosome 1 was present 
in such hybrids'. It appears therefore that there is no synthesis 
of a homologous cross-hybridizing mRNA in this mouse myeloid 
line. No signal distinguishable from the human 550-bp band 
was found in the 'switched on' chromosome 1 containing 
hybrids. Thorough immunohistochemical analysis of normal 
tissues revealed CF antigen only in a few non-keratinizing 
squamous epithelia (tongue and oesophagus), in addition to 
granulocytes (manuscript in preparation). 
Human and mouse DNA digested with restriction enzymes 
PstI, Barn HI, EcoRI and Hind!!! give a single hybridizing band 
with CFA 8-9 insert even with low stringency washes. Digestion 
with BgIII gives three bands but of small size, consistent with 
restriction sites within the gene. This suggests the existence of 
only one gene for this protein in both these species, and the 
absence of any closely related cross-hybridizing genes. Mouse-
human somatic cell hybrids, regardless of whether they express 
CF antigen 2, exhibit a band of human mobility only when 
chromosome 1 is present at high frequency (Fig. 3a). The 
confirmation that this gene is on chromosome I is additional 
evidence that the cloned insert corresponds to the immunologi-
cally recognized protein'- 2. The availability of cell hybrids con-
taining defined fragments of chromosome 1 has allowed us to 
sublocalize the gene locus to the region between bands q12 and 
q22 on the long arm (Fig. 3b). 
Fig. 3 a, Southern blot analysis"' to illustrate mapping of CFA 8-9 in rodent/human somatic cell hybrids. Lane 1, NYX5.6.1 i °; 2, F9.6 (unpublished data); 3, NYX5.640; 4, CML#3; 5, WEH 3127.1.9 T72  6, WEH 3127.1.9 T8; 7, WEH 3127.1.9 77; 8, WEH 3127.1.9 T8; 9, WEHI-TG. Size markers (A fragments) in kb. b, Summary of chromosome analysis of the location of the gene for CF antigen (CFAg). 
Segregation of the CFA 8-9 hybridizing, human-specific restriction fragment with chromosome 1 or fragments of it. WEH 3 127.1.9 Ti and T8 
are subclones of the same hybrid 2, FACS sorted for expression and non-expression respectively of a chromosome- I -encoded cell surface 
marker'. Black squares denote the presence of chromosomes in >50% of cells scored; q, long arm only present. The restriction fragments 
corresponding to the human gene for CFA 8-9 (+ in CFA8 column) are seen whenever the entire chromosome I is present and also in hybrid 
RAG J8 with human chromosome I from the tip of the short arm to band q21 on the long arm (pter-q2l) present. No human CFA8-9 bands 
are present (- in CF Ag column) in hybrid SK 82 which contains only region pter-q12 of chromosome 1. The gene must therefore lie between 
bands q12 and q22 on chromosome 1. Other hybrid cell data support this result. 
Methods. In a, —10 pg of genomic DNA was digested with BgIH, fractionated on 0.8% agarose gels and transferred to nitrocellulose filters. 
After hybridization with labelled cDNA probe CFA 8-9 insert, blots were washed in 2xSSC/0.1% SDS at 68°C. 
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Fig. 4 Alignment of the predicted amino-acid sequence of CF 
antigen with amino-acid sequences of ICaBP from cow, pig and 
rat; bovine SlOOa and b subunits; porcine p11 and human 2A9. 
The calcium binding ligands, as determined by X-ray crystallogra- 
ph °  for the EF-hand region of bovine ICaBP, are marked with 
asterisks. Calcium-binding ligands marked with triangles are from 
the second distinct type of calcium-binding region in ICaBPs and 
SlOO. Amino-acid residues which are identical in CF antigen and 
at least one of the other sequences are boxed. 
The deduced amino-acid sequence of the cloned CF antigen 
gene was compared with all sequences in the NBRF database 
by a method which permits high stringency comparison with all 
the sequences present ' 3. Highly significant homology (optimized 
score: 189, 43% identity over a stretch of 72 amino acids) was 
obtained with bovine SlOOa subunit, a brain-associated calcium-
binding protein ' 4, and the similarity extends to the homologous 
SlOOb subunit. Strong homology was also seen with bovine 
intestinal calcium-binding protein (BICaBP)' 5 and its pig and 
rat homologues. These proteins all belong to a class of calcium-
binding proteins which are postulated to be the major trans-
ducers of biological calcium signals' 6. Like S100 proteins, but 
unlike the intestinal calcium-binding proteins which are 
monomeric, native cystic fibrosis antigen is predominantly in 
dimeric form under non-reducing conditions (M.N. el aL, manu-
script in preparation). Amino-acid comparisons are shown in 
Fig. 4. Two additional sequences, not yet in the NBRF database 
but recently shown to be similar to S100 proteins, are included. 
These are: the sequence for porcine p11 (or plo), a regulatory 
subunit of the protein complex which is a major cellular target 
for tyrosine kinase 178; and the deduced sequence for a cell-cycle 
specific human cDNA molecule, 2A9 9, the protein product of 
which has not yet been studied. 
In the well studied calcium-binding proteins there are two 
types of calcium-binding sites 20. Amino acids which act as 
ion-binding ligands in the conventional EF hand-like site 2° are 
marked with asterisks in Fig. 4. These are well conserved in 
cystic fibrosis antigen, suggesting that calcium binding remains 
a normal function of this protein. The criteria for the conserva-
tion of calcium-binding capacity at the second site (marked with 
triangles) are less clearly defined  20. Equilibrium binding studies, 
using 4'Ca  21  in competition with unlabelled CA 2 , have shown  
that CF antigen binds two atoms of calcium per molecule of 
protein and with an affinity similar to that shown by S100 protein 
(D.J.N.B. and C. Hayward, unpublished data). 
The most widely accepted abnormality demonstrable at the 
cellular level in CF is defective transport of chloride ions across 
epithelia  21 . However, recent patch-clamp analyses of chloride 
channel activity in epithelial cells of the airway, a tissue affected 
in CF, suggest that the conductance characteristics of isolated, 
cell-free chloride channels from CF tissue are indistinguishable 
from those observed for normal cells 6'7. When similar studies 
are carried out with whole cells, the $-adrenergic stimulation 
of chloride channel activity observed in normal cells is absent 
in CF cells. As cAM P generation is unaltered in such CF ce1ls' 22 , 
deviation from normal function might be sought further on in 
the cAMP pathway or in other signal transducing systems. 
Activation of the phosphatidyl inositol pathway" leads to 
mobilization of intracellular calcium. Alteration of any com-
ponent of this system is a candidate for the basic defect in CF 
tissue. Recent investigations have suggested the existence of 
more than one receptor, capable of responding through different 
pathways to signals by certain ligands24'25 . Control of chloride 
channel activity may fall into this category. 
The most likely tissue source for the elevated serum levels of 
cystic fibrosis antigen is granulocytes. This would imply that 
myeloid cells are an affected tissue in CF. There have been 
suggestions that this is the case  26'27, although no clinically 
relevant granulocyte abnormalities have been reported 28. 
Investigation of ion transport with particular reference to cal-
cium metabolism in granulocytes might be fruitful. Calcium-
modulated activation of ion channels has been demonstrated in 
normal human neutrophils 29. Confirmation that the basic defect 
is expressed in granulocytes would be an important step forward 
for CF research because these cells are relatively easily accessible 
from affected and heterozygous individuals. 
Demonstration of granulocytes as a tissue affected in CF 
would suggest that elevated serum levels of cystic fibrosis antigen 
can be attributed to the absence (in homozygotes) or reduction 
(in heterozygotes) in these cells of the normal product of the 
CF gene on chromosome 7 which may be necessary for correct 
assembly of a multi-molecular complex. 
We thank Dr Andrew Coulson for running the database 
comparison, Dr John Goldman for supplying leukophoresis 
samples, Richard Buckland for supplying some hybrid-cell 
DNA, Judy Fletcher for the chromosome analyses, Richard 
Meehan and Nick Hastie for invaluable advice and discussion 
and Professor H. J. Evans for support. J.R.D. is the recipient 
of an MRC Training Award. M.N. is a Royal Society Exchange 
Fellow from the Slovak Academy of Sciences, Bratislava. 
The sequence data in this publication have been submitted 
to the EMBL/GenBank Libraries under the accession number 
Y00278. 
Received 25 November 1986; accepted II February 1987. 
I. Bullock. S., Hayward, C., Manson, J. C., Brock, D. J. H. & Racburn, J. A. Cli,,. Gene, 21, 
336-341 (1982). 
van Heyningen. V. Hayward, C., Fletcher,). & McAuley, C. Nature 315, 513-515 (1985). 
Knowlton, K. G. et aL Nature 318, 380-382 (1985). 
White, K. ci al. Nature 318, 382-384 (1985). 
wainwright, B.). ci at Nature 318, 384-385 (1985). 
Welsh, M. J. & Liedtke, C. M. Nature 322,467-470 (1986). 
Friarel, K. A., Rechkemmer, G. & Shoemaker, K. L Science 233,558-560 (1986). 
Hayward, C., Chung, 5., Brock, 0.3. H. & Van Heyningen, V. I. unman. Mcii,. 91, 117-122 
(1986). 
Minty, A.). ci at I. blot Chem256, 1008-1014 (1981). 
Breitman, T. P.., Scolnick, S. E. & Collins, 5.3. PIne. nain. Acad. Sc,. U.S.A. 277, 2936-2940 
(1980). 
II. Ferrero, 0., Pessando, S., Pagliardi, G. & Rovera, G. Blood 61, 171-179 (1983). 
Geurts van Kessel, A. H. M., Tetteroo, P. A. T., von dem Borne, A. E. 0., Hagemeijer, A. 
& Bootsma. D. PIne. not,,. Acad Set U.SA 80, 3748-3752 (1983). 
Lyall, A., Hill, C., Collins, J. F. & Coulson, A. F. W. in Parallel Computing '83 (eds 
Feilomcier, M., Jouben, G. & Scheudel, U.) 235-240 (North-Holland/Elsevier, Berlin, 
1986). 
Isobe, T. & Okuyama, T. Ear. J. Biocheni. 116,79-86(1981). 
IS. Fullmer, C. S. & Wasserman, K. H. L blot Chem. 236, 5669-5674 (1981). 
16. Van Eldrick, L 3., Zendegui, J. 0., Marshak, D. K. & Watterson, D. M. tnt Rev. CytoL 
77.1-61 (1982). 
NATURE VOL. 326 9 APRIL 1987 	 L.ETTERSTONATURE 
17. Gerke, V. & Weber. K. EMBO 1.4. 2917-2920 (198$). 
(8. Glenney. J. R. & Tick. B. F. Proc. ..at,i. Aca4 Sci U.S.A. 82, 7884-7888 (198$). 
*9. Calabrcua. B.. Battini. R., Kaczmarck, L. de Rid, J. K. & Baserga, R. 1. Not. Cluenv 261. 
12628-12632 (1986). 
Kretsinger, K. H. Ann N.Y. Acart ScL 356.14-19(1980). 
Case, M. Nature 322, 407 (1986). 
Silo, K. & Silo. F. J. din. Invest. 73, 1763-1771 (1984). 
Bemdge, M. J. & Irvine, R. F. Nature 312,315-321 (1984). 
Michell. K. H. & Houslay, M. Trends bioclieni. Sci II, 239-241 (1986). 
2$. Wikelam, M. J. 0., Murphy. G. J., Hruby. V.3. & Houslay, M. Nature 323, 68-71 (1986). 
Gaunt, S. P., Norton, I,.., Herbst, J. & Wood, C. J. din. Invest. 66, 253-258 (1981). 
Davis. P. B., Dieckman, L, Boat, T. F., Stern, K. C. & Doershuk, C. F. I. din Invest. 71, 
1787-1795 (1983). 
Talamo, R. C., Rosenstein, B. J. & Bernin8cr, K. W. in The Metabolic Basis of Inherited 
Disease (cdi Stinbuly, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. L & 
Brown. M. S.) 1889-1917 (McGraw-Hill, New York, 1983). 
Von Tacharner, V., Prod'bom. B., Baggiolini. M. & Reuter, H. Nature 324.369-372 (*986). 
39. Chirgwin, J. M., Przybyla, A. B., MacDonald. K. J. & Rutter, W. J. Biochemistry IS, 
5294-5299 (1979). 
Aviv, H. & Leder. P. Five. natn Acad. ScL U. S. A. 69.1408-1412 (1972). 
Gubler. U. & Hoffman, B. J. Gene 25, 263-269 (1983). 
Huynh, T. V., Young, K. A. & Davis, K. W. in DNA Cloning: A Practical Approach Vol I 
(ed. Gloves, D.) 49-79 (IRL Press, Oxford, 1985). 
Benton. W. & Davis, R. Science 196, 180-182 (1977). 
Maniao..... Fritsch. B. F. & Sambrook. J. Molecular Closing, A Laboratory Manual (Cold 
Spring Harbor Laboratory, New York, 1982). 
Sanger. F., Nicklen, S. & Coulson. A. R. Proc. soot. Aca4 Set U.S.A. 74, 3463-5467 (1977). 
Aden, D. P., Fogel, A., Damjanov, I., Plotkin, B. & Knowles, B. Nature 282. 615 (1979). 
Klein, B. ciot Cancer Res. 26, 1300-1310 (1968). 
Southern, B. M. 1. molec. Blot 98, 503-517 (197$). 
Van Heysingen V. trot Proc. win. AcoA Sd, U.S.A. 82, 8592-8596 (1985). 
4*. Andrews, P. W. et al. Ann. hunt. Genet. 49, 31-39 (1985). 
